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Characterization of the role of the pKM101-encoded T4SS outer membrane core
complex in substrate transfer, pilus biogenesis, and recipient cell contact
Jay Gordon, B.S.
Advisory Professor: Peter Christie, Ph.D.

The bacterial type IV secretion systems (T4SS) encoded on the Escherichia coli pKM101
and R388 conjugative plasmids and the Agrobacterium tumefaciens virB operon are composed of
12 subunits arranged in an architecturally similar fashion. Structural studies of the T4SS from
R388 (TrwR388) highlighted the presence of a distinct outer membrane core complex (OMCC)
and inner membrane complex (IMC) joined together by a central stalk. This thesis is focused on
the development of the pKM101 model system and the role of an OMCC cap region formed by
alpha helical antenna projections (AP) found in VirB10 and TraFpKM101. I introduced various
internal deletions, truncations, and substitutions between TraFpKM101 and VirB10 to study the role
of the AP cap in (i) substrate transfer to recipient plant or bacterial cells, (ii) pilus biogenesis and
donor-specific bacteriophage sensitivity, and (iii) recipient cell contact. My results demonstrate
that the C-terminal tails of VirB10 and TraFpKM101 are essential for DNA transfer and pilus
biogenesis, whereas the AP domains are only important for pilus biogenesis. Neither of these
domains is critical for recipient cell contact as monitored by sensitivity to Pseudomonas
aeruginosa containing a functional type VI secretion system. Finally, I demonstrated that the
IMC of pKM101 is able to functionally pair with the OMCCs from either VirB/VirD4, TrwR388,
or the Ptl T4SS of Bordetella pertussis restoring recipient cell contact and plasmid transfer.
These results highlight the common ancestry between these functionally distinct machines and
support a model where functionally independent IMCs and OMCCs have co-evolved to form the
T4SS in Gram-negative bacteria.
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Chapter 1: Introduction

2
Introduction to the Gram-negative bacterial type IV secretion system
Bacteria constantly adapt to their changing environment. Although they are able to sense
changes in their surroundings and adapt accordingly, many species acclimate to environmental
shifts by delivering DNA and protein substrates through a type IV secretion system (T4SS).
These substrates provide a selective advantage to the bacterium when environmental shifts are
not favorable for survival.

For example, DNA substrates often contain genes conferring

resistance to antibiotics and heavy metals. Acquisition of these traits in clinically-relevant
pathogens has lead to an increase in resistance to most commercially-available antibiotics.
Additionally, many pathogens contain altered T4SSs for delivery of important protein effectors
during the course of infection. Organisms that utilize T4SSs for delivery of protein substrates,
such as Helicobacter pylori, Legionella pneumophila, and Bordetella pertussis will be discussed
later in this chapter (1–4).
These T4SSs can be divided into three classes: (1) Conjugation channels involved in the
dissemination of DNA substrates to recipient prokaryotic cells (2) Protein translocation machines
that deliver protein effectors to target eukaryotic cells (3) Substrate uptake and release T4SSs
responsible for either taking up or releasing protein and DNA substrates into the extracellular
milieu (5). Each of these three classes of T4SSs will be described in greater detail in this
chapter.

Type IV secretion systems are one of many dedicated macromolecular translocation
systems in bacteria
The T4SSs are one of six characterized secretion systems in Gram-negative bacteria.
These secretion systems vary in terms of their overall architecture, subunit makeup, substrate
repertoire, and target cell range. Below, I will briefly discuss each of the secretion systems.
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The type I secretion systems (T1SSs) are found in pathogens, such as uropathogenic
Escherichia coli, which utilize them to secrete monomeric protein effectors, such as the poreforming toxin hemolysin A (6,7). T1SSs are architecturally the simplest of the dedicated
secretion pathways, consisting of three components: (i) An inner membrane complex (IMC)
formed by an ATP-binding cassette (ABC) transporter responsible for energizing the T1SS and
substrate recognition, (ii) a Membrane Fusion Protein (MFP) that forms the inner membrane
(IM) platform, and (iii) the TolC outer membrane factor (OMF) (6) (Figure 1.1). Substrates are
recognized by the T1SS via a C-terminal signal sequence. Upon docking of a substrate with the
ABC transporter/MFP complex, the entire inner membrane platform undergoes a conformational
change that results in recruitment of TolC to the complex (7).

In turn, ATP-mediated

conformational changes open a channel enabling passage of the substrate across the cell
envelope (Figure 1.2).
The type II secretion system (T2SS) is ancestrally related to the type IV pilus system
used by other Gram-negative bacteria for surface adhesion and movement. As with the T1SSs,
the T2SSs characteristically secrete toxins or other enzymes to the milieu (7). For example,
Vibrio cholerae uses a T2SS to secrete the multisubunit cholera toxin during infection (6). There
are four major components to the T2SS: (i) a cytoplasmic ATPase responsible for energizing the
machine, (ii) an IM platform, (iii) an outer membrane pore-forming secretin, and (iv) a
periplasmic pseudopilus (7,8). For secretion via this pathway, substrates are delivered to the
periplasm via the general secretory pathway (GSP) or the twin arginine translocation (TAT)
pathway. Substrates then fold and, in some cases, oligomerize. The folded substrates are then
recruited to the T2SS, where they are thought to localize at the tip of a pseudopilus. Through a
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Figure 1.1 Depiction of the type I through type VI secretion systems: Schematic
illustrating the compositional and structural differences in Gram-negative bacterial secretion
systems.

Depicted are examples of RND multiefflux pumps dedicated to pumping out

antimicrobial compounds, T1SS (uropathogenic Escherichia coli), T2SS (Vibrio cholerae),
T3SS (Salmonella species), T4SS (Agrobacterium tumefaciens), and T6SS (Pseudomonas
aeruginosa). This is Figure 1 in Costa TRD et al. Secretion systems in Gram-negative
bacteria: structural and mechanistic insights. Nat Rev Microbiol. 2015;13:343–59. This
figure was re-published with permission from Nature Publishing Groups. License number
4072830049272.
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Figure 1.2 Secretion of substrates through various bacterial secretion systems.
Illustration of the substrate pathways outside of the cell. a) In RND pumps and the
T1SS, substrates are recognized by the ABC transporter at the IM and shunted into the
periplasm where they are then translocated outside of the cell by the TolC OM protein.
b) Substrates of the T2SS are first moved into the periplasm either through the GSP or
TAT pathways. They are then recognized by the OM secretin which mobilizes them
into the extracellular mileu using force from the pseudopilus piston. c) T3SSs utilize a
needle and translocon protein to form a pore in the target cell membrane. Substrates are
then recognized by an N-terminal signal sequence followed by passage outside of the
cell. d) T4SS substrates are recognized by the VirD4 substrate receptor and are then
mobilized into the target cell in a contact-dependent manner (Discussed in more detail in
this introduction). e) T6SS effectors are loaded into the hollow Hcp tube located in the
cytoplasm. Upon activation, the TssB-TssC tail sheath will contract and move the tail
and substrates outside of the cell. The VgrG spike protein will then puncture the target
cell allowing for the effector and Hcp tube to enter. These illustrations are from Figure
3 in Costa TRD et al. Secretion systems in Gram-negative bacteria: structural and
mechanistic insights. Nat Rev Microbiol. 2015;13:343–59..

This figure was re-

published with permission from Nature Publishing Groups.
4072830049272.

License number
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piston-like extension and retraction mechanism, the pseudopilus is thought to push the substrate
through the secretin pore to the cell exterior (Figure 1.2).
Type III secretion systems (T3SSs) are used by pathogens such as Salmonella, Shigella,
and Yersinia species to inject effector proteins into eukaryotic cells. T3SSs can be divided into
three functional components: (i) a basal body forming the cell envelope-spanning region of the
complex, (ii) the hollow needle complex that allows for target cell contact and substrate passage,
and (iii) translocon proteins at the tip of the needle (7,9). Interestingly, most of the proteins
forming the basal structure are related to the proteins forming the base of the flagella system
involved in motility. During secretion, needle tip and translocon proteins make contact with
target cells and form a pore for substrate passage. Upon pore formation in the target cell,
effector proteins are recognized by a non-cleavable N-terminal signal sequence and shunted
through the T3SS into the target cell (Figure 1.2).
Type V secretion systems (T5SSs) are unique in that there is no membrane spanning
channel. These systems are also known as autotransporters, since the protein being secreted
mediates its own release (10). Autotransporters generally consist of a single polypeptide with
two domains: (i) a C-terminal pore-forming -barrel domain that inserts into the OM and (ii) an
N-terminal passenger domain. Autotransporters are delivered into the periplasm via the GSP.
Once in the periplasm, the autotransporter interacts with chaperones Skp or SurA, and the
resulting complex is delivered to the-barrel assembly machinery (BAM) at the OM. The BAM
complex catalyzes the folding and insertion of the C-terminal -barrel domain and also
coordinates the surface exposure of the passenger domain. Passenger domains are either retained
at the cell surface or released by proteolytic cleavage so that it is free to interact with target cells.
One example of a clinically-relevant autotransporter is the H. pylori vacuolating toxin A (VacA),
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which is involved in target cell pore formation (11,12).
Type VI secretion systems (T6SSs) are employed by Gram-negative bacteria to deliver
toxic effector proteins to prokaryotic and eukaryotic target cells (13). One such example of a
T6SS is the Pseudomonas aeruginosa H1-T6SS.

This T6SS is activated upon membrane

perturbance and delivers toxic effector proteins to neighboring prokaryotic cells. Utilization of
this T6SS for determining requirements within the T4SS for recipient cell contact will be
discussed later in this thesis.

The T6SS is composed of two primary components: (i) a

membrane spanning complex with components similar to the T4SS and (ii) a tubular structure
that delivers the effectors to the recipient cell (14). The tubular structure is ancestrally related to
contractile tails from bacteriophages. This tube can be further divided into three subcomponents:
(a) a hollow tube comprised of the Hcp proteins, (b) a sheath made of TssB-TssC heterodimers,
and (c) a VgrG spike protein (7). Once activated, the TssB-TssC sheath contracts in a similar
manner to a phage tail. This contraction forces the Hcp tail protein and toxic effectors through
the sheath to the cell surface and into target cells (Figure 1.2).
Of all the Gram-negative bacterial secretion systems, the T4SS is the most versatile. The
secretion systems described above have evolved to secrete only protein monomers or
heteromultimeric complexes. T4SSs are able to deliver both protein monomers (H. pylori CagA)
and heteromultimers (B. pertussis Ptx AB toxin) (4,15). Many are also able to deliver DNA
substrates to target cells. Agrobacterium tumefaciens and L. pneumophila utilize the VirB and
Dot/Icm T4SSs, respectively, to deliver DNA or protein effectors to eukaryotic cells as a natural
part of their infection processes. However, these systems also mobilize the transfer of the
promiscuous IncQ plasmid RSF1010 to recipient prokaryotic cells, highlighting the plasticity of
these systems with respect to substrate recognition (16,17). Because these effector translocation
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T4SSs are similar to their conjugative counterparts in subunit composition and operon structure,
and several of these machines translocate both DNA and protein substrates, conjugative T4SSs
likely evolved first as a means to exchange DNA among bacteria. Then, with the appearance of
eukaryotic cells, these machines were adapted for specialized functions such as establishing
commensal, symbiotic, or pathogenic relationships. Interestingly, all of the other dedicated
secretion systems target either prokaryotic or eukaryotic cells. By contrast, T4SSs can utilize the
same channel for substrate delivery into both types of cells. For example, A. tumefaciens utilizes
its VirB/VirD4 T4SS to deliver oncogenic T-DNA and effector proteins to plant cells and also to
mobilize the transfer of promiscuous IncQ plasmids to recipient bacterial cells (18–21). The
details of the A. tumefaciens VirB/VirD4 T4SS will be described in more detail below.

Classification of T4SSs
There are three classes of Gram-negative bacterial T4SSs. These are a) conjugation
systems b) effector translocation systems and c) substrate release and uptake systems (Figure
1.3). In this section, I will discuss each of the three classes in more detail.
Conjugative T4SSs: These are some of the better-studied T4SSs. They include proteins
responsible for the dissemination of virulence traits and antibiotic resistance genes in clinical
settings.

Indeed, rapid horizontal transfer of mobile elements encoding multiple antibiotic

resistance genes is threatening to jeopardize our ability to effectively treat many bacterial
infections.

These T4SSs are encoded on conjugative plasmids or integrative conjugative

elements (ICEs; formerly known as conjugative transposons).
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Figure 1.3 The role of bacterial type IV secretion systems. Schematic depicting the
three different types of type IV secretion systems: a) Conjugations systems used to
deliver plasmids from a donor cell to a recipient cell. b) DNA uptake and release sytems
used to exchange genetic information outside of the cell. c) Effector translocators used
to deliver protein substrates into target eukaryotic cells. This is Figure 1 from “The
versatile bacterial type IV secretion systems.” Nature Reviews Microbiology 1, 137-14;
November 2003. This figure was re-published with permission from Nature Publishing
Group. License # 4081060827678
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Conjugative T4SSs can be divided into two functional sets of proteins. First, there are
the mating pair formation (MPF) proteins, which assemble together to form the translocation
channel (22). The MPF can be further divided into two subassemblies: (1) The membrane
spanning complex and (2) the conjugative pilus at the cell surface. The second set of proteins is
called DNA transfer and replication (Dtr) factors. These proteins process the DNA and localize
it at the entrance of the MPF channel (23). The Dtr system consists of: (1) the conjugative
relaxase that catalyzes a DNA nicking reaction required for transfer, (2) accessory factors that
aid the relaxase in substrate processing and MPF localization, and (3) the substrate receptor,
termed the type IV coupling protein (T4CP), which recognizes signals within the relaxase and
accessory factors and delivers the substrate to the MPF channel.
Protein Translocation T4SSs: Many pathogens utilize the T4SS in order to translocate
toxic effector proteins to target eukaryotic cells. There has been much effort spent trying to
understand the role that these effectors play in the infection process. Developing new drugs to
inhibit effector translocation and activity and vaccines against surface-localized T4SS proteins
are important strategies in fighting these infections.
While conjugative T4SSs deliver both DNA and proteins related to DNA metabolism,
protein translocation T4SSs only deliver protein substrates to their target cell (24). However,
these machines are capable of translocating a wide variety of protein substrates. Although some
translocation channels only have one recognized substrate, others can recognize and deliver
hundreds of protein substrates. H. pylori utilizes the Cag T4SS to infect gastric epithelial cells.
This system only recognizes and delivers one substrate, CagA, which is critical for H. pylori
infection (15,25). However, the Dot/Icm T4SS from L. pneumophila delivers hundreds of
protein effectors during the course of infection. Some of these important effectors include DotA
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(prevents formation of phagolysosome) and RalF (promotes formation of a Legionellacontaining vacuole using membranes from the endoplasmic reticulum) (26–28). The effect that
these effectors have in target cells is an area of intense research to develop new strategies aimed
at prevention and treatment of Legionnaire’s Disease.
In addition to extracellular pathogens, many obligate intracellular organisms use a T4SS
to deliver effectors to their hosts.

These include Anaplasma phagocytophilum (human

granulocytic anaplasmosis) and Rickettsia rickettsii (Rocky Mountain spotted fever) (29–31).
Due to their inability to grow outside of a host cell, these pathogens have been difficult to study
and genetically manipulate. Our lab has recently developed an assay system utilizing chimeric
T4CPs to identify effector proteins (29). This assay will be discussed later in this chapter.
Substrate uptake and release T4SS: Although conjugative and protein translocation
T4SSs require recipient-cell contact prior to substrate delivery, there are examples that secrete
substrates outside of the cell in the absence of target cell interaction. One well-studied pathogen
that utilizes this class of T4SS is B. pertussis. B. pertussis assembles the Ptl T4SS that is
responsible for secretion of multimeric pertussis toxin. This channel does not contain a T4CP.
Instead, individual toxin subunits are delivered into the periplasm through the GSP. Once in the
periplasm, all the toxin subunits fold and assemble and then interact with the T4SS prior to
extracellular release (32–36). Because there is no need for recipient contact, these cells lack
detectable pili on the cell surface.
This class is also able to mediate the extracellular release of DNA.

Neisseria

gonorrhoeae contains a T4SS encoded on a large 57-kb gonococcal genetic island located on the
chromosome. This machine is responsible for DNA release outside of the cell, which can serve

15
as a source of DNA for uptake by other N. gonorrhoeae cells though a process of natural
transformation (37,38).
The H. pylori ComB T4SS is a unique example of a T4SS involved in DNA uptake. This
system contains all of the homologs of the Agrobacterium tumefaciens VirB T4SS except VirB1
and VirB5 (15). This T4SS, however, is not essential for virulence as demonstrated during gerbil
infection experiments.
The initial T4SS classification rubric assigned machines as F-like, P-like, or I-like based
on their subunit similarity to T4SSs encoded by the F, RP4, or R64 plasmids, respectively.
However, these systems can alternatively be broadly classified as type IVA or type IVB systems
(T4SSA and T4SSB). T4SSA machines are similar to the A. tumefaciens VirB/VirD4 system
and those encoded by the pKM101, R388, RP4 and F plasmids (P- and F-like systems). Studies
of L. phenumophila identified genes on its chromosome that had similarities to those of the T4SS
encoded on the IncI R64 plasmid (2,3). Although these loci encode a few proteins distantly
related to subunits of the T4SSA systems, differences in genetic composition, gene order, and
relatedness of homologs suggest a distinct phylogenetic origin. Consequently, these T4SSs were
classified as T4SSB.
I will utilize the functional classification system for the remainder of this thesis, as the
diversity in the T4SSs mentioned in my results section are best highlighted by their functional
differences.

Conjugation systems
As mentioned above, the conjugation systems represent a major T4SS subfamily.
Conjugative plasmids encode the necessary processing factors and T4SS channel for delivery of
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DNA substrates to target cells. Conjugative transfer can be divided into three steps: (i) substrate
processing, (ii) substrate docking with the substrate receptor, also known as the type IV coupling
protein (T4CP), and (iii) substrate transfer through the mating channel (Figure 1.4). Below, I
will discuss each of these steps.
Substrate Processing: For this section, I will describe the events prior to DNA
translocation through the A. tumefaciens VirB system. Preparation of the T-DNA substrates
begins with the formation of the nucleoprotein complex termed the relaxosome. This complex
consists of VirC1, VirC2, and VirD1. VirC1 is a member of the ParA family of proteins
containing a canonical Walker A and B box (39). Members of the ParA family are localized to
the cell pole and are responsible for plasmid segregation after DNA replication (40). VirC1 is a
critical factor during the initiation steps of T-DNA transfer. VirC1, with the help of the VirC2
accessory protein, binds to a sequence adjacent to the right T-DNA border termed overdrive
(41,42). Binding to this site results in the melting of the double-stranded DNA and recruitment
of the VirD2 relaxase (Figure 1.4). VirD2 relaxase cleaves the T-DNA borders to initiate
transfer of the T-DNA substrate through the T4SS. VirC1 recruits the relaxosome to the cell
pole where the T4SS is located to begin transfer of T-DNA into the target plant cell.
Substrate recognition: The relaxosome possesses the signals for recognition by the
substrate receptor or T4CP. In the A. tumefaciens VirB/VirD4 system, the VirD2 relaxase
contains a cluster of positively charged residues at its C-terminus that mediate docking with the
VirD4 receptor (43). Other internal signals and accessory factors, such as VirD1, VirC1, and
VirC2, also contribute to docking of the relaxosome with VirD4 (39) (Figure 1.4).
Most Dtr proteins carry signals for docking only with a cognate T4CP/T4SS. Some Dtr
proteins, however, appear to carry distinct types of signals enabling relaxosome docking and

17

Figure 1.4 Conjugative Transfer of DNA to recipient cells. Key events during
conjugation. (1) The relaxase and other accessory factors gather at the oriT on the
plasmid. (2) The relaxase catalytically nicks the plasmid at the nic site. The
conserved active site Tyr residue covalently binds to the free 5’ end of the nicked
DNA. (3) Utilizing the relaxase translocation signal, the relaxosome docks at MPF
with the T4CP. (4) Upon an unidentified signal, the relaxosome is shunted through
the channel into the MPF.

(5a) The free 3’ end of the nicked strand of the

conjugative plasmid primes second strand synthesis in order to re-create the doublestranded plasmid. (5b) The relaxosome inside the recipient cell will prime synthesis
of a new DNA strand, leading to a new copy of the plasmid in the recipient cell.
This is Figure 1 in Zechner EL et al. Assembly and mechanisms of bacterial type IV
secretion machines. Philos Trans R Soc Lond B Biol Sci. 2012 367:1073–87. This
article is an open-access article under the terms of The Creative Commons
Attribution License.
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subsequent transfer through many different T4SS channels.

One prominent example of a

promiscuous Dtr protein is the MobA relaxase encoded on plasmid RSF1010 (44). MobA, along
with accessory proteins MobB and MobC, is able to mediate the transfer of RSF1010 through
numerous T4SSs, including VirBAt, TrapKM101, TrwR388, and TrbRP4 (16,21,45–48). MobA contains
a cluster of positively-charged residues at its C-terminus similar to VirD2, which are important
for mobilization through the VirBAt T4SS. However, MobA also contains additional signals
within its N- and C-terminal regions, distinct from the positively-charged cluster that are
important for mobilization through the RP4 plasmid-encoded T4SS (44). This combination of
various signal domains throughout MobA likely contributes to its ability to recognize a multitude
of T4CPs. MobB is a membrane protein that is predicted to act as a chaperone by coupling
MobA to the T4CP (44). It is still unclear which regions of the T4CP are responsible for
recognition of MobA.
Translocation through the mating channel: Upon engagement of the DNA substrate
with the T4CP receptor, the substrate is delivered to other subunits of the T4SS for further
processing and ultimately for transfer through the T4SS. As the transferred strand of DNA (Tstrand) is unwound from its template and delivered through the T4SS, second-strand synthesis
reconstitutes the mobile element in the donor cell. Similarly, when the T-strand is delivered to
the recipient cell, it first re-circularizes and then undergoes second-strand synthesis for
generation of a double-stranded, circular element which either replicates autonomously or inserts
into the chromosome (Figure 1.4) (22). The transferred mobile element can reiteratively
assemble a T4SS for further propagation to plasmid-free recipient cells.
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T4SSs in Agrobacterium tumefaciens
The paradigm T4SS from Agrobacterium tumefaciens consists of 11 VirB proteins and a
VirD4 T4CP, which is utilized to deliver oncogenic T-DNA into plant cells (5). This pathogen
causes devastation of many agriculturally important crop species. Virulent strains of A.
tumefaciens contain a large 194-kb plasmid termed the tumor-inducing plasmid (Ti plasmid)
(49). Infection by the VirB/VirD4 system also requires protein effectors (VirE2, VirE3, and
VirF), Dtr factors (VirC1, VirC2, VirD1, and VirD2), and a two-component regulatory system
(VirA and VirG; See below) (39,43,50–57). Another Ti-encoded T4SS is the Trb machine,
which is responsible for conjugative transfer of the Ti plasmid to A. tumefaciens recipient cells.
This operon is similar in gene composition to the trb locus carried on the E. coli conjugative
plasmid RP4, indicative of a common ancestry (58).
The VirB and Trb T4SSs are composed of similar sets of T4SS subunits and they are
both able to transfer the promiscuous plasmid RSF1010 to A. tumefaciens recipient cells (49).
However, there are notable differences between these two systems. The Trb T4SS does not
contain a VirB8 homolog, which is important in the VirB system for T4SS localization, T-DNA
transfer, and pilus biogenesis (59–67). Additionally, the VirB6 homolog in the Trb system,
TrbL, has an extended soluble region at its C-terminus. TrbL is, therefore, part of the “extended
VirB6” family (5). Similar proteins, such as TraG from F-plasmid, are important for mating pair
stabilization and entry exclusion (discussed later) (68).
Once integrated into the plant cell genome, T-DNA gene products synthesize opines,
which are small molecules that serve as important nitrogen and energy sources for the A.
tumefaciens cells (49). Ti plasmids are often categorized based on the opine biosynthetic genes
encoded on the T-DNA. Two of the primary Ti plasmids studied are the octopine pTiA6 and
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nopaline pTiC58 plasmids.

Although these plasmids contain similar VirB T4SSs, there is

sequence variation between the different subunits. The Christie lab has utilized the pTiA6
plasmid for its studies.
Both VirB and Trb proteins are absent under non-inducing conditions. Upon wounding,
plant cells release phenolic compounds, which are sensed by the membrane-bound VirA sensor
kinase (69–71). VirA will autophosphorylate at a critical histidine residue followed by
transferring of the phosphate group to an important aspartate residue on the cytoplasmic response
regulator, VirG. Phosphorylated VirG will, in turn, activate transcription of genes in the vir
regulon (Figure 1.5) (69). This initiates T-DNA processing and assembly of the VirB/VirD4
T4SS culminating in transfer of the oncogenic DNA substrate into plant cells. The VirB/T4SS
system also translocates effector proteins, such as the VirE2 single-stranded DNA binding
protein, to plant cells. Upon transfer, VirE2 binds the single-stranded T-DNA to protect it from
host cell nucleases and transfers it to the plant cell nucleus (51). In the nucleus, the T-DNA
integrates into the genome and T-DNA-associated genes are expressed. Once synthesized in the
plant cell, opines are released from the cell where they can then be imported by A. tumefaciens
(Figure 1.5).
Opines are not only useful as a nutrient source, but they can also serve as signaling
molecules. The presence of high levels of opines induces the expression of Ti plasmid-encoded
traR (Figure 1.5) (49,72). The product, TraR, is a transcriptional regulator that is activated in the
presence of high concentrations of acylhomoserine-lactones (AHL). AHL is produced by Tiencoded TraI and is secreted outside of the cell (Figure 1.5). When cell density is high, the
concentration of AHL outside of the cell will increase as well. After reaching a threshold
concentration, AHL will re-enter the cell and interact with TraR. This AHL-TraR interaction
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Figure 1.5 Plant cell infection by Agrobacterium tumefaciens. An overview of the
A. tumefaciens plant infection process is shown. Once a wounded plant secretes
phenolic compounds, these are sensed by the VirA/VirG two-component signaling
system (1). The VirG response regulator then actives expression of the virB operon
(2). These proteins form the VirB T4SS, which will transmit T-DNA into target plant
cells (3). Once T-DNA is in the plant nucleus, it leads to synthesis of opines, which
are then secreted and taken up by the A. tumefaciens cells (4). Sensing of opines leads
to opine metabolism and expression of traR. TraR is a transcriptional regulator that
senses the presence of AHL. TraI is responsible for production of AHL, which is
secreted outside of the cell (5).

Once cell density rises and the extracellular

concentration of AHL reaches a threshold, it re-enters the cell where it is detected by
TraR (6). TraR then activates Ti plasmid replication and expression of the trb operon
(7). The Trb T4SS then allows for the Ti plasmid to be mobilized into other A.
tumefaciens cells.
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will lead to activation of the tra/trb operon resulting in increased conjugative transfer
frequencies of the Ti plasmid (Figure 1.5). Therefore, while the VirB/VirD4 and Trb T4SSs may
serve different functions, their activation is tied to an abundant food source released by plant
cells and high cell density.

T4SS subunit composition and function.
The A. tumefaciens VirB/VirD4Ti system can be considered an archetypal T4SS. It
contains homologs found in most other T4SSs. For the rest of this chapter, the VirB/VirD4
nomenclature will be used to describe the various subunits. The VirB/VirD4 system can be
divided into different subsets of proteins: (i) The IM ATPases (VirD4 T4CP, VirB11, VirB4),
(ii) the inner membrane complex (VirB3, VirB6, and VirB8), (iii) the outer membrane “core
complex” (OMCC) (VirB7, VirB9, and VirB10), (iv) and a conjugative pilus (VirB2 and VirB5)
(Figure 1.6) (73).

Additionally, most Gram-negative bacterial T4SSs encode a cell wall

hydrolase responsible for making localized degradations in the cell wall. Each of these subunits
will be discussed in greater detail later in this chapter.
An important goal in the Christie lab has been to localize the T4SS within live cells and
determine the genetic and biochemical requirements for its spatial positioning. Previous work
involving fluorescent tagging of Vir subunits in A. tumefaciens has identified the cell pole as the
primary point for machine assembly. GFP-tagged VirC1 was observed bringing the relaxosome
to the cell pole (39). Additionally, our lab has observed polar localization during split-GFP
fluorescence assays (50). Briefly, VirE2 was tagged with the N-terminal half of GFP (residues
1-157) while VirD4 was tagged with its C-terminal half (residues 158-238). Although neither of
these two proteins is individually fluorescent, they form bright foci when produced in the same
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Figure 1.6 Localization of the T4SS subunits relative to the Gram-negative bacterial cell envelope.
Arrangement of the different T4SS components including the IM ATPases (VirD4, VirB4, and VirB11), the
IM proteins (VirB3, VirB6, and VirB8), the core complex (VirB7, VirB9, and VirB10), and a conjugative
pilus (VirB2 and VirB5).
The structure of TrwB is Figure 2C from Gomis-Rüth FX et al. The bacterial conjugation protein
TrwB resembles ring helicases and F1-ATPase. Nature 2001 409:637–41. This image was re-published with
permission from Nature Publishing Group. License Number 4078401439237. The image of VirB4-like
TrwK was derived from Figure 2C in Peña A et al. The hexameric structure of a conjugative VirB4 protein
ATPase provides new insights for a functional and phylogenetic relationship with DNA translocases. J Biol
Chem. 2012 287:39925–32. The American Society for Biochemistry and Molecular Biology does not
require prior permission for re-publication of figures.

The structure of the VirB11-like HP0525 was

published as Figure 3C in Yeo HJ et al. Crystal structure of the hexameric traffic ATPase of the Helicobacter
pylori type IV secretion system Mol Cell. 2000 6:1461–72. This image was re-published with permission
from Elsevier. License Number 4078430588294. The structure of Brucella suis VirB8 was published in
Terradot L, et al. Structures of two core subunits of the bacterial type IV secretion system, VirB8 from
Brucella suis and ComB10 from Helicobacter pylori. Proc Natl Acad Sci U S A. 2005 102:4596–601.
pKM101-encoded TraC was published in Yeo HJ, et al. Structural and functional characterization of the
VirB5 protein from the type IV secretion system encoded by the conjugative plasmid pKM101. Proc Natl
Acad Sci U S A. 2003 100:15947–52. No prior permission is required for reproduction of VirB8 or TraC.
The structure of the F-pilus generated by electron microscopy was published as Figure 2A in Costa TRD, et
al. Structure of the bacterial sex F pilus reveals an assembly of a stoichiometric protein-phospholipid
complex. Cell 2016 166:1436–1444.e10. No prior permission from Elsevier is required for reproduction of
this figure. The pKM101 core complex is figure 2A in Fronzes R, et al. Structure of a Type IV Secretion
System Core Complex Science 2009 323:266–8. This figure was re-published with permission from The
American Association for the Advancement of Science. License # 4113830881899.
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cell, indicating that VirE2 interacts with VirD4 as full length GFP is reconstituted. As the green
foci were localized to the cell pole, these data further validate previous observations with regards
to machine assembly. Once the T4SS is localized within the cell, the requirements for
localization can be uncovered using various deletion mutants and the structure of the channel in
intact cells can be resolved using high-resolution electron microscopy.
Another major breakthrough in our lab’s studies of the VirB/VirD4 T4SS was the
definition of T-DNA translocation pathway. Eric Cascales, a former postdoctoral researcher in
the Christie lab, developed the Transfer DNA Immunoprecipitation (TrIP) Assay to specify the
route of T-DNA (74). In this assay, A. tumefaciens cells were incubated in the presence of
inducing phenolic compounds followed by treatment with formaldehyde to crosslink T-DNA to
the channel components. After membrane isolation and solubilization, VirB proteins were
immunoprecipitated and tested for associated T-DNA.
As predicted based on previous findings, T-DNA first makes contact with the VirD4
substrate receptor. The T-DNA is then shunted to the VirB11 ATPase followed by the VirB6
and VirB8 IM proteins. Finally, T-DNA is translocated to the OM with assistance from the OMassociated VirB9 subunit and the VirB2 pilus protein (Figure 1.7). One striking observation was
the ability to uncouple proteins in the IM from those in the OM. Deletion of genes such as
virB2, virB9, and virB10 still allowed for stable DNA contacts with the IM ATPases and the
VirB6 and VirB8 IM proteins, but abolished any contacts with OM proteins.

These data

supported a “Two-Subassembly” model for the T4SS, in which IM proteins function to deliver
substrates across the IM independently of the OMCC. This model was further supported by the
structure of the TrwR388 VirB3-VirB10 structure, which shows a clear demarcation between IM
and OM proteins (Figure 1.8).
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Figure 1.7 Pathway of T-DNA through the A. tumefaciens VirB/VirD4 T4SS. The pathway
of T-DNA through the T4SS is shown with a red arrow. T-DNA has been demonstrated to
interact with VirD4 and VirB11 in the cytoplasm, VirB6 and VirB8 at the inner membrane, and
VirB2 and VirB9 at the outer membrane.

The structure of TrwB is Figure 2C from Gomis-Rüth FX et al. The bacterial conjugation
protein TrwB resembles ring helicases and F1-ATPase. Nature 2001 409:637–41. This image
was re-published with permission from Nature Publishing Group. License Number
4078401439237. The structure of the VirB11-like HP0525 was published as Figure 3C in Yeo
HJ et al. Crystal structure of the hexameric traffic ATPase of the Helicobacter pylori type IV
secretion system Mol Cell. 2000 6:1461–72. This image was re-published with permission from
Elsevier. License Number 4078430588294. This image was re-published with permission from
Elsevier. License Number 4078430588294. The structure of Brucella suis VirB8 was published
in Terradot L, et al. Structures of two core subunits of the bacterial type IV secretion system,
VirB8 from Brucella suis and ComB10 from Helicobacter pylori. Proc Natl Acad Sci U S A.
2005 102:4596–601. No prior permission is required for reproduction of VirB8.

The pKM101

core complex structure is Figure 4 from Fronzes R, et al. The structural biology of type IV
secretion systems. Nat Rev Microbiol. 2009 7:703–14.

This image was re-published with

permission from Nature Publishing Group. License # 4092681298982.
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Figure 1.8 Structure of the TrwR388 type IV secretion system along with localization of
subunits. (A) Structure of the TrwR388 TrwM/VirB3-TrwE/VirB10 structure generated by the
Waksman laboratory. (B) Localization of a subset of subunits including VirB4 (blue; structure of
VirB4 from plasmid R388), VirB8 (structure of VirB8 periplasmic domain from Brucella suis),
and the VirB7-VirB9-VirB10 outer membrane complex (yellow, blue, and red; structure of the
TraN-TraO-TraF outer membrane complex from pKM101).

The image of VirB4-like TrwK was derived from Figure 2C in Peña A et al. The hexameric
structure of a conjugative VirB4 protein ATPase provides new insights for a functional and
phylogenetic relationship with DNA translocases. J Biol Chem. 2012 287:39925–32.

The

American Society for Biochemistry and Molecular Biology does not require prior permission for
re-publication of figures. The structure of Brucella suis VirB8 was published in Terradot L, et al.
Structures of two core subunits of the bacterial type IV secretion system, VirB8 from Brucella suis
and ComB10 from Helicobacter pylori. Proc Natl Acad Sci U S A. 2005 102:4596–601.
pKM101-encoded TraC was published in Yeo HJ, et al. Structural and functional characterization
of the VirB5 protein from the type IV secretion system encoded by the conjugative plasmid
pKM101. Proc Natl Acad Sci U S A. 2003 100:15947–52. No prior permission is required for
reproduction of VirB8 or TraC.

The structure of the TraN-TraO-TraF heteromultimer was

generated using pymol (http://pymol.org) based on the 3ZBI file deposited into the NCBI protein
database. The structure of the R388 core complex is Figure 2A from Low H, et al. Structure of a
type IV secretion system Nature 2014 508:550–3. This figure was re-published with permission
from Nature Publishing Group. License #4113871389804.
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The pKM101 plasmid
pKM101 has historical significance for its use in the Ames test (75) for detection of
mutagens. One of the hallmark features of the pKM101 plasmid is the presence of two genes,
mucA and mucB, which are under the control of a LexA repressor (Figure 1.9) (76). The proteins
encoded by these genes, MucA and MucB, form an error-prone DNA polymerase which, similar
to the DNA polymerase involved in the SOS response, incorporates many mutations into the
bacterial chromosome and can even synthesize DNA across double-stranded breaks (77–81).
Besides antibiotic resistance, this plasmid provides the cell with a greater ability to survive
exposure to UV light and other mutagenic compounds. For this reason, Salmonella containing
pKM101 was chosen as the strain for use in the Ames test (75).
Recently, structural studies described an overall architecture for the distal portion of
pKM101-encoded T4SS (82,83). Importantly, this T4SS is highly related to other systems, such
as the VirB/VirD4Ti and TrwR388 T4SSs (82–85). The respective tra/virB/trw gene clusters are
similar in size and are composed of genes encoding functional homologs.

Although the

sequence identities among homologs of these systems range from 20% to 40%, there have been
demonstrated instances of cross-complementation between them. For example, pKM101 deleted
of its region encoding the Dtr proteins (TraK, TraJ, and TraI) is complemented by the
corresponding proteins from R388 (TrwA, TrwB, and TrwC) (86). The TrwB substrate receptor,
therefore interacts productively not only with the R388 relaxosome, but also with the pKM101encoded channel. Furthermore, the TraCpKM101 pilin subunit partially restores pilus biogenesis
when produced in an A. tumefaciens ∆virB5 mutant (87). Additionally, complementation of a
∆virB6 mutant with traD leads to release of VirB2 and VirB5 to the extracellular environment
(88). Finally, expression of TraLpKM101 partially complements a ∆virB1 mutation in
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Figure 1.9 The pKM101 plasmid. A linear layout of the pKM101 plasmid depicting the
regions of interest on the plasmid.

The tra operon is shown associated with the

conjugation-encoding region of the plasmid. Additionally, the genes encoding MucA and
MucB are depicted in the region associated with DNA damage repair. Other regions of
interest include the origin of replication (oriV) and beta-lactamase (bla).
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A. tumefaciens (89). These results highlight a common ancestry between these three systems,
which will be explored in further detail throughout this thesis.
The Waksman lab has solved structures of both the TrapKM101 and TrwR388 OMCCs
(82,85,90). Both subassemblies are composed of 14 copies of homologs of the A. tumefaciens
VirB7, VirB9, and VirB10 subunits arranged as a 1 MDa tetradecameric structure.

Both

OMCCs are similar in their overall size of 180Å in width and height. The Waksman lab also
solved a larger TrwR388 substructure composed of the OMCC joined to the IMC. The IMC is a
2.5 MDa structure that contains leg-like structures consisting of two hexamers of VirB4
homologs. These hexamers are attached to an IM platform composed of 12 copies each of
homologs of VirB3, VirB5, and VirB8 and 24 copies of a VirB6 homolog. This IMC is
connected to the OMCC by a thin central stalk. The IMC and OMCC are two distinct complexes
(Figure 1.8). Along with the data from the TrIP assay in A. tumefaciens, these findings suggest
the possibility that the T4SS is composed of two functionally independent subassemblies.

Contributions of T4SS subunits to channel assembly and functionality
Although subunit composition across Gram-negative bacterial T4SSs can vary, many
resemble that of the type IVA system from A. tumefaciens. Below, I will discuss each of the
subunits in detail. I will use the VirB/VirD4 nomenclature for each of the subunits unless
otherwise specified.
VirD4: VirD4 serves two important roles during secretion: (i) Substrate recognition and
delivery to the MPF and (ii) IM ATPase activity. This family of proteins can be divided into
three domains: an N-terminal transmembrane domain, a nucleotide binding domain (NBD), and
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an all-alpha domain (AAD). The crystal structure of the TrwBR388 soluble domain (SD; NBD and
AAD) depicts a ball-structure 110Å in diameter and 90Å in height with a 20Å central channel
(91). Together with the TM domain, the structure of VirD4 contains a “ball and stem” structure
similar to the F1F0 ATPases. These proteins are also structurally related to the FtsK and SpoIIIE
double-stranded DNA pumps found in E. coli and Bacillus species respectively, leading to a
proposed model of VirD4 pumping DNA through its central channel (92–94) .
The VirD4 N-terminal domain is located in the first 87 residues and is important for
anchoring the SD into the membrane. The Llosa laboratory demonstrated that the TM domain of
TrwBR388 was necessary for associations with the rest of the channel, particularly with the
VirB10 homolog, TrwE (95). While deletion of the TM domain would abolish transfer in most
T4SSs, there are unique T4CPs that contain separate TM domains. One notable example is
Orf10 from the Streptococcus agalactiae pIP501 conjugative plasmid (5,96). A small open
reading frame (ORF) upstream of orf10 encodes a protein with transmembrane helices.
Introduction of a frameshift mutation near the end of this small ORF restored an architecture
similar to VirD4, indicating that these peculiar T4CPs arose from previous frameshift mutations.
Interestingly, some SDs can still retain attenuated functionality when the TM is deleted. The
TcpA T4CP from the Clostridium perfringens pCW3 plasmid is still able to transfer DNA in the
absence of a TM domain (5). These results suggest that the SD is able to associate with the
T4SS, likely using contacts with IMC subunits.
The NBD contains a canonical Walker A box (GxxxxGK(T/S)). It is the region most
similar to the FtsK and SpoIIIE DNA pumps. The AAD consists of seven alpha helices and
bears structural resemblance to the XerD recombinase (5). The Christie lab has demonstrated
that SD is primarily involved in substrate recruitment and recognition. When the SD of VirD4
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was fused to the DivIVA polar localization protein, VirE2 was then localized at the cell poles
(50). Recent work in our lab, however, has focused on substrate recognition. Neal Whitaker and
Trista Berry, both former members of the Christie lab, made chimeric T4CPs containing the Nterminal TM domain of TraJpKM101 and the SD from other VirD4s, including those from A.
tumefaciens, A. phagocytophilum, and Wolbachia pipientis. These chimeric T4CPs lost their
ability to transfer pKM101, but were able to transfer heterologous protein substrates from their
respective T4SSs (29). These results highlighted a common ancestry between T4CPs from both
conjugative and effector T4SSs as well as the conservation of functionality for all of the different
SDs. However, the exact mechanism of substrate recognition by the T4CP remains unclear.
Previous work from our lab using the VirB/VirD4Ti and Prg/PcfpCF10 systems suggests that the
AAD at the base of the SD is responsible for substrate recognition (97). Dr. Yang “Grace” Li, a
current member of the Christie lab, is currently using unnatural amino acid photocrosslinking, a
technology that will be discussed later in this thesis, to identify amino acids in TraJpKM101 which
are responsible for recognition of the TraIpKM101 relaxase.
VirB4: VirB4 is a universally important IM ATPase among T4SSs in both Gramnegative and Gram-positive bacteria. It is a large protein >80kDa in size and contains both a
Walker A and Walker B box for ATPase activity. The Walker A domain has been demonstrated
to be important for substrate transfer in the VirB/VirD4Ti and Trw388 T4SSs (98–101). Despite
being important for transfer, the TrIP assay did not detect an interaction between T-DNA and
VirB4. However, some evidence suggests that there may be an interaction despite these previous
results. The structure of VirB4 C-terminal domain from Thermoanearobacter pseudethanolicus
was solved by X-ray crystallography and appeared structurally similar to TrwBR388 (91,102).
Additionally, the VirB4 homolog in the Enterococcus faecalis Prg/Pcf T4SS, PrgJ, was bound to
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substrates as this system does not contain a VirB11 protein (103). This is likely the case in other
Gram-negative bacterial T4SSs, such as the F-plasmid, that also do not contain a VirB11
homolog.
The VirB4 subunit has also been implicated as an important player in pilus biogenesis.
Studies by the Christie lab highlighted conformational changes in VirB2 pilin subunits induced
by VirB4 using the substituted cysteine accessibility method (SCAM) (104). SCAM was also
used to demonstrate that VirB4 mediates pilin subunit dislodging from the IM as Cys residues
located in the cytoplasm were labeled in the presence of VirB4 indicating movement of the pilin
subunit into the periplasm. It is not known at this time if pilin subunits come into direct contact
with VirB4.

Using unnatural amino acid photocrosslinking, future studies will address a

potential VirB4-VirB2 interaction as well as the genetic requirements for this interaction.
VirB11: The VirB11 family of ATPases form a double-ringed hexamer with the Nterminal ring associated with the inside leaflet of the IM and the C-terminal ring forming a tight
constriction in the cytoplasm (105). VirB11 contains Walker A and B boxes in its N-terminal
ring which is used to power the channel. The TrIP assay demonstrated close contacts between TDNA and VirB11 during substrate transfer with deletions of virB11 blocking movement to the
IMC (74). Because substrates going through the T4SS are unfolded prior to translocation,
VirB11 is predicted to be the “unfoldase” preparing protein substrates for movement into the
channel. This prediction is also supported by work from the Galan laboratory in which they
demonstrated that InvC, a VirB11-like protein, unfolded substrates prior to translocation through
a Salmonella T3SS (106). In addition to directly interacting with substrates, VirB11 is also an
important ATPase for powering translocation across the OM. VirB11 ATPase activity, along
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with that of VirD4, is important for switching VirB10 into an active conformation (107). It is
likely that VirB10 acts as an energy transducer and activates proteins in the OM. (see below)
Additional work in our lab highlighted the importance of VirB11-mediated conformational
changes in VirB2 using SCAM (104). These results have lead to a model suggesting VirB11
acts as a “Traffic ATPase”. VirB11 will associate with VirB4 in order to aid in pilin subunit
release from the IM during pilus biogenesis and will then associate with VirD4 and VirB10
during substrate transfer ( 106).
VirB3: VirB3 is a small peptide containing two TM domains placing the N and C termini
in the cytoplasm. VirB3 is not very well characterized, but its importance in T-DNA transfer and
pilus biogenesis has been well demonstrated. Interestingly, the placement of the virB3 gene
directly upstream of the virB4 is seen in other operons encoding T4SSs (5). VirB4 has been
shown to be critical for VirB3 stability in A. tumefaciens and this might be the case in other
systems. In addition to VirB4, VirB3 also requires VirB2, VirB7, and VirB8 for stability (109).
However, how these proteins maintain proper levels of VirB3 is still unknown.
VirB6: VirB6 is a polytopic IM protein which comprises an integral part of the IMC
(5,110). VirB6 is part of the translocation route for T-DNA across the IM as it makes close
contact with the substrate (110). The VirB6 protein family can be divided into two categories:
(i) Non-extended VirB6 and (ii) extended VirB6. VirB6Ti and TraDpKM101 are examples of nonextended VirB6 proteins as they only contain TM helices along with short cytoplasmic and
periplasmic tails. VirB6 proteins classified as ‘extended-VirB6’s’, by contrast, contain large,
soluble domains at their C-terminal ends. This domain in TraGF was shown to interact with
entry exclusion (Eex) proteins in the IM of the target cell (68). Thus, the soluble C-terminal
extension could either stretch into the target cell or a C-terminal fragment derived by protease
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cleavage could be delivered into the target cell to exert its inhibitory function in donor-donor cell
contacts.
VirB8: VirB8 is a bitopic protein found in most Gram-negative T4SSs. It contains a
short cytoplasmic N-terminal tail, a TM domain, and a large periplasmic domain consisting of
extended beta sheets and five alpha helices. This arrangement has been observed with the
structures of VirB8 homologs including VirB8B.

suis,

TcpCpCW3, VirB8B. henselae, and TraEpKM101

(111–114). VirB8 is important for T-DNA transfer as it makes contacts with T-DNA going
across the IM and it has been demonstrated to make contact with VirB5 during pilus biogenesis
in A. tumefaciens. Additionally, VirB8 has been postulated to act as a nucleation factor. The
Das laboratory demonstrated tight clustering of VirB9 and VirB10 only in the presence of VirB8
(61). However, the extent of this role is not resolved as VirB6 and VirD4 also display similar
localization patterns as VirB8 in the absence of a T4SS (115,116).
VirB7: VirB7 was shown to be an OM lipoprotein which is responsible for anchoring the
core complex into the OM (117,118). VirB7 is anchored on the periplasmic side of the OM
where it makes contact with and stabilizes the VirB9 subunit . The VirB7-VirB9 heterodimer
also stabilizes VirB10 and other components of the IMC (119).

VirB7 forms a disulfide

crosslink with VirB9 and fits along groove-like structures at the outer face of VirB9 (118,120–
122). VirB7 was also shown to be critical for movement of T-DNA substrates between VirD4
and VirB11 during T-DNA translocation (74). While VirB7 is critical for building a functional
channel, TrwHR388 is not essential for plasmid transfer of R388 (123). Therefore, the TrwR388
T4SS must have another mechanism for anchoring into the OM not seen in other T4SSs. While
VirB7 is a small protein in most conjugative T4SSs, some larger versions have been previously
described. For example, HP0532 from H. pylori contains a large, surface-displayed C-terminal
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end which was associated with the pilus structure (124). The biological significance of this
observation is not well understood.
VirB9: VirB9 is a largely hydrophilic protein localized in the periplasm which is critical
for structural integrity of the core complex. As mentioned above, VirB9 makes contacts with
VirB7 that are necessary for its stability as well as proper positioning in the OM (122). VirB9
also makes critical contacts with VirB10 which are necessary for the stability of VirB10 (119).
The crystal structure of the pKM101 core complex reveals that VirB9 is on the outer face of the
complex while VirB10 is on the inside forming the hollow chamber which likely allows for
substrates to pass through (82,125). These essential VirB9-VirB10 contacts occur at the outer
face of the VirB10 -barrel. In addition to structural integrity of the T4SS, VirB9 also plays a
role in substrate discrimination as various insertion mutations alternatively block T-DNA
transfer or RSF1010 mobilization (126).
VirB10: VirB10 is a critical component of the OMC, but unlike the VirB7 and VirB9, it
is also part of the IMC as it makes contacts with the IM ATPases as well as IM proteins, such as
VirB8 (59). VirB10 consists of a small cytoplasmic N-terminal tail, a single -helical domain
that spans the IM, a large proline-rich region (PRR) in the periplasm, a large periplasmic barrel structure, a small alpha helical projection spanning the OM termed the antenna projection
(AP), and a small C-terminal tail, which folds back into the hollow channel chamber (Figure
1.10) (82,127). Because it spans both membranes, VirB10 is predicted to have two critical roles.
One is that of a scaffolding protein in which VirB10 bridges the two separate IM and OM
complexes. Secondly, VirB10 likely acts as an energy transducer between the IM ATPases and
the OM proteins such as VirB9 (107).
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Figure 1.10 Structure of the pKM101 core complex. (A) The structure of the
pKM101 core complex depicting the arrangement of TraN (yellow), TraO (blue),
and TraF (red). Dimensions of the core complex are listed above and below. (B)
Crystal structure of the C-terminal half of TraF. The domains of interest of TraF are
listed including the cytoplasmic N-terminal tail, the TM domain, the proline-rich
region, the lever arm, the antenna projection (AP), and the C-terminal tail. The
structure of the TraN-TraO-TraF heteromultimer was generated using pymol
(http://pymol.org) based on the 3ZBI file deposited into the NCBI protein database.
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VirB10 also plays a critical role in pilus biogenesis. Previous studies on VirB10 have
highlighted the importance of the N-terminal half and -barrel of VirB10 for pilus biogenesis
(128). But recently, the C-terminal domain of VirB10 has also been examined for its role. The
middle of three invariant glycines at the N-terminal end of the AP (G269xxG272xxG275) has been
shown to be critical for pilus biogenesis and a G272R mutation resulted in a gating defect for
VirE2 release and loss of detectable pilus (125). Additionally, deletions and partial deletions
within the AP resulted in a loss of pilus biogenesis while only moderately affecting substrate
transfer (127). Therefore, one intriguing model is that VirB10 also functions as a pilus-building
platform that interacts with pilin subunits and mediates their assembly into the pilus polymer at
the outer membrane. Data presented in the Results section below will address this model.
The conjugative pilus: One of the key features of most Gram-negative bacterial T4SSs
is the presence of a conjugative pilus. Conjugative pili are utilized by the T4SS in order to
establish mating junctions between donor and recipient cells. While the VirB2 major pilin
subunit was previously shown to make contact with DNA substrates in A. tumefaciens, passage
of substrates through a pilus structure has not yet been demonstrated. While previous studies
using the F-plasmid T4SS have demonstrated transfer of substrates across long distances, these
studies were inconclusive as to whether DNA was passing through a pilus structure (129–132).
Pilus biogenesis has also been extensively studied in the A. tumefaciens VirB T4SS
(Figure 1.11). During pilin subunit maturation, VirB2 subunits are inserted into the IM. VirB2
contains a long signal sequence which is cleaved by the LepB signal peptidase (133). Following
cleavage of the signal sequence, the N and C termini are joined together by an unidentified
protein to form a cyclic peptide (133,134). These subunits are then subsequently used to form a
mature pilus.
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Figure 1.11 Pilus biogenesis in Agrobacterium and F-like pED208. (A) Depiction of the
pilin subunit processing pathway previously described in A. tumefaciens.

VirB2 is

composed of two large hydrophobic regions and two hydrophilic regions in the cytoplasm
and periplasm.

After insertion into the membrane, the 47-residue signal sequence in

cleaved by the LepB signal peptidase. The N- and C-terminal tails are covalently joined to
create a cyclic peptide. (B) Structure of the pilus from the F-like pED208 plasmid. The
pilus is composed of five layers wrapped together. Each layer is composed of the TraA
pilin subunit which is joined to a phosphatidylglycerol molecule which orients the head
group into the pilus channel lumen.

The structures of the F-pilus generated by electron microscopy and TraA subunit
were published as Figures 2A and 5SB in Costa TRD, et al. Structure of the bacterial sex F
pilus reveals an assembly of a stoichiometric protein-phospholipid complex. Cell 2016
166:1436–1444.e10. No prior permission from Elsevier is required for reproduction of
these figures.
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The pilin subunit of F plasmid, TraAF, is structurally similar to VirB2, but processed
differently. TraAF uses proton motive force to drive itself into the IM (135). TraAF insertion
also requires the presence of the pilin subunit chaperone, TraQ (136). Once inside the IM, TraAF
is subjected to cleavage of its N-terminal signal sequence by LepB followed by acetylation of the
new N-terminal amino acid by TraX (137,138). Unlike VirB2, TraAF is not cyclized during
pilus maturation. These processed TraAF pilin subunits are then incorporated into a mature pilus.
Recently, the structure of the pilus from the F-like plasmid pED208 was solved using cryoelectron microscopy at 3.6Å resolution (139). The pED208 pilus is comprised of five helical
arrangements that are all composed of the TraA pilin subunit. TraA subunits are oriented in such
a way that the N- and C-termini are oriented outward while the small cytoplasmic loop
connecting the two alpha helices are located inside of the pilus lumen. In addition to TraAF, these
studies confirmed the presence of phoshatidylglycerol in the pilus contributing to its structure
(Figure 1.11). The lipid heads were shown to be localized inside of the pilus lumen giving it a
slight electronegative charge. The Waksman laboratory predicts that this allows for efficient
transfer of DNA through the pilus lumen. Future studies are needed to confirm the presence of
DNA or protein substrates inside of the pilus.

T4SSs: Substrate channel vs. Pilus Assembly Machines
The Christie lab has identified numerous mutations in the VirBTi and TrapKM101
(discussed below) that block substrate transfer or pilus biogenesis, but not both (125,127). These
types of mutations have been referred to as “uncoupling mutations” as they uncouple these two
important processes. Various mutational analyses have uncovered these in different T4SSs
highlighting some similarities as well as informative differences. For example, TrwHR388 is not
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important for R388 plasmid transfer, although its homolog in the VirBTi system, VirB7, is
essential (67,123). Additionally, deletion of virB1 in the VirBTi system abolishes detectable pilus
production while still allowing for attenuated T-DNA transfer (67). During my analysis of TraF
and the OMCC from pKM101, I uncovered more of these mutations, which I will discuss in
more detail later in this thesis.
Although most uncoupling mutations yield a Tra+Pil- phenotype, mutations and deletions
of components in the Dtr proteins have revealed a Tra-Pil+ phenotype, including deletions of the
relaxase and T4CP. When transposon insertions were constructed in the RP4 Dtr region, E. coli
cells containing these mutant plasmids were more sensitive to killing by P. aeruginosa
containing a functional T6SS than cells containing wild-type RP4 (140). These mutants might
make more pili to provide better contact with recipient cells.
Taken together, these suggest that the T4SS functions either as “pilus assembly” or a
“substrate translocation” machine. In its default mode, the T4SS mediates assembly of the pilus,
which extends and retracts stochastically in ‘search’ of bacterial recipient cells. Once the pilus
establishes contact with a potential recipient, the pilus retracts to bring the two cells together to
form the mating junction. The T4SS then switches to the substrate transfer mode, where it
engages substrates and pumps them into recipient cells. (Figure 1.12).

The goals of my research
Shortly before I joined the Christie lab, the Waksman laboratory published the crystal
structure of the pKM101 OMCC O-layer (90). Similar to the ComB10 crystal structure, VirB10like TraF displayed a unique alpha-helical projection at its C-terminal end (90,111). When
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Figure 1.12 Substrate versus pilus channel. (a) Cartoon illustration of the T4SS assembly
pathway with VirB3, VirB6, VirB8, and VirB4 forming the IMC, VirB7, VirB9, and VirB10
forming the OMC, and VirB2 and VirB5 arranging themselves into a conjugative pilus. (b)
During substrate translocation, VirD4 and VirB11 will associate with the MPF channel. Upon
substrate docking and ATPase activity, these IM ATPases will trigger VirB10 into an active
conformation. This will allow the substrate to pass through the channel. (c) During pilus
biogenesis, VirB4 will associate with VirB11. These ATPases will trigger the release of
VirB2 from the membrane in order to form an extracellular pilus.

This is Figure 6 from Fronzes R, et al. The structural biology of type IV secretion
systems. Nat Rev Microbiol. 2009 7:703–14. This figure was re-published with permission
from Nature Publishing Groups. License number 4073250457937.
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placed in the context of the core complex, these helices appeared to form the OM substrate pore,
though previous experiments in the Christie lab identified this region as an important factor in
pilus biogenesis. My goal was to further define the role of the AP in building a functional T4SS.
Some of the questions I sought to address included: (i) Which regions of the AP and C-terminal
tail are critical for substrate transfer, pilus biogenesis, and recipient-cell contact? (ii) Are the AP
and C-terminal domains of VirB10 and TraF functionally similar? (iii) Are the IMC and OMCC
subassemblies separate functional complexes? Important observations made during my time in
the Christie lab include: (i) both the AP and C-terminal tail are critical for building of a cognate
conjugative pilus, although only the C-terminal tail is essential for plasmid transfer, (ii) the Cterminal half of VirB10 and TraF are functionally similar as demonstrated by mutual
substitutions between the two proteins, (iii) the IMC and OMCC are functionally-distinct
subassemblies as demonstrated by the ability to pair heterologous OMCCs and IMCs along with
the different TraF/VirB10 N-terminal sequence requirements in the IMC.
During my investigation into the role of the OMCC in building a functional T4SS, I,
along with other members of the Christie lab began developing and utilizing the pKM101 T4SS.
Our initial motivation for choosing a new model system was related to the structural information
available. Because a crystal structure of TraF was available, we could use it to make testable
predictions about the roles of various domains of interest. Additionally, much less time is
required to perform genetic analysis using E. coli pKM101 for our model system. Finally, E.
coli provided tools that were not available with A. tumefaciens, such as donor-specific
bacteriophages PRD1 and IKe (141,142). These phages are not only useful tools for monitoring
pilus production, but they can also act as morphologically distinct markers when identifying the
location of the T4SS in the cell membrane.
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I contributed to this effort by assisting in developing the E. coli pKM101 T4SS as the
new model system in the Christie lab. I, along with other members of the Christie lab, developed
markerless deletions of each pKM101 tra gene on the native plasmid, allowing us to minimize
polar effects on downstream genes, and complementing plasmids under the arabinose-inducible
PBAD promoter. Additionally, I developed the use of new tools and assays not available in the A.
tumefaciens system, including the use of donor-specific bacteriophages and the Pseudomonas
aeruginosa T6SS killing assay to monitor T4SS machine function. These tools allowed for new
insight into the stages at which mutations block conjugation.

In Chapters 3-6, I will describe

my efforts to develop the pKM101 T4SS and define the contributions of the VirB10/TraF AP
and C-terminal tail in building a functional translocation channel.
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Chapter 2: Materials and Methods
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Bacterial strains and growth conditions
Escherichia coli strain DH5α was used for plasmid construction and the Pseudomonas
aeruginosa type VI killing assay. P. aeruginosa strain PW9164, a strain of PAO1 with as
ISphoA insertion in the retS locus was used for the type VI killing assays. E. coli strain MG1655
was used during conjugation assays and phage sensitivity assays (143). Strain WM1650 was
used as recipient cell during conjugation assays (144). Strain MC4100 was used for surface
display assays and TOP10 was used for p-benzoyl-l-phenylalanine (pBpa) crosslinking
experiments (145). All E. coli and P. aeruginosa strains were grown in Lysogeny Broth (LB) at
37ºC with shaking. When necessary, E. coli cells were grown in the presence of the following
antibiotics: carbenicillin (50 g/ml), kanamycin (50 g/ml), spectinomycin (100 g/ml),
chloramphenicol (20 g/ml), tetracycline (20 g/ml), and rifampicin (50 g/ml). P. aeruginosa
was grown in LB without antibiotic selection.
Agrobacterium tumefaciens strains A348 and PC1010 variants were used for studies exploring
T4SS function with T-DNA transfer and VirB2 surface assays (67,146). A. tumefaciens cells
were grown in MG/L at room temperature with shaking (110). During induction of virulence
genes, cells were incubated in acidic ABIM along with 100 M acetosyringone for 24 hours
(125). When necessary, A. tumefaciens was grown in MG/L in the presence of carbenicillin (100
g/ml), kanamycin (100 g/ml), and gentamycin sulfate (100 g/ml). During vir gene induction,
cells were grown in the absence of antibiotics.
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Table 2.1 Bacterial strains
Strains

Relevant characteristics

Source

Gibco-BRL/
Invitrogen

MG1655

Genotype: F– Φ80lacZΔM15 Δ(lacZYA-argF) U169
recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ–
thi-1 gyrA96 relA1
Genotype: K-12 F– λ– ilvG– rfb-50 rph-1

HME45

W3110 gal490 pgl8 λcI857 (cro-bioA)

(154)

MC4100

Genotype: F- [araD139]B/r Δ(argF-lac)169*
&lambda- e14- flhD5301 Δ(fruK-yeiR)725 (fruA25)‡
relA1 rpsL150(strR) rbsR22 Δ(fimB-fimE)632(::IS1)
deoC1
Genotype: F- mcrA Δ(mrr-hsdRMS-mcrBC)
φ80lacZΔM15 ΔlacX74 nupG recA1 araD139 Δ(araleu)7697 galE15 galK16 rpsL(StrR) endA1 λCAG18477; Tet linked to priA(+)

(145)

A348

A136 containing the pTiA6NC plasmid

(146)

PC1010

A348 deleted of the virB10 gene from pTiA6NC

(67)

PAO1 containing an ISphoA in the retS locus

Pseudomonas
aeruginosa Stock
Center, University
of Washington

E. coli
DH5α

TOP10

WM1650

(143)

Invitrogen

(144)

A. tumefaciens

P. aeruginosa
PW9164
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Table 2.2 E. coli vectors
Name
pBAD24
pBAD33
pBAD24Spc
pBAD24Kan
pHP45Ω
pBB50
pGB2
pUC4K
pKVD10
pSU1443
pZZ11
pEVOL

pSJ503

Relevant characteristics
Crbr; ColE1 expression vector with arabinoseinducible PBAD promoter.
Camr; pACYC184/p15 plasmid with arabinoseinducible PBAD promoter
Spcr; pBAD24 with spectinomycin resistance gene
from pHP45Ω inserted into bla gene.
Kanr; pBAD24 with kanamycin resistance gene from
pUC4K inserted into the bla gene
Spcr; source of spcr cassette
Kanr; source of sacB-kan cassette
Spcr; plasmid with pSC101 origin of replication
Kanr; source of kan cassette
Crbr; source of virB10 cassette
Kanr; R388 containing a deletion of the trwB locus
Crbr; pPC914KS expressing PvirB::GST
Camr; pACYC184/p15 plasmid encoding tRNA
synthetase/tRNA for incorporation of p-benzoyl-lphenylalanine into proteins of interest
Crbr; pZZ11 with a 3xFLAG tag sequence cloned
between NcoI and BamHI

Source
(147)
(147)
This study
(29)
(148)
(67)
(149)
Amersham
(127)
(150)
(110)
(168)

This study

Table 2.3 E. coli expression plasmids
Name
pKM101
pJG57
pJG58
pJG59
pJG60
pJG61
pJG62
pJG65
pJG66
pJG68
pJG69

Relevant characteristics
Crbr; Deletion derivative of IncN conjugative
plasmid R46
Kanr; pBAD24Kan with PBAD::traF/AP-CTvirB10
Kanr; pBAD24Kan with PBAD::traF/BB-CTvirB10
Spcr; pBAD24Spc with PBAD::traF
Spcr; pBAD24Spc with PBAD::traF/APvirB10
Spcr; pBAD24Spc with PBAD::traF/5xGly loop
substitution
Spcr; pBAD24Spc with PBAD::traF with NT His tag
Spcr; pBAD24Spc with PBAD::traF/AP flexible
loopvirB10
Spcr; pBAD24Spc with PBAD::traF/CTvirB10
Spcr; pBAD24Spc with PBAD::traF/NTvirB10
Spcr; pBAD24Spc with PBAD::traF/TMvirB10

Source
(152)
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
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pJG70
pJG2005
pJG76
pJG95
pJG96
pJG97
pJG98
pJG99
pJG101
pJG134
pJG150
pMS22
pMS24
pMS26
pMS28
pMS30
pMS32
pMS35
pMS36
pMS38
pMS40
pJG125
pJG142
pJG143
pJG144

pJG145

pJG151

pJG152

Spcr; pBAD24Spc with PBAD::traF/PRRvirB10
Spcr; pBAD24Spc with PBAD::traF/TM-CTvirB10
Spcr; pBAD24Spc with PBAD::traFΔ307-354
(Deletion of the TraF AP domain)
Spcr; pBAD24Spc with PBAD::traFΔ302-386
(Deletion of the TraF AP and C-terminal tail)
Spcr; pBAD24Spc with PBAD::traFΔ354-386
(Deletion of the TraF C-terminal tail)
Spcr; pBAD24Spc with PBAD::traFΔCT9
Spcr; pBAD24Spc with PBAD::traFΔCT1
Spcr; pBAD24Spc with PBAD::traFR373E
Spcr; pBAD24Spc with PBAD::traFΔ373-377
(Deletion of the conserved RDLDF domain)
Spcr; pBAD24Spc with PBAD::traF/BB-APvirB10
Spcr; pBAD24Spc with PBAD::traF/BBvirB10
Kanr; pBAD24Kan with PBAD::traL
Kanr; pBAD24Kan with PBAD::traM
Kanr; pBAD24Kan with PBAD::traA

This study
This study
This study

Kanr; pBAD24Kan with PBAD::traB
Kanr; pBAD24Kan with PBAD::traC
Kanr; pBAD24Kan with PBAD::traD
Crbr; pBAD24 with PBAD::traN
Kanr; pBAD24Kan with PBAD::traE
Kanr; pBAD24Kan with PBAD::traO
Kanr; pBAD24Kan with PBAD::traG
Crbr; pCGR108 containing a deletion of traF flanked
by SacI and XhoI restriction sites
Spcr; oriT-traI fragment was cloned into the pGB2
cloning vector
Crbr; pCGR108 containing a deletion of traN through
traF flanked by SacI and XhoI restriction sites
Crbr; pCGR108 encoding the chimeric tra:virB
operon (virB7-traE-virB9-traF/virB10 fragment
cloned into pJG143 using SacI and XhoI restriction
sites.)
Crbr; pCGR108 encoding chimeric tra:trw operon
(trwH-traE-trwF-traF/trwE fragment cloned into
pJG143 using SacI and XhoI restriction sites.)
Crbr; pCGR108 encoding chimeric tra:ptl operon
(ptlI-traE-ptlF-traF/ptlG fragment cloned into
pJG143 using SacI and XhoI restriction sites.)
Crbr; pJG125 with the allele encoding for NT FLAG

This study
This study
This study
This study
This study
This study
This study
This study

This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

This study
This study
This study

This study

This study

This study
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pJG160
pJG161
pJG162

pJG163

pJG164

pJG165

pJG166

pJG158

pJG153

pJG154

pJG155

pJG156

pJG157

pJG202
pJG203
pJG1002
pJG1003
pJG1004

TraF cloned between the SacI and XhoI restriction
sites
Crbr; pCGR108 containing a deletion of traC flanked
by SacI and XhoI restriction sites
Crbr; pCGR108 containing a deletion of traE flanked
by SacI and XhoI restriction sites
Crbr; pJG125 with the allele encoding for AP FLAG
TraF cloned between the SacI and XhoI restriction
sites
Crbr; pJG125 with the allele encoding for CT FLAG
TraF cloned between the SacI and XhoI restriction
sites
Crbr; pJG125 with the allele encoding for Lever
FLAG TraF cloned between the SacI and XhoI
restriction sites
Crbr; pJG160 with the allele encoding for CT FLAG
TraC cloned between the SacI and XhoI restriction
sites
Crbr; pJG161 with the allele encoding for CT FLAG
TraE cloned between the SacI and XhoI restriction
sites
Crbr; pJG125 with the allele encoding for NT FLAG
TraF Δ307-354 cloned between the SacI and XhoI
restriction sites
Crbr; pJG125 with the allele encoding for NT FLAG
TraF ΔCT9 cloned between the SacI and XhoI
restriction sites
Crbr; pJG125 with the allele encoding for NT FLAG
TraF Δ373-377 cloned between the SacI and XhoI
restriction sites
Crbr; pJG125 with the allele encoding for NT FLAG
TraF / AP-CTvirB10 cloned between the SacI and XhoI
restriction sites
Crbr; pJG125 with the allele encoding for NT FLAG
TraF / AP-CTptlG cloned between the SacI and XhoI
restriction sites
Crbr; pJG125 with the allele encoding for NT FLAG
TraF /AP-CTtrwE cloned between the SacI and XhoI
restriction sites
Crbr; pUC57 plasmid containing the tra:virB operon
Crbr; pUC57 plasmid containing the tra:ptl operon
Spcr; pKM101 containing a deletion of the traM
locus
Crbr; pKM101 containing a deletion of the traA locus
Spcr; pKM101 containing a deletion of the traB locus

This study
This study
This study

This study

This study

This study

This study

This study

This study

This study

This study

This study

This study

This study
This study
This study
This study
This study
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pJG1005
pJG1006
pJG1008
pJG1010
pJG1011
pCGR100

pJG122
pJG123
pJG124
pCGR108

pCGR113
pJG111
pJG112
pJG113
pJG114
pJG115
pJG116
pJG117
pJG118
pJG119
pJG204
pJG205
pJG206
pJG207
pJG208

Spcr; pKM101 containing a deletion of the traC locus
Spcr; pKM101 containing a deletion of the traD locus
Spcr; pKM101 containing a deletion of the traE locus
Crbr; pKM101 containing a deletion of the traF locus
Spcr Kanr; pKM101 containing a sacB-kan insertion
into the traG locus
Camr; mini-pKM101 in pBAD33 (korB-traG cloned
between the SacI and XbaI sites. (This plasmid is
missing the kikA locus.)
Camr; pCGR100 containing a deletion of traL
Camr; pCGR100 containing a deletion of traO
Camr; pCGR100 containing a deletion of traN

This study
This study
This study
This study
This study

Crbr; mini-pKM101 in pBAD24 (korB-traG cloned
between the NcoI and XbaI sites. This plasmid is
missing the kikA locus.)
Camr; kikA cloned in pBAD33 between SacI and
XbaI restriction sites
Spcr; pBAD24Spc with PBAD::traF/NT 6xHis:CT
FLAG P185Amber mutation
Spcr; pBAD24Spc with PBAD::traF/NT 6xHis:CT
FLAG W304Amber mutation
Spcr; pBAD24Spc with PBAD::traF/NT 6xHis:CT
FLAG F316Amber mutation
Spcr; pBAD24Spc with PBAD::traF/NT 6xHis:CT
FLAG N325Amber mutation
Spcr; pBAD24Spc with PBAD::traF/NT 6xHis:CT
FLAG Y334Amber mutation
Spcr; pBAD24Spc with PBAD::traF/NT 6xHis:CT
FLAG Q343Amber mutation
Spcr; pBAD24Spc with PBAD::traF/NT 6xHis:CT
FLAG Y352Amber mutation
Spcr; pBAD24Spc with PBAD::traF/NT 6xHis:CT
FLAG F377Amber mutation
Spcr; pBAD24Spc with PBAD::traF/NT 6xHis:CT
FLAG N386Amber mutation
Crbr; pBAD24 with PBAD::traF/ CT FLAG A2Amber
mutation
Crbr; pBAD24 with PBAD::traF/ CT FLAG V6Amber
mutation
Crbr; pBAD24 with PBAD::traF/ CT FLAG
E11Amber mutation
Crbr; pBAD24 with PBAD::traF/ CT FLAG
T16Amber mutation
Crbr; pBAD24 with PBAD::traF/ CT FLAG

This study

This study

This study
This study
This study

This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
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pJG209
pJG210
pJG211
pJG212
pJG213
pJG214
pRP100
pRP101
pRP107
pRP109
pRP110
pYGL24

S23Amber mutation
Crbr; pBAD24 with PBAD::traF/ CT FLAG
G27Amber mutation
Crbr; pBAD24 with PBAD::traF/ CT FLAG
N32Amber mutation
Crbr; pBAD24 with PBAD::traF/ CT FLAG
V43Amber mutation
Crbr; pBAD24 with PBAD::traF/ CT FLAG
L45Amber mutation
Crbr; pBAD24 with PBAD::traF/ CT FLAG
L49Amber mutation
Crbr; pBAD24 with PBAD::traF/ CT FLAG
Kanr; mini-pKM101 containing an IncN origin of
replication
Kanr; pRP100 containing a deletion of the traL locus
Kanr; pRP100 containing a deletion of the traN locus
Kanr; pRP100 containing a deletion of the traO locus
Kanr; pRP100 containing a deletion of the traF locus
Spcr; pJG142 containing an HA tag on the C-terminal
end of TraK, a strep tag on the C-terminal end of
TraJ, and a 6xHis tag on the C-terminal end of TraI

This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

Table 2.4 Agrobacterium tumefaciens expression plasmids
Name
pJG1
pJG2
pJG3
pJG4
pJG5
pJG6
pJG7
pJG8
pJG9
pJG10
pJG11
pJG12
pJG13
pJG14
pJG15
pJG40
pJG42

Relevant characteristics
Crbr Kanr; pKVD10 with a G269R mutation in VirB10
Crbr Kanr; pKVD10 with a G269K mutation in VirB10
Crbr Kanr; pKVD10 with a G269W mutation in VirB10
Crbr Kanr; pKVD10 with a G269C mutation in VirB10
Crbr Kanr; pKVD10 with a G269D mutation in VirB10
Crbr Kanr; pKVD10 with a G272R mutation in VirB10
Crbr Kanr; pKVD10 with a G272K mutation in VirB10
Crbr Kanr; pKVD10 with a G272W mutation in VirB10
Crbr Kanr; pKVD10 with a G272C mutation in VirB10
Crbr Kanr; pKVD10 with a G272D mutation in VirB10
Crbr Kanr; pKVD10 with a G275R mutation in VirB10
Crbr Kanr; pKVD10 with a G275K mutation in VirB10
Crbr Kanr; pKVD10 with a G275W mutation in VirB10
Crbr Kanr; pKVD10 with a G275C mutation in VirB10
Crbr Kanr; pKVD10 with a G275D mutation in VirB10
Crbr Kanr; pKVD10 with a 3xFLAG tag cloned into an
SphI site at virB10 codon 298.
Crbr Kanr; pKVD10 with a 3xFLAG tag cloned into an

Source
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This study
This study
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pJG44
pJG52
pSJ501
pSJ502
pSJ510
pSJ511
pSJ512

SphI site at virB10 codon 329.
Crbr Kanr; pKVD10 with a 3xFLAG tag cloned into an
SphI site at virB10 codon 332.
Crbr Kanr; pKVD10 with a 2xFLAG tag inserted
between virB10 codons 310 and 311.
Crbr; pKVD10 with codons 284-337 of virB10 replaced
with codons 302-353 of traF
Crbr; pKVD10 with codons 284-377 of virB10 replaced
with codons 302-386 of traF
Crbr; pBSIISK+ NdeI expressing Plac::virB10.298 SphI
Crbr; pBSIISK+ NdeI expressing Plac::virB10.329 SphI
Crbr; pBSIISK+ NdeI expressing Plac::virB10.331 SphI

This study
This study
This study
This study
This study
This study
This study

Table 2.5 Native pKM101 deletion primers

Name
Sequence
TraM_FWD_SacB/Kan 5’ TCTGCAATCAACAGAAGATAGTGAGTAAGGAGAAA
CCATGGTCGACCTGCAGGTCGACTC 3’
TraM_RVS_SacB/Kan 5’ CGCACCTTTGAAAAGCGGTCTTTTCCCGTCAACGA
CCATGGGAAAGCCACGTTGTGTCT 3’
TraA_FWD_SacB/Kan 5’ GGGGACTTTTGTCCCCCAAAGTGAGGACTACAAAG
CCATGGTCGACCTGCAGGTCGACTC 3’
TraA_RVS_SacB/Kan 5’ATCAATTTTTTTTGGCTTCGTAGCGGTGGCAGCTCCCTGG
CCATGGGAAAGCCACGTTGTGTCT 3’
TraB_FWD_SacB/Kan 5’ TCCTCTGTTGACTACTAACGTAAGGGTTTAAAATA
CCATGGTCGACCTGCAGGTCGACTC 3’
TraB_RVS_SacB/Kan 5’ GCCGGTGGTCAGCAGCACTGCCGTAAGTGATTTTT
CCATGGGAAAGCCACGTTGTGTCT 3’
TraC_FWD_SacB/Kan 5’ CTGGCGCCTGACGGCTTAACAACGAGGCAAAACT
CCATGGTCGACCTGCAGGTCGACTC 3’
TraC_RVS_SacB/Kan 5’ CACCAGGAAGAAAGGGATAAGCAGCfAGTAGTTTTT
CCATGGATCCTGATGTTACATTGCAC 3’
TraD_FWD_SacB/Kan 5’ AATTAACTCACCGAAAATTTAAGAGTAAGGAGGCA
CCATGGTCGACCTGCAGGTCGACTC 3’
TraD_RVS_SacB/Kan 5’ GCTAATCAGAAGAACTCCCATAAGCAATAAGCTG
CCCATGGGAAAGCCACGTTGTGTCT 3’
TraE_FWD_SacB/Kan 5’ CGGTTGATACGCAAGGTGGTCGAAATGAAAGCTAA
CCATGGTCGACCTGCAGGTCGACTC 3’
TraE_RVS_SacB/Kan
5’ GACTGACAAAACGACTGCTGAAAGAAGTAGTTTTT
CCATGGATCCTGATGTTACATTGCAC 3’
TraF_FWD_SacB/Kan 5’ ATGTGCGCAGGGTTCAAATTGGGGAGGATAACTGA
CCATGGTGGTATGAAAGCCTTTGTCA 3’
TraF_RVS_SacB/Kan
5’ GCGCAGTGGGCCAAGTTGATAGAAAGCTGCATCAG
CCATGGGGGAAAGCCACGTTGTGTCTCA 3’
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TraG_FWD_SacB/Kan
TraG_RVS_SacB/Kan

5’ AAAGTCGCTTAGCGCCCGCTTTTCTTCAGGAGTAA
CCATGGTCGACCTGCAGGTCGACTC 3’
5’ AAATGCTGCGGCCAGAAGCCAGGTTGCTAATTTTT
CCATGGATCCTGATGTTACATTGCAC 3’

Table 2.6 Inverse PCR deletion primers
Name
TraL_Del_Inv._FWD
TraL_Del_Inv._RVS
TraO_Del_Inv._FWD
TraO_Del_Inv._RVS
TraN_Del_Inv._FWD
TraN_Del_Inv._RVS
TraN Del. RVS SacI
TraF_Del._Inv._FWD
TraF_Del._Inv._RVS
TraC_Del._RVS_SacI
TraC_Del._FWD_XhoI
TraE_Del._RVS_SacI
TraE_Del._FWD_XhoI
TraF Del. RVS SacI
TraF Del. FWD XhoI

Sequence
5’ GGTTATGAATGGAACGTTTGTATC 3’
5’ TTATGTTTCACCGCGTAATTG 3’
5’ ATGGCCCGTAAAAGTGTCG 3’
5’ GGGGCAGCCCTCAGTTAAC 3’
5’ ATGAAAGCTAATAAAAAAACAGGGC 3’
5’ TACGGCATCCATTATCGG 3’
5’ GATATGAGCTCTACGGCATCCATTATCGG 3’
5’CTTCAGGAGTAATCATGACTGATGCAGC 3’
5’ CAGTTATCCTCCCCAATTTGAACCC 3’
5’ ATATATGAGCTCGAGTTTTGCCTCGTTGTTAAGCCGTCAG 3’
5’ATATATACTCGAGTATGAAAAAACTACTGCTGCTTATCCCTTTC
TTCCTGG 3’
5’ TATATATGAGCTCATTAGCTTTCATTTCGACCACCTTGCGTATC
3’
5’ATATATACTCGAGCCCCATGAAAAAACTACTTCTTTCAGCAGT
C 3’
5’ TATATGAGCTCTCAGTTATCCTCCCCAATTTG 3’
5’ ATATACTCGAGAAAAGTCGCTTAGCGCCC 3’

Table 2.7 pKM101 gene cloning primers
Name
traL_FWD_NcoI
traL_RVS_XhoI_KpnI
traM_FWD_NcoI
traM_RVS_XhoI_KpnI
traA_FWD_NcoI
traA_RVS_XhoI_KpnI
traB_FWD_NcoI
traB_RVS_XhoI
traC_FWD_NcoI
traC_RVS_XhoI_KpnI

Sequence
5’CATGCCATGGATGAGTAAACATCCAAAACTCCTGGTTCTC 3’
5’GATGGTACCATGCTCGAGTCATTCCCCCTTCGCTGTTTC 3’
5’ CATGCCATGGATGACCACGTTGTTTAAGAAGTATGGCC3’
5’ CGGGGTACCCCGCTCGAGTCAGCTTCCTACGCCCGTCA 3’
5’ CATGCCATGGATGTTCGTTGACGGGAAAAGACCG 3’
5’ CGGGGTACCCCGCTCGAGTTAAACCCTTACGTTAGT
AGTCAACAGAGGAATAAGAC 3’
5’ CATGCCATGGATGAGAGCTGCCACCGCTACG 3’
5’ CCGCTCGAGTTAAGCCGTCAGGCGCCAG 3’
5’ CATGCCATGGATGAAAAAATCACTTACGGCAGTGCTG 3’
5’ CGGGGTACCCCGCTCGAGTCAGTTAATTGAAGGTGACGC
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TraC_FWD_SacI
TraC_FLAG_RVS_XhoI
traD_FWD_NcoI
traD_RVS_XhoI_KpnI
traN_FWD_NcoI
traN_RVS_XhoI_KpnI
traE_FWD_NcoI
traE_RVS_XhoI_KpnI
TraE FWD SacI
TraE FLAG RVS XhoI
traO_FWD_NcoI
traO RVS XhoI KpnI
traG_FWD_NcoI
traG_RVS_XhoI_KpnI
kikA_sac1_F
kikA_xba1_R

GGTAAC 3’
5’ GATATGAGCTCATGAAAAAATCACTTACGGCAGTGCTGCTG
3’
5'CTATATACTCGAGTCATTTGTCATCGTCATCTTTATAATCGTT
AATT GAAGGTGACGCGGTAACGTCC 3’
5’ CATGCCATGGCATTCACCCTGGTACAAGACAT 3’
5’ CGGGGTACCCCGCTCGAGTTATGCAGCCTTCTTCCCGCG 3’
5’ CATGCCATGGATGCGCAGCTTATTGCTTATGGGA 3’
5’CGGGGTACCCCGCTCGAGTTAGCTTTCATTTCGACCACCTTGC
3’
5’CATGCCATGGATGAAAGCTAATAAAAAAACAGGGCTTACAC
GT 3’
5’ CGGGGTACCCCGCTCGAGTCAGTTAACTTCCGGGTTGACGC
3’
5’ GATATGAGCTCAAAAAAACAGGGCTTACACGTGAAGCC 3’
5’CATATATCTCGAGTCATTTGTCATCGTCATCTTTATAATCGTT
AACTTCCGGGTTGACGCGATAACTC 3’
5’CATGCCATGGATGAAAAAACTACTTCTTTCAGCAGTCGTTTT
GT 3’
5’CGGGGTACCCCGCTCGAGTCAGTTATCCTCCCCAATTTGAAC
CC 3’
5’ CATGCCATGGATGACTGATGCAGCTTTCTATCAACTTGG 3’
5’ CGGGGTACCCCGCTCGAGTTACAGGCTCCCGTTCACACACTG
3’
5’ AAAGAGCTCAGGAGGAATTCACCATGAAGAAACTCTTAATA
CCTCTGAT 3’
5’ CCTGTCTAGACTATAAGCGAACTTTCCC 3’

Table 2.8 traF cloning primers
Name
TraF_FWD_NcoI
TraF_RVS_XhoI
TraF_RVS_L307_B10
B10_FWD_S286_TraF
B10_RVS_XhoI
TraF_RVS_A193_B10
B10_FWD_T173_TraF
B10_AP_RVS_TraF
TraF_CT_FWD_B10
TraF_AP2_RVS_B10
B10_Loop_FWD_TraF
B10_Loop_RVS_TraF

Sequence
5’ CATGCCATGGCCCGTAAAAGTGTCGATGTAGA 3’
5’ GCTCTCGAGTTAGTTGTCTGCGAGCGTATAAACGCC 3’
5’ GCATGGCTCCGCTCAGACGCTCCCACATATGGGC 3’
5’ GTGGGAGCGTCTGAGCGGAGCCATGCTCTTGAGTG 3’
5’ CAACTCGAGTTAAGAGCGGCGGTTCCTCCC 3’
5’ GCGGCAAGAGCGTAGCGCGGCTAGCCTTCAGC 3’
5’ GGCTAGCCGCGCTACGGCTCTTGCCGCACCC 3’
5’ GAGGGTAGGGGGTATGTTGATGGTCGCCTTAAGGGCTG 3’
5’ ACCATCAACATACCCCCTACCCTCTACGATCAGCAGG 3’
5’ GGTGCTAGCTGCCGTTAAGGTGTCAGAGAACAACGAA
ATCATG 3’
5’ GCAGCTAGCACCTACGCTGGCAG 3’
5’ AGTTGTTTGTTCACCGTTATTTTGAAAGCTG 3’
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TraF_AP3_FWD_B10
TraF_NT_His_FWD_NcoI
TraF_5xGly_FWD
TraF_5xGly_RVS
TraF_R373E_RVS
TraF_N386_Amber_RVS
TraF_S354_RVS_B10
B10_I355_FWD_TraF
TraF_ΔAP_FWD
TraF_ΔAP_RVS
TraF_FLAG_331_FWD
TraF_FLAG_330_RVS
TraF_ΔAPCT_RVS
TraF_ΔCT_RVS
TraF_F377_Amber_RVS
TraF_ΔRDLDF_RVS
F:TrwE_O.L._APCT_FWD
F:TrwE_O.L._APCT_RVS
F:PtlG_O.L._FWD
F:PtlG_O.L._RVS
PtlG_RVS_XhoI
VirB10_FWD_NcoI
VirB10_NT_RVS_TraF
TraF_TM_FWD_VirB10
TraF_NT_RVS_B10_TM
B10_TM_FWD

5’ GAACAAACAACTTCTGAAGCACTCCGCTCTTACATGT
CTATC 3’
5’ GATACCATGGGACATCATCATCACCACCACAATAACGA
TAGTCAGCAAGCGGCACATG 3’
5’ GGAGGTGGAGGTGGATCTGAAGCACTCCGCTCTTACATG
TCTATCC 3’
5’ TCCACCTCCACCTCCCGTTAAGGTGTCAGAGAACAAC
GAAATCATG 3’
5’GTATCTCGAGTTAGTTGTCTGCGAGCGTATAAACGCCGCT
GAAATCGAGGTCCTCGGCAAC 3’
5’GTATCTCGAGTTACTAGTCTGCGAGCGTATAAACGCCGCT
G 3’
5’ GGTTGGCGGTATAGACATGTAAGAGCGGAGTGCTTC
AGAC 3’
5’ TCTTACATGTCTATACCGCCAACCCTGAAGAAGAAT
CAG 3’
5’ ATGTGGGAGCGTATCCCCCCTACCCTCTACGATCAGC 3’
5’ GGTAGGGGGGATACGCTCCCACATATGGGCATCC 3’
5’ GATTACAAGGACGATGACGATAAAAACATTCAGTA
CAACAGCACAGAAAACAGCG 3’
5’ TTTATCGTCATCGTCCTTGTAATCATTACTCTGCGTC
TGGTTAACCAGCGC 3’
5’ GTATCTCGAGCTAGGCATCCACCTGGCCCGG 3’
5’ GTATCTCGAGCTAAGACATGTAAGAGCGGAGTGC
TTCAGACG 3’
5’ GTATCTCGAGTTAGTTGTCTGCGAGCGTATAAACGC
CGCTCTAATCGAGGTCGCGGGCAAC 3’
5’ CTATATCTCGAGTTAGTTGTCTGCGAGCGTATAAACGC
CGCTGGCAACAAAAATGCTCACCGCATCAC 3’
5’ CCGGGCCAGGTGGATGATCGGCATTTTTGGGAG
CGTTTCG 3’
5’ CCAAAAATGCCGATCATCCACCTGGCCCGGAATCCC 3’
5’ ATGTGGGAGCGTCTGGGCGGTGCACTGTTACTGAGT
GTTCTGG 3’
5’TAACAGTGCACCGCCCAGACGCTCCCACATATGGGCATCC
3’
5’ CATATATCTCGAGTCATTCATTTGTGCCGCGCAGG 3’
5’GATACCATGGGACATCATCATCACCACCACAATAACGATA
GTCAGCAAGCGGCACATG 3’
5’ CATCAGTATGACAAATTTCTGAGACCCCGAAAGACGCC 3’
5’ CGGCGTCTTTCGGGGGCCTTTGTCATACTGATGGCGCTGC
3’
5’ TAACGATAACGCGAGAACGACACCTCCGACGATCAA
TTTCTGAGATTTCATACGAGGAGCCGAACGG 3’
5’ CAGAAATTGATCGTCGGAGGTGTCGTTC 3’
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TraF_PRR_FWD_B10_TM
TraF_TM _RVS_B10
B10 _PRR_FWD_TraF
B10_PRR_RVS_TraF
TraF_FWD_B10_PRR
VirB10_RVS_R284_TraF
TraF_FWD_L307_VirB10
VirB10_RVS_I335_TraF
TraF_FWD_P356_VirB10
TraF_FWD_SacI
TraF_NT_FLAG_SacI_FWD
TraF_FLAG_CT_RVS_XhoI
Lever_FLAG_FWD
Lever_FLAG_RVS

5’ GTCGGAGGTGTCGTTCTCGCGTTATCGTTAAGCCTCA
TTTGGCTAGGTAAAATTCGCGCCCCGGCTAAAGC 3’
5’CTTCTTTTGACGCCCACCCATGACCGTAATCCCGATGAAT
AC 3’
5’ATTACGGTCATGGGTGGGCGTCAAAAGAAGGTGAATGAC
AAC 3’
5’ ATTAGCCATGACTCCGGCCCTGCTGGGCTGCAG 3’
5’CAGCCCAGCAGGGCCGGAGTCATGGCTAATCCCAGCCTG
ACTG 3’
5’ GATCGCACCAGCCAGACGCTGCCAGAAGTGGCTGTCG 3’
5’ CACTTCTGGCAGCGTCTGGCTGGTGCGATCATGATTTC 3’
5’ GTAGAGGGTAGGGGGTATGTTGATGGTCGCCTTAAGG
GCTGTCTC 3’
5’GCGACCATCAACATACCCCCTACCCTCTACGATCAGCAGG
3’
5’GATAGAGCTCATGGCCCGTAAAAGTGTCGATGTAGATCAG
GAAC 3’
5’ GATAGAGCTCATGGATTATAAAGATGACGATGACAAAGC
CCGTAAAAGTGTCGATGTAGATCAGGAAC 3’
5’ CTATCTCGAGTTATTTGTCATCGTCATCTTTATAATCGTTG
TCTGCGAGCGTATAAACGCCG 3’
5’GATTATAAAGATGACGATGACAAAACTCCTGCAAGGCTG
AAGGCTAGC 3’
5’TTTGTCATCGTCATCTTTATAATCCAGGTTTTTAGCGAGTG
CTGAACTACCTTCGC 3’

Table 2.9 traF amber mutant primers
Name
2_amber_Inv_FWD
2_amber_Inv_RVS
6_amber_Inv_FWD
6_amber_Inv_RVS
11_amber_Inv_FWD
11_amber_Inv_RVS
16_amber_Inv_FWD
16_amber_Inv_RVS
23_amber_Inv_FWD
23_amber_Inv_RVS
27_amber_Inv_FWD
27_amber_Inv_RVS
32_amber_Inv_FWD
32_amber_Inv_RVS

Sequence
5’ TAGCGTAAAAGTGTCGATGTAGATCAGG 3’
5’ CATGGTGAATTCCTCCTGCTAG 3’
5’ TAGGATGTAGATCAGGAACTCGATGAAAAC 3’
5’ ACTTTTACGGGCCATGGTG 3’
5’ TAGCTCGATGAAAACACCGGAG 3’
5’ CTGATCTACATCGACACTTTTACGG 3’
5’ TAGGGAGACGGTGAATTTGAAAG 3’
5’ TTCACCGTCTCCGGTGTTTTC 3’
5’ TAGAACCGCCGTTCGGCTCCTCG 3’
5’ GCCATTAAATCCGCCACGC 3’
5’ TAGGCTCCTCGTATGAAAGCCTTTG 3’
5’ ACGGCGGTTACTGCCATTAAATC 3’
5’ TAGGCCTTTGTCATACTGATGGCGC 3’
5’ CATACGAGGAGCCGAACGGC 3’
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5’ TAGGTATTCATCGGGATTACGGTCATG 3’
5’ AGCAAGCAGCGCCATCAG 3’
5’ TAGATCGGGATTACGGTCATGGG 3’
5’ TACCAAAGCAAGCAGCGCC 3’
5’ TAGGTCATGGGTAAAATTCGCGCC 3’
5’ AATCCCGATGAATACCAAAGCAAG 3’
5’ GCTAAAAACCTGACTTAGGCAAGGCTGAAGGCTAGCCGC 3’
5’AGCCTTCAGCCTTGCCTAAGTCAGGTTTTTAGCGAGTGCTGAA
CTACCTTC 3’
W304_FWD_Overlap
5’ GTGGATGCCCATATGTAGGAGCGTCTGGCTGGTGCGATC 3’
W304_RVS_Overlap
5’ ACCAGCCAGACGCTCCTACATATGGGCATCCACCTGGCC 3’
F316_FWD_Overlap
5’ ATCATGATTTCGTTGTAGTCTGACACCTTAACGGCGCTGG 3’
F316_RVS_Overlap
5’ CGTTAAGGTGTCAGACTACAACGAAATCATGATCGCACCAGC
3’
N325_FWD_Overlap
5’TTAACGGCGCTGGTTTAGCAGACGCAGAGTAATAACATTCAG
TACAACAGCAC 3’
N325_RVS_Overlap
5’ATTACTCTGCGTCTGCTAAACCAGCGCCGTTAAGGTGTCAGAG
3’
Y334_FWD_Overlap
5’AGTAATAACATTCAGTAGAACAGCACAGAAAACAGCGGTGGG
3’
Y334_RVS_Overlap
5’GTTTTCTGTGCTGTTCTACTGAATGTTATTACTCTGCGTCTGGT
TAACCAGC 3’
Q343_FWD_Overlap
5’ GAAAACAGCGGTGGGTAGCTGGCGTCTGAAGCACTCCGC 3’
Q343_RVS_Overlap
5’ TGCTTCAGACGCCAGCTACCCACCGCTGTTTTCTGTGCTG 3’
Y352_FWD_Overlap
5’GAAGCACTCCGCTCTTAGATGTCTATCCCCCCTACCCTCTACG
ATCAG 3’
Y352_RVS_Overlap
5’ AGGGGGGATAGACATCTAAGAGCGGAGTGCTTCAGACGCC 3’
F377_FWD_Overlap
5’ GCCCGCGACCTCGATTAGAGCGGCGTTTATACGCTCGCAG 3’
F377_RVS_Overlap
5’CGTATAAACGCCGCTCTAATCGAGGTCGCGGGCAACAAAAAT
G 3’
N386_RVS_FLAG_XhoI 5’CTATCTCGAGTTATTTGTCATCGTCATCTTTATAATCCTAGTCT
GCGAGCGTATAAACGCCGC 3’
43_amber_Inv_FWD
43_amber_Inv_RVS
45_amber_Inv_FWD
45_amber_Inv_RVS
49_amber_In_ FWD
49_amber_Inv_RVS
P185_FWD_Overlap
P185_RVS_Overlap

Table 2.10 Mini-pKM101 primers
pKM101_2700SacI_F
pKM101_2700NcoI_F
pKM101_13500Xba_R

5’ GCGAGCTCTCCGCAAAATCAATAAGTTCG 3’
5’ TTTCCATGGTCCGCAAAATCAATAAGTTCGC 3’
5’ AATTCTAGAGCCAGAAGCCAGGTTGCTAAT 3’

oriT_NcoI_F
TraI_HindIII_R
TraJ_CT_Strep_F

5’ GCTCCATGGTACCCTCATTTAGAATGAT 3’
5’ CGATAAGCTTCATCAGATTTCATGGCC 3’
CAATTCGAAAAGTGAAGGAGGAATTCACCATGCTTGATATAACC
ACGATTACC
5’ AGGATGAGACCAGATCTCCCTCAGTTCAATGCC 3’
5’ CATCATCATTGATGAAGCTTGGCTGTTTTGGCGGATG 3’

TraJ_CT_Strep_R
TraI_CT_6HIS_F
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5’ ATGATGATGGATTTCATGGCCCCCTTCTTCATGCTC 3’
5’CCAGATTATGCTTGAAGGAGGAATTCACCATGGACGATAGAGA
AAGAGGCTTAGCATTTTTATTTGC 3’
TraK_CT_HA_R
5’ AACATCATATGGATAGCGCTCCTTTTTTGGTTCCCAGACTTTG
3’
RSP005
5’ ACACACCCATGGCTTCAACTCAGCAAAAGTT 3’
RSP006
5’ AAATCGTACTTGTATTGACCGATGTTACATTGCACAAGAT 3’
RSP007
5’ ATCTTGTGCAATGTAACATCGGTCAATACAAGTACGATTT 3’
RSP008
5’ ACACACTCTAGAATCTATCATGAACAGATCTCAC 3’
TrwH_FWD_KpnI_SacI 5’ GATATGGTACCAGGAGGAAGAGCTCATGAAAA
CCATCATTTTTGCAATTTTGATGACG 3’
TrwH_RVS_TraE
5’ TTTTTTTATTAGCTTTCATAGTGCCCCTCGCTGAATTTCC 3’
TraE_FWD_TrwH
5’ TCAGCGAGGGGCACTATGAAAGCTAATAAAAAAA
CAGGGCTTACACGTGAAGC 3’
TraE_RVS_TrwF
5’ AGCTAGTTTCTTCATGGGGCAGCCCTCAGTTAACTTCCG 3’
TrwF_FWD_TraE
5’ ACTGAGGGCTGCCCCATGAAGAAACTAGCTATCGTT
GCATTGCTGGC 3’
TrwF_RVS_TraF
5’CACTTTTACGGGCCATTAGTTGCCTCCTTTGTTGACGCGAC
TraI_CT_6HIS_R
TraK_CT_HA_F

3’
TraF_FWD_TrwF
TraF_RVS_TrwE
TrwE_FWD_TraF
TrwE_RVS_XhoI

5’ CAAAGGAGGCAACTAATGGCCCGTAAAAGTGTCGATG
TAGATCAG 3’
5’ GTTGCCAAGGCGGCCAGCGCGGCTAGCCTTCAGCC 3’
5’ AAGGCTAGCCGCGCTGGCCGCCTTGGCAACCGTGAC 3’
5’ CATATCTCGAGCTACTTAGTGGGGATGCTTTCGAGA
CTGTAGACATC 3’

Table 2.11 Agrobacterium tumefaciens virB10 primers
B10_298_SphI_FWD
B10_298_SphI_RVS
B10_329_SphI_FWD
B10_329_SphI_RVS
B10_332_SphI_FWD
B10_332_SphI_RVS
B10_288_RVS_TraF
TraF_307_FWD_B10
TraF_335_RVS_B10

B10_339_FWD_TraF
3xFLAG_FWD_SphI
3xFLAG_RVS_SphI
3xFLAG_Sense_NcoI_NdeI_Xh
oI_BamHI

5’ TGCCAGGCAGCTAGCACCTACGCTGGC 3’
5’ TGCGAAGGCGCCTTGAACAGCACTCAAGAG 3’
5’ TGCAAGGCGACCATCAACATACCGCCAAC 3’
5’ TGCAAGGGCTGTCTCAGTTGTTTGTTCACCG 3’
5’ TGCATCAACATACCGCCAACCCTGAAGAAGA 3’
5’ TGCGGTCGCCTTAAGGGCTGTCTCAGTTGTTTGTTC 3’
5’ CTTCTGGCAGCGTTTTAGCGGAGCCCTGGCTGGTGCGATC 3’
5’ CGTTTTAGCGGAGCCCTGGCTGGTGCGATCATGATTTCG 3’

5’
ACCCTGATTCTTCTTGATAGACATGTAAGAGCGGAGTGCTTCAGA
C 3’
5’ TCTTACATGTCTATCAAGAAGAATCAGGGTGACACGGTTTCC 3’
5’GATATATAGCATGCGATTACAAGGACGATGACGATAAGGACTA
TAAAGATGACG 3’
5’CATATATGCATGCCTTATCATCATCATCCTTATAATCCTTGTCAT
CG 3’
5’GATATATACCATGGGATTACAAGGACGATGACGATAAGGACTA
TAAAGATGACGATGACAAGGATTATAAGGATGATGATGATAAGC
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3xFLAG_Antisense_NcoI_NdeI
_XhoI_BamHI

VirB10_FWD_NdeI
virB10_310_2xFLAG_FWD
virB10_310_2xFLAG_RVS
B10_AP_Del_RVS
B10_AP_Del_FWD
B10_288_RVS_TraF
TraF_307_FWD_B10
TraF_335_RVS_B10
B10_339_FWD_TraF
G269R_FWD
G269R_RVS
G269K_FWD
G269K_RVS
G269W_FWD
G269W_RVS
G269C_FWD
G269C_RVS
G269D_FWD
G269D_RVS
G272R_FWD
G272R_RVS
G272K_FWD
G272K_RVS
G272W_FWD
G272W_RVS
G272C_FWD
G272C_RVS
G272D_FWD
G272D_RVS
G275R_FWD
G275R_RVS
G275K_FWD
G275K_RVS
G275W_FWD

ATATGCTCGAGGGATCCATATATC 3’
5’GATATATGGATCCCTCGAGCATATGCTTATCATCATCATCCTTA
TAATCCTTGTCATCGTCATCTTTATAGTCCTTATCGTCATCGTCCTT
GTAATCCCATGGTATATATC 3’

5’GATATATATACATATGGGAAATAACGATAGTCAGCAAGC
GGCACATG 3’
5’GATGACGATAAGGACTATAAAGATGACGATGACAAGGGG
ATGAGCTTCAACAGCTTTCAAAATAACGGTG 3’
5’ATCTTTATAGTCCTTATCGTCATCGTCCTTGTAATCGCCAC
CCGAGCTGCCAGCGTAGG 3’
5’ TCCGCTAAAACGCTGCCAG 3’
5’ ACCCTGAAGAAGAATCAGGGTG 3’
5’CTTCTGGCAGCGTTTTAGCGGAGCCCTGGCTGGTGCGATC
3’
5’CGTTTTAGCGGAGCCCTGGCTGGTGCGATCATGATTTCG 3’
5’ACCCTGATTCTTCTTGATAGACATGTAAGAGCGGAGTGCT
TCAGAC 3’
5’TCTTACATGTCTATCAAGAAGAATCAGGGTGACACGGTTT
CC 3’
5’ GGACGAACTCCGTCGCCCAGGATTGCCGG 3’
5’ ATCCTGGGCGACGGAGTTCGTCCGCGCTTGGCG 3’
5’ GGACGAACTCAAGCGCCCAGGATTGCCGG 3’
5’ ATCCTGGGCGCTTGAGTTCGTCCGCGCTTGGCG 3’
5’ GGACGAACTCTGGCGCCCAGGATTGCCGG 3’
5’ ATCCTGGGCGCCAGAGTTCGTCCGCGCTTGGCG 3’
5’ GGACGAACTCTGCCGCCCAGGATTGCCGG 3’
5’ ATCCTGGGCGGCAGAGTTCGTCCGCGCTTGGCG 3’
5’ GGACGAACTCGACCGCCCAGGATTGCCGG 3’
5’ ATCCTGGGCGGTCGAGTTCGTCCGCGCTTGGCG 3’
5’ CTCGGTGCCCACGTTTGCCGGGCTCGGTCGAC 3’
5’ CGAGCCCGGCAAACGTGGGCGACCGAGTTCGTCC 3’
5’ CTCGGTGCCCAAAGTTGCCGGGCTCGGTCGAC 3’
5’ CGAGCCCGGCAACTTTGGGCGACCGAGTTCGTCC 3’
5’ CTCGGTGCCCATGGTTGCCGGGCTCGGTCGAC 3’
5’ CGAGCCCGGCAACCATGGGCGACCGAGTTCGTCC 3’
5’ CTCGGTGCCCATGCTTGCCGGGCTCGGTCGAC 3’
5’ CGAGCCCGGCAAGCATGGGCGACCGAGTTCGTCC 3’
5’ CTCGGTGCCCAGACTTGCCGGGCTCGGTCGAC 3’
5’ CGAGCCCGGCAAGTCTGGGCGACCGAGTTCGTCC 3’
5’ CCAGGATTGCCGCGTTCGGTCGACAGCCACTTCTGG 3’
5’ GCTGTCGACCGAACGCGGCAATCCTGGGCGACC 3’
5’ CCAGGATTGCCGAAGTCGGTCGACAGCCACTTCTGG 3’
5’ GCTGTCGACCGACTTCGGCAATCCTGGGCGACC 3’
5’ CCAGGATTGCCGTGGTCGGTCGACAGCCACTTCTGG 3’
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G275W_RVS
G275C_FWD
G275C_RVS

5’ GCTGTCGACCGACCTCGGCAATCCTGGGCGACC 3’
5’ CCAGGATTGCCGTGCTCGGTCGACAGCCACTTCTGG 3’
5’ GCTGTCGACCGAGCACGGCAATCCTGGGCGACC 3’

G275D_FWD
G275D_RVS

5’ CCAGGATTGCCGGACTCGGTCGACAGCCACTTCTGG 3’
5’ GCTGTCGACCGAGTCCGGCAATCCTGGGCGACC 3’

Plasmid modifications
Plasmid pBAD24Spc was created by isolation of the spcr gene as a SmaI fragment from
pHP45Ω and inserting it into the ScaI site within the crbr gene on pBAD24 (147,148).
pKM101Spcr was constructed by introduction of the same spcr gene as an EcoRI fragment into
the unique EcoRI site within the crbr gene of pKM101.

Construction of pKM101 tra gene deletions
Eight of the 11 tra genes were deleted from pKM101 by recombineering. Briefly,
pKM101 or pKM101Spcr were transferred by conjugation into E. coli strain HME45, which
contains the bacteriophage λ red system under the control of the cI857 repressor. For
construction of each tra gene deletion, the sacB-kanr cassette from plasmid pBB50 was PCR
amplified, so that it carried flanking NcoI sites and 35 basepairs (bps) of 5’ and 3’ sequences that
were complementary to regions immediately upstream and downstream of a tra gene of interest.
HME45(pKM101Crbr) or HME45(pKM101Spcr) cells were temperature-induced for expression
of the red-gam genes, and the kanr amplicons were introduced by electroporation with Kanr
selection for transformants. Because pKM101 is a multicopy plasmid, we eliminated plasmids
lacking the integrated sacB-kan cassette by subculturing the Kanr transformants for 4 days in LB
broth containing kanamycin (200 g ml-1). Isolated plasmids were digested with NcoI and
religated to delete the sacB-kanr cassette, and ligation mixes were introduced into DH5α with

71
selection for Crbr or Spcr. Transformants were screened for kanamycin sensitivity, and tra
deletion mutations were confirmed by sequencing across the deletion junction.

Construction of mini-pKM101 plasmids
The Christie lab constructed 3 mini-pKM101 plasmids with a goal of simplifying genetic
manipulations of the tra gene cluster. We constructed pCGR108 by introduction of the tra region
from pKM101 into pBAD24. For this region, we amplified a ~10-kilobase region of pKM101
encompassing the upstream regulatory region and tra promoter through traG. This fragment was
amplified with primers pKM101_2700NcoI_F and pKM101_13500XbaI_R and the resulting
PCR product was introduced into pBAD24 using NcoI and XbaI restriction sites. The second
mini-pKM101 plasmid, pCGR100, was constructed by amplifying the same ~10-kilobase region
from pCGR108 using primers pKM101_2700SacI_F and pKM101_13500Xba_R with pKM101
as a template. The resulting PCR product was digested with SacI and XbaI and ligated into a
SacI/XbaI digested pBAD33 plasmid.

The third mini-pKM101 plasmid, pRP100, was

constructed by joining three PCR amplification products: i) the tra gene cluster extending from
the 3’ end of kikA through the end of traG, ii) the pKM101 oriV replication origin, and iii) an
nptII gene encoding Kanr. The ~10-kb tra gene cluster was cut from plasmid pCGR125, a variant
of pCGR108 containing the upstream kikA locus, using SacI and XbaI restriction enzymes, a ~3kb region encompassing the replication origin was amplified with primers RSP007 and RSP008,
and the nptII gene was amplified with primers RSP005 and RSP006 using plasmid pUC4K as a
template. The replication origin and nptII gene were joined together using overlapping PCR,
digested with SacI and XbaI, and ligated to the tra operon. The resulting product was
transformed into E. coli DH5α with Kanr as a selection for self-replicating pRP100.
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Transformants were screened for plasmids bearing the three PCR fragments followed by
sequence analysis of the PCR fragment junctions. We also confirmed that each of the minipKM101 plasmids encodes a fully functional Tra T4SS.

Construction of pRP100 and pCGR108 variants and a mobilization plasmid
Plasmid pJG125 contains a deletion of the traF locus flanked by 5’ SacI and 3’ XhoI restriction
sites.

It was constructed using inverse PCR using primers TraF_Del._RVS_SacI and

TraF_Del._FWD_XhoI with pCGR108 as a template.
Plasmid pJG143 contains a deletion of traN through traF flanked by 5’ SacI and 3’ XhoI
restriction sites. It was constructed using inverse PCR using primers TraN_Del._RVS_SacI and
TraF_Del._FWD_XhoI with pCGR108 as a template.
Plasmid pRP101 contains a deletion of the traL locus. It was constructed using inverse PCR
using primers TraL_Del._Inv._FWD and TraL_Del._Inv._RVS with pRP100 as a template.
Plasmid pRP107 contains a deletion of the traN locus. It was constructed using inverse PCR
using primers TraN_Del._Inv._FWD and TraN_Del._Inv._RVS with pRP100 as a template.
Plasmid pRP109 contains a deletion of the traO locus. It was constructed using inverse PCR
using primers TraO_Del._Inv._FWD and TraO_Del._Inv._RVS with pRP100 as a template.
Plasmid pRP110 contains a deletion of the traF locus. It was constructed using inverse PCR
using primers TraF_Del._Inv._FWD and TraF_Del._Inv._RVS with pRP100 as a template.
Plasmid pJG142 contains the pKM101 origin of transfer (oriT) as well as the genes encoding
the TraK accessory protein, TraJ T4CP, and TraI relaxase. This region was PCR amplified using
primers oriT_NcoI_F and TraI_HindIII_R with pKM101 as a template. This PCR product was
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cloned into a pGB2 plasmid which had been digested with HindIII followed by blunt-ending
with Klenow polymerase (149).
Plasmid pJG160 contains a deletion of the traC locus flanked by 5’ SacI and 3’ XhoI restriction
sites.

It was constructed using inverse PCR using primers TraC_Del._RVS_SacI and

TraC_Del._FWD_XhoI with pCGR108 as a template.
Plasmid pJG161 contains a deletion of the traE locus flanked by 5’ SacI and 3’ XhoI restriction
sites.

It was constructed using inverse PCR using primers TraE_Del._RVS_SacI and

TraE_Del._FWD_XhoI with pCGR108 as a template.
Plasmid pJG165 contains mini-pKM101 with a C-terminally FLAG tagged TraC.

It was

constructed by amplifying traC using primers TraC_FWD_SacI and TraC_FLAG_RVS_XhoI
with pKM101 as a template. The resulting PCR product was digested with SacI and XhoI and
ligated into a SacI/XhoI digested pJG60 plasmid.
Plasmid pJG166 contains mini-pKM101 with a C-terminally FLAG tagged TraE.

It was

constructed by amplifying traC using primers TraE_FWD_SacI and TraE_FLAG_RVS_XhoI
with pKM101 as a template. The resulting PCR product was digested with SacI and XhoI and
ligated into a SacI/XhoI digested pJG61 plasmid.
Plasmid pYGL24 contains the oriT through traI region of pKM101 with TraK, TraJ, and TraI
tagged with HA, Strep, and 6xHis tags, respectively. It was made through sequential additions
of tags using inverse PCR. A Strep tag was added to TraJ by amplifying pJG142 with primers
TraJ_CT_Strep_F and TraJ_CT_Strep_R. Once traJ contained a Strep tag sequence at its 3’ end,
traI had a 6xHis tag sequence added to its 3’ end with primers TraI_CT_6HIS_F and
TraI_CT_6HIS_R. A sequence encoding an HA tag at the 3’ end of traK was added using
primers TraK_CT_HA_F and TraK_CT_HA_R
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Construction of pKM101 complementing plasmids
Plasmid pMS22 expresses PBAD::traL, producing TraL. It was constructed by PCR amplification
of traL using primers traL_FWD_NcoI and traL_RVS_XhoI_KpnI and pKM101 as a template.
The resulting PCR fragment was digested with NcoI and KpnI for introduction into NcoI/KpnIdigested pBAD24Kan.
Plasmid pMS24 expresses PBAD::traM, producing TraM. It was constructed by PCR
amplification of traM using primers traM_FWD_NcoI and traM_RVS_XhoI_KpnI and pKM101
as a template. The resulting PCR fragment was digested with NcoI and KpnI for introduction into
NcoI/KpnI-digested pBAD24Kan.
Plasmid pMS26 expresses PBAD::traA, producing TraA. It was constructed by PCR
amplification of traA using primers traA_FWD_NcoI and traA_RVS_XhoI_KpnI and pKM101
as a template. The resulting PCR fragment was digested with NcoI and KpnI for introduction into
NcoI/KpnI-digested pBAD24Kan.
Plasmid pMS28 expresses PBAD::traB, producing TraB. It was constructed by PCR amplification
of traB using primers traB_FWD_NcoI and traB_RVS_XhoI_KpnI and pKM101 as a template.
The resulting PCR fragment was digested with NcoI and KpnI for introduction into NcoI/KpnIdigested pBAD24Kan.
Plasmid pMS30 expresses PBAD::traC, producing TraC. It was constructed by PCR
amplification of traC using primers traC_FWD_NcoI and traC_RVS_XhoI_KpnI and pKM101
as a template. The resulting PCR fragment was digested with NcoI and KpnI for introduction into
NcoI/KpnI-digested pBAD24Kan.
Plasmid pMS32 expresses PBAD::traD, producing TraD. It was constructed by PCR
amplification of traD using primers traD_FWD_NcoI and traD_RVS_XhoI_KpnI and pKM101
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as a template. The resulting PCR fragment was digested with NcoI and KpnI for introduction into
NcoI/KpnI-digested pBAD24Kan.
Plasmid pMS35 expresses PBAD::traN, producing TraN. It was constructed by PCR
amplification of traN using primers traN_FWD_NcoI and traN_RVS_XhoI_KpnI and pKM101
as a template. The resulting PCR fragment was digested with NcoI and KpnI for introduction into
NcoI/KpnI-digested pBAD24.
Plasmid pMS36 expresses PBAD::traE, producing TraE. It was constructed by PCR amplification
of traE using primers traE_FWD_NcoI and traE_RVS_XhoI_KpnI and pKM101 as a template.
The resulting PCR fragment was digested with NcoI and KpnI for introduction into NcoI/KpnIdigested pBAD24Kan.
Plasmid pMS38 expresses PBAD::traO, producing TraO. It was constructed by PCR
amplification of traO using primers traO_FWD_NcoI and traO_RVS_XhoI_KpnI and pKM101
as a template. The resulting PCR fragment was digested with NcoI and KpnI for introduction into
NcoI/KpnI-digested pBAD24Kan.
Plasmid pMS40 expresses PBAD::traG, producing TraG. It was constructed by PCR
amplification of traG using primers traG_FWD_NcoI and traG_RVS_XhoI_KpnI and pKM101
as a template. The resulting PCR fragment was digested with NcoI and KpnI for introduction into
NcoI/KpnI-digested pBAD24Kan.
Plasmid pCGR113 expresses native kikA from the pBAD promoter. It was constructed by PCR
amplification of kikA using primers kikA_sac1_F and kikA_xba1_R and pKM101 as a template.
The resulting PCR fragment was digested with SacI and XbaI for introduction into SacI/XbaIdigested pBAD33.
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Construction of traF alleles
Plasmid pJG59 expresses PBAD::traF, producing TraF. It was constructed by PCR
amplification of traF using primers TraF_FWD_NcoI and TraF_RVS_XhoI and pKM101 as a
template. The resulting PCR fragment was digested with NcoI and XhoI for introduction into
NcoI/SalI-digested pBAD24Spc.
Plasmid pJG62 expresses PBAD::his6-traF, producing N-terminally 6xHis-tagged TraF. It was
constructed by PCR amplification of traF using primers TraF_NT_His_FWD_NcoI and
TraF_RVS_XhoI and pKM101 as a template. The resulting PCR product was digested with
NcoI and XhoI for introduction into NcoI/SalI-digested pBAD24Spc.
Plasmid pJG95 expresses PBAD::traF1-301, producing TraF deleted of its antennae projection
(AP) and C-terminal tail (CT). It was constructed by amplifying basepairs (bps) 1-903 of traF
using primers TraF_NT_His_FWD_NcoI and TraF_ APCT_RVS, and pKM101 as a
template. The resulting PCR product was digested with NcoI and XhoI for introduction into
NcoI/SalI-digested pBAD24Spc.
Plasmid pJG96 expresses PBAD::traF1-353, producing TraF deleted of its CT. It was
constructed by amplifying bps 1-1059 of traF using primers TraF_NT_His_FWD_NcoI and
TraF_CT_RVS and pKM101 as a template. The resulting PCR product was digested with
NcoI and XhoI for introduction into NcoI/SalI-digested pBAD24Spc.
Plasmid pJG76 expresses PBAD::traF 307-354, producing TraF deleted of its AP domain. It
was constructed by PCR amplifying traF codons 1-307 using TraF_NT_His_FWD_NcoI and
TraF_AP_RVS and codons 355-386 using TraF_ AP_FWD and TraF_RVS_XhoI_off of
pKM101. These PCR products were joined together by overlapping PCR, and the resulting
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fragment was digested with NcoI and XhoI for introduction into NcoI/SalI-digested
pBAD24Spc.
Plasmid pJG61 expresses PBAD::traF-5xGly, producing TraF with a pentaglycine substitution
of the AP loop. It was created by using primers TraF_NT_His_FWD_NcoI and
TraF_5xGly_RVS to PCR amplify codons 1-322, and primers TraF_5xGly_FWD and
TraF_RVS_XhoI to amplify codons 346-386. The two PCR products were joined together by
overlapping PCR, and the resulting product was digested with NcoI and XhoI for introduction
into NcoI/SalI-digested pBAD24Spc.
Plasmid JG101 expresses PBAD::traF373-377, producing TraF deleted of the conserved
RDLDF (residues 369-373) motif in the CT. It was created by using primers
TraF_NT_His_FWD_NcoI and TraF_RDLDF_RVS and pKM101 as a template for PCR
amplification. The PCR product was digested with NcoI and XhoI for introduction into
NcoI/SalI-digested pBAD24Spc.
Plasmids pJG97 expresses PBAD::traFCT9, producing TraF deleted of its last 9 residues. traF
CT9

was

PCR

amplified

using

primers

TraF_NT_His_FWD_NcoI

and

TraF_F377_Amber_RVS and pKM101 as a template. The PCR product was digested with
NcoI and XhoI for introduction into NcoI/SalI-digested pBAD24Spc.
Plasmids pJG98 expresses PBAD::traFCT1, producing TraF deleted of its last residues. traF
CT1

was

PCR

amplified

using

primers

TraF_NT_His_FWD_NcoI

and

TraF_N386_Amber_RVS and pKM101 as a template. The PCR product was digested with
NcoI and XhoI for introduction into NcoI/SalI-digested pBAD24Spc.
Plasmids pJG99 expresses PBAD::traFR373E, producing TraF with an R373E mutation. traF
was PCR amplified using primers TraF_NT_His_FWD_NcoI and TraF_R373E_RVS and
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pKM101 as a template. The PCR product was digested with NcoI and XhoI for introduction
into NcoI/SalI-digested pBAD24Spc.
Plasmid pJG68 expresses PBAD::traF/NTvirB10, producing the TraF/NTVirB10 chimera. It was
constructed by amplifying virB10 codons 1-29 using primers VirB10_FWD_NcoI and
VirB10_NT_RVS_TraF with pKVD10 as a template and traF codons 40-386 were amplified
using primers TraF_TM_FWD_VirB10 and TraF_RVS_XhoI with pKM101 as a template.
The two fragments were combined using overlapping PCR and the resulting product was
digested with NcoI and XhoI for introduction into NcoI/SalI-digested pBAD24Spc.
Plasmid pJG69 expresses PBAD::traF/TMvirB10, producing the TraF/TMDVirB10 chimera. It was
constructed by amplifying traF codons 1-40 using primers TraF_NT_His_FWD_NcoI and
TraF_NT_RVS_B10_TM

and

codons

60-386

with

TraF_PRR_FWD_B10_TM

and

TraF_RVS_XhoI with pKM101 as a template. The two fragments were combined using
overlapping PCR and the resulting product was digested with NcoI and XhoI for introduction
into NcoI/SalI-digested pBAD24Spc.
Plasmid pJG2005 expresses PBAD::traF/TM-CTvirB10, producing the TraF/TMD-CTVirB10
chimera.

It

was

constructed by amplifying

traF

codons

1-40 using primers

TraF_NT_His_FWD_NcoI and TraF_NT_RVS_B10_TM with pKM101 as a template and
amplifying virB10 codons 29-377 using primers B10_TM_FWD and B10_RVS_XhoI with
pKVD10 as a template. The two fragments were combined using overlapping PCR and the
resulting product was digested with NcoI and XhoI for introduction into NcoI/SalI-digested
pBAD24Spc.
Plasmid pJG70 expresses PBAD::traF/PRRvirB10, producing the TraF/PRRVirB10 chimera. It was
constructed by amplifying traF codons 1-60 using primers TraF_NT_His_FWD_NcoI and
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TraF_TM_RVS_B10 and codons 194-386 using primers TraF_FWD_B10_PRR and
TraF_RVS_XhoI with pKM101 as a template. Codons 51-172 of virB10 were amplified using
primers B10_PRR_FWD_TraF and B10_PRR_RVS_TraF with pKVD10 as a template. The
three fragments were combined using overlapping PCR and the resulting product was digested
with NcoI and XhoI for introduction into NcoI/SalI-digested pBAD24Spc.
Plasmid pJG150 expresses PBAD::traF/BBvirB10, producing the TraF/BBVirB10 chimera. It was
constructed by amplifying traF codons 1-193 and virB10 codons 173-286 using
TraF_NT_His_FWD_NcoI and VirB10_RVS_R284_TraF with pJG58 as a template. Codons
307-386 of traF were amplified using TraF_FWD_L307_VirB10 and TraF_RVS_XhoI with
pKM101 as a template. The two fragments were combined using overlapping PCR and the
resulting product was digested with NcoI and XhoI for introduction into NcoI/SalI-digested
pBAD24Spc.
Plasmid pJG134 expresses PBAD::traF/BB-APvirB10, producing the TraF/BB-APVirB10 chimera.
It was constructed by amplifying traF codons 1-193 and virB10 codons 173-335 using primers
TraF_NT_His_FWD_NcoI and VirB10_RVS_I335_TraF with pJG58 as a template. Codons
356-386 of traF were amplified using primers TraF_FWD_P356_VirB10 and TraF_RVS_XhoI
and pKM101 as a template. The two fragments were combined using overlapping PCR and the
resulting product was digested with NcoI and XhoI for introduction into NcoI/SalI-digested
pBAD24Spc.
Plasmid pJG57 expresses PBAD::traF/AP-CTvirB10, producing the TraF/AP-CTVirB10 chimera. It
was constructed by amplifying codons 1-307 of traF using TraF_NT_His_FWD_NcoI and
TraF_RVS_L307_B10 with pKM101 as a template, and the region of virB10 encoding residues
286-377 was amplified using B10_FWD S286_TraF and B10_RVS_XhoI with pKVD10 as a
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template. The two PCR products were joined by overlapping PCR, and the resulting product
was digested with NcoI and XhoI for introduction into NcoI/SalI-digested pBAD24Kan.
Plasmid pJG58 expresses PBAD::traF/BB-CTvirB10, producing the TraF/BB-AP-CTVirB10
chimera.

It

was

constructed

by

amplifying

codons

1-193

of

traF

using

TraF_NT_His_FWD_NcoI and TraF_RVS_A193_B10 with pKM101 as a template, and the
region of virB10 encoding residues 173-377 was amplified using B10_FWD T173_TraF and
B10_RVS_XhoI with pKVD10 as a template. The two PCR products were joined by
overlapping PCR, and the resulting product was digested with NcoI and XhoI for introduction
into NcoI/SalI-digested pBAD24Kan.
Plasmid pJG60 expresses PBAD::traF/APvirB10, producing the TraF/APVirB10 chimera. It was
constructed by amplifying codons 1-307 of traF and codons 286-335 of virB10 using
TraF_NT_His_FWD_NcoI and B10_AP_RVS TraF with pJG57 as a template. Codons 356386 of traF were amplified using TraF_CT_FWD_B10 and TraF_RVS_XhoI with pKM101 as
a template. These fragments were joined by overlapping PCR, and the resulting product was
digested with NcoI and XhoI for introduction into NcoI/SalI-digested pBAD24Spc.
Plasmid pJG65 expresses PBAD::traF/APLvirB10, producing the TraF/APLVirB10 chimera. It was
constructed by amplifying codons 1-322 of traF using TraF_NT_His_FWD_NcoI and
TraF_AP2_RVS_B10, and codons 364-386 using TraF_AP3_FWD_B10 and TraF_RVS_XhoI
with pKM101 as a template. Codons 301-325 of virB10 were PCR amplified using
B10_Loop_FWD_TraF and B10_Loop_RVS_TraF with pKVD10 as a template. The three
PCR fragments were joined by overlapping PCR, and the resulting fragment was digested with
NcoI and XhoI for introduction into NcoI/SalI-digested pBAD24Spc.

81
Plasmid pJG66 expresses PBAD::traF/ CTvirB10, producing the TraF/CTVirB10 chimera. It was
constructed by amplifying codons 1-354 of traF using primers TraF_NT_His_FWD_NcoI and
TraF_S354_RVS_B10 with pKM101 as a template, and codons 335-377 of virB10 using
primers B10_I355_FWD_TraF and B10_RVS_XhoI with pKVD10 as a template. These PCR
products were joined by overlapping PCR, and the resulting fragment was digested with NcoI
and XhoI for introduction into NcoI/SalI-digested pBAD24Spc.
Plasmid pJG152 contains mini-pKM101 which produces NT FLAG TraF. It was constructed
by amplifying traF using TraF_NT_FLAG_SacI_FWD and TraF_RVS_XhoI and pKM101 as a
template. The resulting fragment was digested with SacI and XhoI and introduced into a
SacI/XhoI digested pJG125 plasmid.
Plasmid pJG158 contains mini-pKM101 which produces NT FLAG TraF deleted of its AP
domain (307-354). It was constructed by amplifying traF using TraF_NT_FLAG_SacI_FWD
and TraF_RVS_XhoI and pJG76 as a template. The resulting fragment was digested with SacI
and XhoI and introduced into a SacI/XhoI digested pJG125 plasmid.
Plasmid pJG154 contains mini-pKM101 which produces NT FLAG TraF deleted of the
conserved RDLDF motif (373-377).

It was constructed by amplifying traF using

TraF_NT_FLAG_SacI_FWD and TraF_ΔRDLDF_RVS and pJG101 as a template.

The

resulting fragment was digested with SacI and XhoI and introduced into a SacI/XhoI digested
pJG125 plasmid.
Plasmid pJG153 contains mini-pKM101 which produces NT FLAG TraF deleted of the the Cterminal

nine

residues

(CT9).

It

was

constructed

by amplifying

traF

TraF_NT_FLAG_SacI_FWD and TraF_F377_Amber_RVS and pJG97 as a template.

using
The
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resulting fragment was digested with SacI and XhoI and introduced into a SacI/XhoI digested
pJG125 plasmid.
Plasmid pJG155 contains mini-pKM101 which produces NT FLAG TraF/AP-CTVirB10. It was
constructed

by

amplifying

traF/AP-CTvirB10

using

TraF_NT_FLAG_SacI_FWD

and

B10_RVS_XhoI and pJG57 as a template. The resulting fragment was digested with SacI and
XhoI and introduced into a SacI/XhoI digested pJG125 plasmid.
Plasmid pJG157 contains mini-pKM101 which produces NT FLAG TraF/AP-CTTrwE. It was
constructed by amplifying traF codons 1-300 using primers TraF_NT_FLAG_SacI_FWD and
F:TrwE_O.L._APCT_RVS with pKM101 as a template and trwE codons 303-395 using
F:TrwE_O.L._APCT_FWD and TrwE_RVS_XhoI with pJG145 as a template. The resulting 2
PCR fragments were joined together by overlapping PCR and the resulting fragment was
digested with SacI and XhoI and introduced into a SacI/XhoI digested pJG125 plasmid.
Plasmid pJG156 contains mini-pKM101 which produces NT FLAG TraF/AP-CTPtlG. It was
constructed by amplifying traF codons 1-307 using primers TraF_NT_FLAG_SacI_FWD and
F:PtlG O.L. RVS with pKM101 as a template and ptlG codons 294-374 using
F:PtlG_O.L._FWD and PtlG_RVS_XhoI using pJG203 as a template. The resulting 2 PCR
fragments were joined together by overlapping PCR and the resulting fragment was digested
with SacI and XhoI and introduced into a SacI/XhoI digested pJG125 plasmid.
Plasmid pJG162 contains mini-pKM101 which produces AP FLAG TraF. It was constructed
by amplifying traF codons 1-330 using primers TraF_FWD_SacI and TraF_FLAG_330_RVS
and codons 331-386 with primers TraF_FLAG_331_FWD and TraF_RVS_XhoI with pKM101
as a template. The resulting fragments were joined via overlapping PCR and the resulting PCR
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fragment was digested with SacI and XhoI and introduced into a SacI/XhoI digested pJG125
plasmid.
Plasmid pJG163 contains mini-pKM101 which produces CT FLAG TraF. It was constructed
by amplifying traF using primers TraF_FWD_SacI and TraF_FLAG_CT_RVS_XhoI with
pKM101 as a template. The resulting fragment was digested with SacI and XhoI and introduced
into a SacI/XhoI digested pJG125 plasmid.
Plasmid pJG164 contains mini-pKM101 which produces Lever FLAG TraF. It was constructed
by amplifying traF codons 1-183 using primers TraF_FWD_SacI and Lever_FLAG_RVS and
codons 184-386 with primers Lever_FLAG_FWD and TraF_RVS_XhoI with pKM101 as a
template. The resulting fragments were joined via overlapping PCR and the resulting PCR
fragment was digested with SacI and XhoI and introduced into a SacI/XhoI digested pJG125
plasmid.

Construction of chimeric operons
Plasmid pJG202 contains the chimeric tra:virB operon. A DNA fragment encoding virB7-traEvirB9-traF/BB-CTvirB10 was designed with each gene codon optimized for expression in E. coli.
The DNA fragment contained flanking SacI and XhoI restriction sites and was cloned as a bluntended fragment into an EcoRV-digested pUC57-Amp plasmid. DNA fragment synthesis and
cloning was performed by Genewiz Inc.
Plasmid pJG203 contains the chimeric tra:ptl operon. A DNA fragment encoding ptlI-traEptlF-traF/BB-CTptlG was designed with each gene codon optimized for expression in E. coli. The
chimeric traF:ptlG gene contains codons 1-172 of traF followed by codons 160-374 of ptlG.
The DNA fragment contained flanking SacI and XhoI restriction sites and was cloned as a blunt-
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ended fragment into an EcoRV-digested pUC57-Amp plasmid. DNA fragment synthesis and
cloning was performed by Genewiz Inc.
Plasmid pJG144 contains mini-pKM101 producing the chimeric Tra:VirB T4SS. The tra:virB
fragment from pJG202 was digested from the plasmid using SacI and XhoI and introduced into a
SacI/XhoI digested pJG143 plasmid.
Plasmid pJG151 contains mini-pKM101 producing the chimeric Tra:Ptl T4SS. The tra:ptl
fragment from pJG203 was digested from the plasmid using SacI and XhoI and introduced into a
SacI/XhoI digested pJG143 plasmid.
Plasmid pJG145 contains mini-pKM101 producing the chimeric Tra:Trw T4SS.

It was

constructed by amplifying trwH using primers TrwH_FWD_KpnI_SacI and TrwH_RVS_TraE,
trwF using primers TrwF_FWD_TraE and TrwF_RVS_TraF, and trwE codons 197-395 using
primers TrwE_FWD_TraF and TrwE_RVS_XhoI using pSU1443 as a template (150). traE was
amplified using primers TraE_FWD_TrwH and TraE_RVS_TrwF and traF codons 1-193 were
amplified using primers TraF_FWD_TrwF and TraF_RVS_TrwE using pKM101 as a template.
The five PCR products were joined together by overlapping PCR and the resulting product was
digested with using SacI and XhoI and introduced into a SacI/XhoI digested pJG143 plasmid.

Construction of traF amber mutants for photocrosslinking
Plasmid pJG111 expresses PBAD::traF-P185amber producing TraF with pBpa incorporated at
position 185.

It

was constructed by amplifying codons 1-184 using primers

TraF_NT_His_FWD_NcoI and P185_RVS_Overlap and codons 186-386 using primers
P185_FWD_Overlap and TraF_FLAG_CT_RVS_XhoI with pKM101 as a template. These
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fragments were joined through overlapping PCR and the resulting PCR fragment was digested
with NcoI and XhoI and ligated into an NcoI/SalI digested pBAD24Spc.
Plasmid pJG112 expresses PBAD::traF-W304amber producing TraF with pBpa incorporated at
position 304.

It

was constructed by amplifying codons 1-303 using primers

TraF_NT_His_FWD_NcoI and W304_RVS_Overlap and codons 305-386 using primers
W304_FWD_Overlap and TraF_FLAG_CT_RVS_XhoI with pKM101 as a template. These
fragments were joined through overlapping PCR and the resulting PCR fragment was digested
with NcoI and XhoI and ligated into an NcoI/SalI digested pBAD24Spc.
Plasmid pJG113 expresses PBAD::traF-F316amber producing TraF with pBpa incorporated at
position 316.

It

was constructed by amplifying codons 1-315 using primers

TraF_NT_His_FWD_NcoI and F316_RVS_Overlap and codons 317-386 using primers
F316_FWD_Overlap and TraF_FLAG_CT_RVS_XhoI with pKM101 as a template. These
fragments were joined through overlapping PCR and the resulting PCR fragment was digested
with NcoI and XhoI and ligated into an NcoI/SalI digested pBAD24Spc.
Plasmid pJG114 expresses PBAD::traF-N325amber producing TraF with pBpa incorporated at
position 325.

It

was constructed by amplifying codons 1-324 using primers

TraF_NT_His_FWD_NcoI and N325_RVS_Overlap and codons 326-386 using primers
N325_FWD_Overlap and TraF_FLAG_CT_RVS_XhoI with pKM101 as a template. These
fragments were joined through overlapping PCR and the resulting PCR fragment was digested
with NcoI and XhoI and ligated into an NcoI/SalI digested pBAD24Spc.
Plasmid pJG115 expresses PBAD::traF-Y334amber producing TraF with pBpa incorporated at
position 334.

It

was constructed by amplifying codons 1-333 using primers

TraF_NT_His_FWD_NcoI and Y334_RVS_Overlap and codons 335-386 using primers
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Y334_FWD_Overlap and TraF_FLAG_CT_RVS_XhoI with pKM101 as a template. These
fragments were joined through overlapping PCR and the resulting PCR fragment was digested
with NcoI and XhoI and ligated into an NcoI/SalI digested pBAD24Spc.
Plasmid pJG116 expresses PBAD::traF-Q343amber producing TraF with pBpa incorporated at
position 343.

It

was constructed by amplifying codons 1-342 using primers

TraF_NT_His_FWD_NcoI and Q343_RVS_Overlap and codons 344-386 using primers
Q343_FWD_Overlap and TraF_FLAG_CT_RVS_XhoI with pKM101 as a template. These
fragments were joined through overlapping PCR and the resulting PCR fragment was digested
NcoI and XhoI and ligated into an NcoI/SalI digested pBAD24Spc.
Plasmid pJG117 expresses PBAD::traF-Y352amber producing TraF with pBpa incorporated at
position 352.

It

was constructed by amplifying codons 1-351 using primers

TraF_NT_His_FWD_NcoI and Y352_RVS_Overlap and codons 353-386 using primers
Y352_FWD_Overlap and TraF_FLAG_CT_RVS_XhoI with pKM101 as a template. These
fragments were joined through overlapping PCR and the resulting PCR fragment was digested
with NcoI and XhoI and ligated into an NcoI/SalI digested pBAD24Spc.
Plasmid pJG118 expresses PBAD::traF-F377amber producing TraF with pBpa incorporated at
position 377.

It

was constructed by amplifying codons 1-376 using primers

TraF_NT_His_FWD_NcoI and F377_RVS_Overlap and codons 378-386 using primers
F377_FWD_Overlap and TraF_FLAG_CT_RVS_XhoI with pKM101 as a template. These
fragments were joined through overlapping PCR and the resulting PCR fragment was digested
NcoI and XhoI and ligated into an NcoI/SalI digested pBAD24Spc.
Plasmid pJG119 expresses PBAD::traF-N386amber producing TraF with pBpa incorporated at
position 386. It was constructed by amplifying traF using primers TraF_NT_His_FWD_NcoI
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and N386_RVS_FLAG_XhoI with pKM101 as a template. This PCR product was digested
with NcoI and XhoI and ligated into an NcoI/SalI digested pBAD24Spc.
Plasmid pJG214 expresses PBAD::traF-CT_FLAG, producing TraF with a C-terminal FLAG
tag. It was constructed by PCR amplification of traF using primers TraF_FWD_NcoI and
TraF_CT_FLAG_RVS_XhoI and pKM101 as a template. The resulting PCR fragment was
digested with NcoI and XhoI and ligated into an NcoI/SalI digested pBAD24Spc.
Plasmid pJG204 expresses PBAD::traF-A2amber producing TraF with pBpa incorporated at
position 2.

It was constructed using inverse PCR using primers 2_amber_Inv_FWD and

2_amber_Inv_RVS with pJG214 as a template.
Plasmid pJG205 expresses PBAD::traF-V6amber producing TraF with pBpa incorporated at
position 6.

It was constructed using inverse PCR using primers 6_amber_Inv_FWD and

6_amber_Inv_RVS with pJG214 as a template.
Plasmid pJG206 expresses PBAD::traF-E11amber producing TraF with pBpa incorporated at
position 11. It was constructed using inverse PCR using primers 11_amber_Inv_FWD and
11_amber_Inv_RVS with pJG214 as a template.
Plasmid pJG207 expresses PBAD::traF-T16amber producing TraF with pBpa incorporated at
position 16. It was constructed using inverse PCR using primers 16_amber_Inv_FWD and
16_amber_Inv_RVS with pJG214 as a template.
Plasmid pJG208 expresses PBAD::traF-S23amber producing TraF with pBpa incorporated at
position 23. It was constructed using inverse PCR using primers 23_amber_Inv_FWD and
23_amber_Inv_RVS with pJG214 as a template.
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Plasmid pJG209 expresses PBAD::traF-G27amber producing TraF with pBpa incorporated at
position 27. It was constructed using inverse PCR using primers 27_amber_Inv_FWD and
27_amber_Inv_RVS with pJG214 as a template.
Plasmid pJG210 expresses PBAD::traF-N32amber producing TraF with pBpa incorporated at
position 32. It was constructed using inverse PCR using primers 32_amber_Inv_FWD and
32_amber_Inv_RVS with pJG214 as a template.
Plasmid pJG211 expresses PBAD::traF-V43amber producing TraF with pBpa incorporated at
position 43. It was constructed using inverse PCR using primers 43_amber_Inv_FWD and
43_amber_Inv_RVS with pJG214 as a template.
Plasmid pJG212 expresses PBAD::traF-L45amber producing TraF with pBpa incorporated at
position 45. It was constructed using inverse PCR using primers 45_amber_Inv_FWD and
45_amber_Inv_RVS with pJG214 as a template.
Plasmid pJG213 expresses PBAD::traF-L49amber producing TraF with pBpa incorporated at
position 49. It was constructed using inverse PCR using primers 49_amber_Inv_FWD and
49_amber_Inv_RVS with pJG214 as a template.

Construction of A. tumefaciens plasmids
Plasmid pJG1 expresses Plac::virB10-G269R encoding VirB10 with a G269R mutation. It was
constructed by amplifying codons 1-268 using primers VirB10_FWD_NdeI and G269R_RVS
and codons 270-377 using primers G269R_FWD and B10_RVS_XhoI with pKVD10 as a
template. These two fragments were joined together via overlapping PCR and the resulting
PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.
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Plasmid pJG2 expresses Plac::virB10-G269K encoding VirB10 with a G269K mutation. It was
constructed by amplifying codons 1-268 using primers VirB10_FWD_NdeI and G269K_RVS
and codons 270-377 using primers G269K_FWD and B10_RVS_XhoI with pKVD10 as a
template. These two fragments were joined together via overlapping PCR and the resulting
PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.
Plasmid pJG3 expresses Plac::virB10-G269W encoding VirB10 with a G269W mutation. It
was constructed by amplifying codons 1-268 using primers VirB10_FWD_NdeI and
G269W_RVS and codons 270-377 using primers G269W_FWD and B10_RVS_XhoI with
pKVD10 as a template. These two fragments were joined together via overlapping PCR and
the resulting PCR product was cloned into NdeI/XhoI digested pKVD10 vector.
Plasmid pJG4 expresses Plac::virB10-G269C encoding VirB10 with a G269C mutation. It was
constructed by amplifying codons 1-268 using primers VirB10_FWD_NdeI and G269C_RVS
and codons 270-377 using primers G269C_FWD and B10_RVS_XhoI with pKVD10 as a
template. These two fragments were joined together via overlapping PCR and the resulting
PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.
Plasmid pJG5 expresses Plac::virB10-G269D encoding VirB10 with a G269D mutation. It was
constructed by amplifying codons 1-268 using primers VirB10_FWD_NdeI and G269D_RVS
and codons 270-377 using primers G269D_FWD and B10_RVS_XhoI with pKVD10 as a
template. These two fragments were joined together via overlapping PCR and the resulting
PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.
Plasmid pJG6 expresses Plac::virB10-G272R encoding VirB10 with a G272R mutation. It was
constructed by amplifying codons 1-271 using primers VirB10_FWD_NdeI and G272R_RVS
and codons 273-377 using primers G272R_FWD and B10_RVS_XhoI with pKVD10 as a

90
template. These two fragments were joined together via overlapping PCR and the resulting
PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.
Plasmid pJG7 expresses Plac::virB10-G272K encoding VirB10 with a G272K mutation. It was
constructed by amplifying codons 1-271 using primers VirB10_FWD_NdeI and G272K_RVS
and codons 273-377 using primers G272K_FWD and B10_RVS_XhoI with pKVD10 as a
template. These two fragments were joined together via overlapping PCR and the resulting
PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.
Plasmid pJG8 expresses Plac::virB10-G272W encoding VirB10 with a G272W mutation. It
was constructed by amplifying codons 1-271 using primers VirB10_FWD_NdeI and
G272W_RVS and codons 273-377 using primers G272W_FWD and B10_RVS_XhoI with
pKVD10 as a template. These two fragments were joined together via overlapping PCR and
the resulting PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.
Plasmid pJG9 expresses Plac::virB10-G272C encoding VirB10 with a G272C mutation. It was
constructed by amplifying codons 1-271 using primers VirB10_FWD_NdeI and G272C_RVS
and codons 273-377 using primers G272C_FWD and B10_RVS_XhoI with pKVD10 as a
template. These two fragments were joined together via overlapping PCR and the resulting
PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.
Plasmid pJG10 expresses Plac::virB10-G272D encoding VirB10 with a G272D mutation. It
was constructed by amplifying codons 1-271 using primers VirB10_FWD_NdeI and
G272D_RVS and codons 273-377 using primers G272D_FWD and B10_RVS_XhoI with
pKVD10 as a template. These two fragments were joined together via overlapping PCR and
the resulting PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.
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Plasmid pJG11 expresses Plac::virB10-G275R encoding VirB10 with a G275R mutation. It
was constructed by amplifying codons 1-274 using primers VirB10_FWD_NdeI and
G275R_RVS and codons 276-377 using primers G275R_FWD and B10_RVS_XhoI with
pKVD10 as a template. These two fragments were joined together via overlapping PCR and
the resulting PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.
Plasmid pJG12 expresses Plac::virB10-G275K encoding VirB10 with a G275K mutation. It
was constructed by amplifying codons 1-274 using primers VirB10_FWD_NdeI and
G275K_RVS and codons 276-377 using primers G275K_FWD and B10_RVS_XhoI with
pKVD10 as a template. These two fragments were joined together via overlapping PCR and
the resulting PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.
Plasmid pJG13 expresses Plac::virB10-G275R encoding VirB10 with a G275W mutation. It
was constructed by amplifying codons 1-274 using primers VirB10_FWD_NdeI and
G275W_RVS and codons 276-377 using primers G275W_FWD and B10_RVS_XhoI with
pKVD10 as a template. These two fragments were joined together via overlapping PCR and
the resulting PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.
Plasmid pJG14 expresses Plac::virB10-G275C encoding VirB10 with a G275C mutation. It
was constructed by amplifying codons 1-274 using primers VirB10_FWD_NdeI and
G275C_RVS and codons 276-377 using primers G275C_FWD and B10_RVS_XhoI with
pKVD10 as a template. These two fragments were joined together via overlapping PCR and
the resulting PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.
Plasmid pJG15 expresses Plac::virB10-G275D encoding VirB10 with a G275D mutation. It
was constructed by amplifying codons 1-274 using primers VirB10_FWD_NdeI and
G275D_RVS and codons 276-377 using primers G275D_FWD and B10_RVS_XhoI with
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pKVD10 as a template. These two fragments were joined together via overlapping PCR and
the resulting PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.
Plasmid pSJ501 expresses Plac::virB10-TraF_AP encoding VirB10 containing the AP of TraF.
It was constructed through PCR amplification of virB10 codons 1-287 with primers
VirB10_FWD_NdeI

and

B10_288_RVS_TraF

and

codons

339-377

with

primers

B10_339_FWD_TraF and B10_RVS_XhoI with pKVD10 as a template. Codons 307-335 of
traF were amplified using primers TraF_307_FWD_B10 and TraF_335_RVS_B10 with
pKM101 as a template. These three fragments were joined together using overlapping PCR
and and the resulting PCR fragment was digested with NdeI and XhoI and ligated into an
NdeI/XhoI digested pKVD10 vector.
Plasmid pSJ502 expresses Plac::virB10-TraF_AP-CT encoding VirB10 containing the AP and
C-terminal tail of TraF. It was constructed through PCR amplification of virB10 codons 1-287
with primers VirB10_FWD_NdeI and B10_288_RVS_TraF with pKVD10 as a template and
traF codons 307-386 with primers TraF_307_FWD_B10 and TraF_RVS_XhoI.

These

fragments were joined together with overlapping PCR and the resulting PCR fragment was
digested with NdeI and XhoI and ligated into an NdeI/XhoI digested pKVD10 vector.
Plasmid pSJ503 contains a 3x FLAG sequence cloned into a pZZ11 plasmid.
constructed

by

annealing

primers

3xFLAG_Sense_NcoI_NdeI_XhoI_BamHI

It was
and

3xFLAG_Antisense_NcoI_NdeI_XhoI_BamHI followed by digestion with NcoI and XhoI and
ligating into an NcoI/XhoI digested pZZ11 plasmid.
Plasmid pSJ504 expresses Plac::virB10-∆AP encoding VirB10 with an AP deletion (residues
288-337).

It was constructed through inverse PCR with primers B10_AP_Del_FWD and

B10_AP_Del_RVS with pKVD10 as a template.
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Plasmid pSJ510 expresses Plac::virB10-298.SphI encoding VirB10 with an Ala-Cys insertion
at position 298. It was constructed through inverse PCR with primers B10_298_SphI_FWD
and B10_298_SphI_RVS with pKVD10 as a template.
Plasmid pSJ511 expresses Plac::virB10-329.SphI encoding VirB10 with an Ala-Cys insertion
at position 329. It was constructed through inverse PCR with primers B10_329_SphI_FWD
and B10_329_SphI_RVS with pKVD10 as a template.
Plasmid pSJ512 expresses Plac::virB10-332.SphI encoding VirB10 with an Ala-Cys insertion
at position 332. It was constructed through inverse PCR with primers B10_332_SphI_FWD
and B10_329_SphI_RVS with pKVD10 as a template.
Plasmid pJG40 expresses Plac::virB10-298.3xFLAG encoding VirB10 with a 3x FLAG
insertion at position 298. It was constructed by amplifying the 3x FLAG sequence using
primers 3xFLAG_FWD_SphI and 3xFLAG_RVS_SphI with pSJ503 as a template.

The

resulting PCR product was digested with SphI and ligated into an SphI digested pSJ510
plasmid.
Plasmid pJG42 expresses Plac::virB10-329.3xFLAG encoding VirB10 with a 3x FLAG
insertion at position 329. It was constructed by amplifying the 3x FLAG sequence using
primers 3xFLAG_FWD_SphI and 3xFLAG_RVS_SphI with pSJ503 as a template.

The

resulting PCR product was digested with SphI and ligated into an SphI digested pSJ511
plasmid.
Plasmid pJG44 expresses Plac::virB10-332.3xFLAG encoding VirB10 with a 3x FLAG
insertion at position 332. It was constructed by amplifying the 3x FLAG sequence using
primers 3xFLAG_FWD_SphI and 3xFLAG_RVS_SphI with pSJ503 as a template.

The
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resulting PCR product was digested with SphI and ligated into an SphI digested pSJ512
plasmid.
Plasmid pJG52 expresses Plac::virB10-310.2xFLAG encoding VirB10 with a 2x FLAG
insertion at position 310.

It was constructed by amplifying codons 1-309 using primers

VirB10_FWD_NdeI and virB10_310_2xFLAG_RVS and codons 311-377 using primers
virB10_310_2xFLAG_FWD and B10_RVS_XhoI with pKVD10 as a template. These two
fragments were joined together via overlapping PCR and the resulting PCR product was
digested with NdeI and XhoI and ligated into an NdeI/XhoI digested pKVD10 vector.

Conjugation assays
Donor and recipient cells were inoculated from glycerol stocks into 2 ml of LB
containing antibiotics and grown overnight at 37°C with shaking. Cells were diluted 1:100 in
antibiotic-free media and incubated for 1 h with shaking at 37°C. For induction from the PBAD
promoter, arabinose was added (0.2 % final concentration) followed by incubation for 1 h with
shaking at 37°C. Donors and recipients (2.5 µl) were mixed on a nitrocellulose filter on LB
media containing 0.2% arabinose and the mating mix was incubated for 2 h at 37°C. For broth
matings, induced donors were mixed with recipients at a 1:1 volumetric ratio and incubated at
37°C for 2 h. Filter and broth mating mixtures were serially diluted and plated on media
selective for transconjugants and donors. Frequency of transfer was calculated as the number of
transconjugants per donor (Tcs/D). Experiments were performed at least three times in duplicate
or triplicate, and results are reported as the mean frequency of transfer.
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Phage infection assays
Strains carrying plasmids of interest were grown and, when necessary, induced with
arabinose as described above for the conjugation assays. Fifty microliters of cells at a
concentration of ~108 ml-1 were spread on an LB plate containing appropriate antibiotics and
arabinose, and allowed to dry. Five microliters of the bacteriophages PRD1 (106 pfu, final
concentration) or IKe (108 pfu, final concentration) were spotted onto the lawns of cells, and
plates were incubated overnight at 37°C. Sensitivity to PRD1 and IKe was quantified in a plaque
assay, as described previously (45). Briefly, cells were grown and induced with 0.2% arabinose.
Approximately 107 cells were incubated with a series of 10-fold dilutions of PRD1 or IKe for 20
min at room temperature. The mix was added to 5 ml of 0.4% melted LB agar, which was then
overlaid on a 1.5% LB agar plate containing antibiotics and arabinose. Plates were incubated at
37°C overnight, and phage sensitivity was reported as the concentration of phage in plaque
forming units (pfu)/ml.

Steady state level detection
E. coli strains were grown and induced for production of TraF variants of interest in LB
media, harvested, and normalized to equivalent optical densities (OD600). Total protein extracts
were subjected to SDS-PAGE, proteins were transferred to nitrocellulose membranes, and blots
were developed with primary antibodies and HRP-conjugated secondary antibodies for
detection of the TraF proteins by chemiluminescence.
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Pseudomonas aeruginosa type VI killing assay
T4SS-mediated killing of E. coli by the Pseudomonas aeruginosa type VI secretion
system (T6SS) was carried out as previously described (140). Briefly, 2 ml of E. coli DH5α
donors and a P. aeruginosa PAO1 retS mutant were incubated overnight with shaking at 37°C,
then resuspended in 2 ml of antibiotic-free LB followed by a 1:100 dilution in 5 ml of
antibiotic-free LB. Cells were then incubated with shaking at 37°C for 2 h, pelleted and
resuspended in 100 µl LB. P. aeruginosa (17 µl) were mixed with E. coli (3µl) on filters placed
on LB plates and incubated for 3 h at 37°C. Cells were resuspended in 1 ml of LB and serial
dilutions were spotted onto plates containing spectinomycin 300 µg/ml and rifampicin 100
µg/ml to select for growth of E. coli. T6SS killing of E. coli is presented as E. coli cell viability
in colony forming units (CFU) per ml.

pBpa incorporation and UV crosslinking
Site-directed photocrosslinking of pBpa-incorporated TraF variants was carried as
described previously (151). Briefly, E. coli TOP10 cells containing the amber mutant of
interest and the pEVOL plasmid were grown overnight at 37ºC with shaking in the presence of
antibiotics. The next day, cells were diluted 1:20 into fresh LB containing antibiotics and
grown at 37ºC to an OD600 between 0.6 and 0.9. The cells were then concentrated 20-fold in
antibiotic-free LB containing 0.2% arabinose and 1mM pBpa. The cells were incubated at 37ºC
with shaking for 1 hour. When testing for interactions between TraF and other proteins, cells
were resuspended in PBS and exposed to UV light at 365nm for 10 minutes, while incubated on
ice in the dark. Cells were spun down and stored at -80ºC until further processing.
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Membrane solubilization and TraF purification
Cells frozen at -80ºC were thawed and resuspended in TE buffer (Tris-HCl pH8.0, 1mM
EDTA pH 8.0). Cells were next lysed with a bead beater homogenizer. Beads and unbroken
cells were spun out at 13,000 RPM for 30 minutes at 4ºC. The whole cell lysate was spun down
at ~200,000 x g for 1 hour. The membrane pellet was resuspended in solubilization buffer
(100 mM Tris-HCl pH 8.0, 300 mM NaCl, 1mM EDTA, 2% Triton-X 100) and incubated at
4ºC for 2 hours with gentle shaking. Samples were spun again at 200,000 x g for 1 hour to
remove insoluble material. The supernatant was incubated with 20 l of pre-equilibrated αFLAG magnetic beads (Sigma) overnight at 4ºC with gentle shaking. Magnetic beads were
washed 3 times with 1ml of solubilization buffer per wash. α-FLAG magnetic beads were
incubated with 3xFLAG peptide (Sigma) at a concentration of 200 g/ml at 4ºC for 1 hour to
elute TraF off of the beads. The beads were removed from the supernatant, mixed with 2x
Laemmli’s buffer, and run on an SDS-PAGE gel followed by Western blotting.

T-DNA transfer assays
A. tumefaciens cells were streaked onto MG/L plates containing the appropriate
antibiotics and grown from 2-3 days at 28ºC. Leaves from Kalanchoe daigremontiana were
wounded with a sterile toothpick followed by an inoculation of A. tumefaciens cells from the
MG/L plate into the wound. Following inoculation, wounded Kalanchoe daigremontiana were
incubated at room temperature in the dark for 5-7 days followed by incubation in light for 1-2
months. Plant tumors were scored based on their size relative to tumors formed by the wildtype A348 strain.
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Colony immunoblot (Agrobacterium tumefaciens)
Colony immunoblots were used to detect the presence of VirB2 on the cell surface. A.
tumefaciens were streaked onto MG/L plates and incubated at 28ºC for 2-3 days. Following
growth on agar plates, colonies were inoculated into 2 ml of MG/L broth containing appropriate
antibiotics and grown overnight at room temperature (~25ºC). The next day, cells were spun
down and resuspended in 2.5 ml ABIM broth containing 100 M acetosyringone followed by
incubation at room temperature for 24 hours. Cells were spotted on ABIM agar and incubated
at 18ºC for four days. Cells were then blotted onto nitrocellulose membranes for 30 minutes.
Membranes were then incubated in 5% non-fat dry milk for 20 minutes in order to block the
membrane as well as wash off excess cells. Cells were then incubated with primary α-VirB2
antibodies followed by secondary antibodies and development with chemiluminescence
reagents.

Colony immunoblot (Escherichia coli)
E. coli cells were inoculated from glycerol stocks into 2 ml LB broth containing
antibiotics and incubated overnight at 37ºC with agitation. The next day, cells were subcultured
1:100 into fresh LB without antibiotics. These cells were incubated at 37ºC with agitation for
2.5 hours. Nitrocellulose was placed on a fresh LB plate without antibiotics and 5 l of each
subculture was added to the nitrocellulose and incubated at 37ºC for 2 hours. Afterwards,
nitrocellulose membranes were blocked in 5% non-fat dry milk for 20 minutes. Membranes
were then incubated with α-FLAG primary antibodies followed by secondary antibodies and
development with chemiluminescence reagents.
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Chapter 3: Contributions of the VirB10 GxxGxxG
Motif and Antenna Projection in T-DNA Transfer and
Pilus Biogenesis
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Introduction
The Agrobacterium tumefaciens VirB/VirD4 type IV secretion system (T4SS) is
assembled from 11 VirB proteins and the VirD4 substrate receptor, also termed the type IV
coupling protein (T4CP) (5). A. tumefaciens uses this T4SS to deliver oncogenic T-DNA and
effector proteins to plant cells. Previous analyses established that all of the VirB proteins except
VirB1 are essential for delivery of T-DNA and effector proteins to plants and for mobilization of
an RSF1010 plasmid substrate to A. tumefaciens recipient cells (67). The VirB/VirD4 T4SS is
similar to the Escherichia coli pKM101-encoded Tra conjugation system in terms of its transfer
loci and subunit composition (152). A structure of the pKM101 outer membrane “core complex”
was solved by the Waksman laboratory by cryo-electron microscopy, and a portion of this
complex (the O-layer) also was solved by X-ray crystallography (82,90). The core complex is
predicted to extend from the periplasmic face of the inner membrane across the periplasm to the
cell exterior. It consists of 14 copies each of the VirB7-like TraN, VirB9-like TraO and VirB10like TraF subunits arranged in a ~1 MDa barrel-shaped structure. In the X-ray structure, TraF
lines the inner chamber of the translocation channel, TraO comprises the outer wall, and TraN
anchors the subassembly to the outer membrane (Figure 1.10).
In collaboration with Dr. Lois Banta, the Christie lab identified and characterized a
mutation in VirB10 at position 272 (G272R) that conferred non-specific release of the secretion
substrate VirE2 to the cell exterior (125).

This mutation had no effect on intercellular

transmission of T-DNA or effector proteins, but completely blocked biogenesis of the T-pilus
(125). In the crystal structure of the TrapKM101 O-layer, the corresponding Gly residues in TraF
line the interior chamber of core complex near the OM-spanning cap domain. G272 is one of
three highly conserved Gly residues arrayed as a GxxGxxG motif among VirB10 homologs
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(Figures 3.1 and 3.2) (125). Results of the G272R mutational analyses led to a prediction that
these conserved Gly residues might mark the site of a gate within the core complex chamber that
controls substrate release as well as extension of the T pilus across the OM. In agreement with
this proposal, the Christie lab provided evidence that the G272R mutation locks VirB10 in an
activated conformation required for substrate transfer that is achieved in wild-type cells only
when DNA substrates are docked with the VirD4 receptor and when both VirD4 and VirB11 are
competent for hydrolysis of ATP (107,125). When I joined the Christie laboratory, I decided to
further define the importance of the GxxGxxG motif in regulating substrate transfer and pilus
biogenesis.
The crystal structure of the pKM101 core complex also shows that the conserved
GxxGxxG motif is located near the antennae projection (AP) of TraF, which as mentioned in
Chapter 1, assembles as a putative OM-spanning cap domain. As part of a mutational analysis of
VirB10At, the Christie lab had shown that a “deletion” of the AP attenuated DNA transfer, but
blocked detectable pilus biogenesis (127). However, the assignment of this AP domain was
based on a previous X-ray structure of the ComB10 subunit associated with the ComB DNAuptake T4SS in Helicobacter pylori (111). With the availability of an X-ray structure of the Olayer of the TrapKM101 T4SS, we reassigned VirB10’s AP domain boundaries and I also evaluated
the contributions of the AP to T-DNA transfer and pilus assembly in A. tumefaciens.
The goals of my studies in A. tumefaciens, therefore, were to further define the
contributions of VirB10’s conserved GxxGxxG motif and the AP domain to elaboration of the
translocation channel and the T pilus. In the course of my studies, through a collaboration with
Dr. Gabriel Waksman’s laboratory, we also succeeded in purifying the core complex from the A.
tumefaciens VirB/VirD4 T4SS and solving its structure by negative-staining transmission
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Figure 3.1 Alignment of VirB10 and homologs. VirB10 along with its homologs from
plasmid pKM101 (TraF), plasmid R388 (TrwE) and the Bordetella pertussis Ptl T4SS (PtlG).
Sequences were aligned with Multalin (http://multalin.toulouse.inra.fr/multalin); "Multiple
sequence alignment with hierarchical clustering" F. Corpet, 1988, Nucl. Acids Res., 16 (22),
10881-10890)and recreated for the AP and C-terminal regions. Regions of interest, including
the GxxGxxG motif and AP α2 and α3 helices, are highlighted above the sequence and were
annotated based on the structure and sequence of TraF.
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Figure 3.2 Location of the conserved GxxGxxG motif. (A) Structural model of the Cterminal half of VirB10, derived from the TraF structure within the pKM101 O-layer X-ray
structure using the Pymol algorithm (http://pymol.org).

The location of the G269 (Green),

G272 (Red), and G275 (Yellow) residues at the base of the helix-loop-helix AP domain
(Blue) are shown. (B) Top-down view of the core complex with the position of G275 circled
in yellow. (C) Cut-away view of the core complex O-layer highlighting the position of G727
circled in red. (D) Side view depicting the positions of G269 and G275 circled in green and
yellow, respectively. The structure of the core complex O-layer was generated using Pymol
(http://pymol.org) based on the 3ZBI file deposited into the NCBI protein database.

105

106
electron microscopy at a resolution of 21Å. Results of these studies, coupled with additional
experiments focusing on the TrapKM101 system (see next chapters), underscored the structural and
functional conservation of core complexes associated with the type IVa secretion systems.
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Results
Mutations in G269 and G272 attenuate T-DNA transfer into plant cells
To evaluate the functional importance of the conserved GxxGxxG motif located between
residues 269 and 275 of VirB10, I substituted each of the Gly residues with amino acids varying
in sized or charge: Arg or Lys (positively-charged), Asp (negatively-charged), Trp (bulky
aromatic), Cys (neutral, potentially useful for crosslinking studies) (Figure 3.3). Plasmids
expressing the virB10 mutant alleles were introduced into the virB10 mutant strain PC1010. I
next tested for the capacities of the mutant strains to deliver oncogenic T-DNA to plant cells.
Interestingly, all strains delivered T-DNA to plants, as monitored by formation of tumors on
infected plants (Figure 3.4). Strains expressing virB10 alleles bearing Gly275 substitutions
generally incited robust tumor development, with the exception of virB10G275C, which
supported only very attenuated tumor formation. Strains expressing alleles with Gly269 or G272
substitutions

were

avirulent

(G269R),

strongly

attenuated

in

virulence

(G269K/D,

G272R//K/W/D), or moderately attenuated in virulence (G269W/C, G272C).

These Gly

residues, which are more highly conserved than G275 among the VirB10 homologs, thus do not
tolerate distinct types of substitutions.
I next evaluated the effects of Gly substitutions on assembly of the T pilus, whose
production can be monitored using a colony immunoblot assay to detect extracellular VirB2 pilin
(125,128).

Interestingly, Gly275 tolerated all substitutions without detectable effects on

accumulation of surface-exposed VirB2 pilin. By contrast, Arg substitutions of both Gly269 and
Gly272 abolished detectable surface pilin, as did a Trp substitution of G272 (Figure 3.4). These
findings confirm and extend findings from the Christie lab by showing substitutions not only of
positively-charged Arg, but also a bulky Trp residue at position 272 completely blocked pilus
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Figure 3.3 Substitution of the conserved glycines. Locations of the G269 G272, and
G275 residues on a structural model of the C-terminal half of VirB10 (residues 151 –
377) derived from TraF’s structure in the TrapKM101 O-layer X-ray structure (EMDB –
5031) At left, amino acids substituted for each of the conserved Gly residues. The

structure of TraF was generated using Pymol (http://pymol.org) based on the 3ZBI file
deposited into the NCBI protein database.
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Figure 3.4 Effects of glycine belt mutations on T-DNA transfer and pilus biogenesis.
Histograms depicting the level of T-DNA transfer as relative tumor size on Kalanchoe
daigremontiana leaves and surface-displayed VirB2 for each GxxGxxG mutant. Each strain was
placed on six separate leaves and tumors were scored compared to tumors formed by the wildtype A348 strain. Each strain was inoculated on six leaves and tumors were scored after 1 month
incubation. Tumor size on K. daigremontiana leaves were scaled from no detectable tumors (-) to
tumors similar both in size and kinetics of appearance to tumors incited by wild-type A348 (+++).
Tumors that were barely detectable were scored as one plus and tumors that were appreciably
smaller than those incited by A348 as two pluses. Surface-localized VirB2 was detected by
colony immunostaining using α-VirB2 antibodies as previously described.

111

112
production while permitting at least a low level of substrate transfer to plant cells.

Other

mutations in G272, as well as mutations in G269, conferred attenuated virulence, suggestive of
perturbing effects on assembly of the translocation channel.

By contrast, the less-highly

conserved G275 residue was more tolerant of the engineered substitutions.

The VirB10 AP is essential for pilus production, but not for substrate transfer.
The VirB10 AP helices are predicted to form the OM pore. As mentioned in the
introduction for this chapter, a previously-constructed VirB10 AP deletion mutation did not
completely abolish the AP (127). I deleted the VirB10 AP using boundaries based on the
alignment with TraF within the TrapKM101 O-layer (90). This new mutant protein, VirB10ΔAP,
supported T-DNA transfer but not pilus biogenesis. The VirB10 AP, which is predicted to span
the OM, is therefore critical for pilus polymerization but not for intercellular substrate transfer.
I next wanted to determine which regions of the AP contributed to pilus production. I
inserted 3x FLAG tags into the 2 or 3 helices, which are predicted to span the OM, and a 2x
FLAG tag into the flexible loop presumptively extending from the cell surface. None of these
epitope insertions blocked substrate transfer or pilus biogenesis despite the presence of many
negatively-charged residues in the FLAG sequence (Figure 3.5). The presence of an AP domain
is critical for pilus biogenesis, but this motif is able to withstand sizable mutations without
disruption of function.
The AP domains of TraF and VirB10 share approximately 31% identity with no
concentrated regions of homology. We next tested whether the AP domains of TraF and VirB10
were functionally exchangeable. S. Jakubowski constructed two chimeras of TraF and VirB10:
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Figure 3.5 Effects of AP FLAG tag insertion on T-DNA transfer and pilus biogenesis. (A)
Depiction of the VirB10 C-terminal half along with 2x and 3x FLAG insertions. (B) Western blot
depicting the steady state levels of the VirB10 AP mutants. Cells numbers were normalized based on
OD600 readings and cell lysates were run on an SDS-PAGE gel followed by Western blotting with αVirB10 antibodies. (C) Surface detection of VirB2 pilin subunits using colony immunoblotting.
Colonies were grown on acidic ABIM inducing agar for four days at 18°C followed by detection of
pilin subunits on the cell surface with α-VirB2 antibodies. (D) Histogram depicting the levels of TDNA transfer for each of the AP mutants into K. daigremontiana leaves.

Tumor size on K.

daigremontiana leaves were scaled from no detectable tumors (-) to tumors similar both in size and
kinetics of appearance to tumors incited by wild-type A348 (+++).

Tumors that were barely

detectable were scored as one plus and tumors that were appreciably smaller than those incited by
A348 as two pluses
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(i) one containing an AP substitution (VirB10/APTraF) and (ii) the other including the C-terminal
tail as well (VirB10/AP-CTTraF). Similar to the other AP mutant proteins, VirB10/APTraF and
VirB10/AP-CTTraF supported T-DNA transfer, establishing that the APs of these homologs were
exchangeable. However, only VirB10/APTraF supported pilus production, indicating that the Cterminal tail is important for production of an extracellular pilus (Figure 3.5).

The structure of the A. tumefaciens VirB core complex resembles those of pKM101 and
R388.
The VirB/VirD4At, TrapKM101, and TrwR388 T4SSs are similar in gene arrangements and
subunit compositions. Structures of the OMCC subassemblies from the TrapKM101 and TrwR388
have been solved by cryo-electron microscopy or negative-staining electron microscopy
(82,84,90). Both of these structures are highly similar, suggesting the possibility that OMCCs
associated with the type IVa T4SSs are highly conserved in overall architecture and function. To
evaluate this idea further, we collaborated with the Waksman laboratory to obtain a structure of
the OMCC from the A. tumefaciens VirB/VirD4 T4SS. We inserted a Strep-tag sequence at the
end of virB10 carried on the pTi plasmid, and were able to confirm that subassemblies enriched
from the corresponding A. tumefaciens strain (A348.B10ST) by detergent solubilization and
Strep-tag affinity pull-down assays yielded ring-shaped complexes that were similar in
appearance to the pKM101 and R388 OMCCs, as determined by negative-staining EM. We sent
this strain to the Waksman laboratory where the VirB/VirD4 OMCC was further purified and
structurally resolved at 21Å resolution using negative staining electron microscopy. Similar to
the pKM101 OMCC, the VirB complex can be divided into an inner layer (I-layer) and an outer
layer (O-layer). The dimensions of the VirB complex are similar to the TrapKM101, and TrwR388
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OMCCs (Figure 3.6). However, the VirBAt structure is more cylindrical than its TrapKM101 and
TrwR388 OMCC counterparts and contains a broad pore-forming cup domain at the cell surface.
The significance of these differences is not understood at this time. Future studies on the VirBAt
core complex producing higher resolution images are required to better define the functional
significance of any structural differences observed among the core complexes solved to date.
At this time, however, the findings strongly support a proposal that the OMCCs of the
type IVa T4SSs employed by Gram-negative bacterial species share a common structural
arrangement, function, and ancestry.
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Figure 3.6 Structure of the A. tumefaciens VirB core complex. Negative-stain EM structure of
the A. tumefaciens outer-membrane core complex (OMCC) and comparison with the NS-EM
structure of the OMCC (EMDB-5032) encoded by E.coli pKM101. A) A. tumefaciens OMCC
side view (left) and cut-away side view (right). B) E.coli pKM101 OMCC side view (left) and
cut-away side view (right). C) Representation of the cut-away side view of the overlay of A.
tumefaciens and E.coli pKM101 OMCC’s. D) Cross-section of overlaid A. tumefaciens and E.coli
pKM101 OMCC complexes. Dashed line S in panel C indicates the level of the cross section
shown in panel D.

This figure was modified from Figure 6 in Gordon et al. Use of chimeric type IV secretion
systems to define contributions of outer membrane subassemblies for contact-dependent
translocation Molecular Microbiology 2017 doi: 10.1111/mmi.13700. It was re-published with
permission from John Wiley and Sons Publishing Group. License # 4113880880825
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Discussion
Previous studies in the Christie lab identified unique phenotypes associated with
mutations in the VirB10 GxxGxxG motif and AP domain (125,127). Both a G272R and AP
partial deletion blocked pilus biogenesis, but still allowed for detectable T-DNA transfer into
plant cells. When I joined the Christie lab, I decided to further define the role of G272 and the
surrounding G269 and G275 residues through a series of mutations substituting at each position
amino acids of different sizes and charges. Additionally, I intended to further define the role of
the AP helices through re-construction of another AP deletion as well as FLAG tag insertions.
Below, I will discuss my findings in greater detail and propose a model for their role in pilus
biogenesis and T-DNA transfer.
Mutations at G269 and G272 had the most detrimental effect on T-DNA transfer. In
contrast, most mutations at G275 were generally phenotypically silent. G269 and G272 are
located on the side and inner wall of the chamber, respectively where as G275 is predicted to be
situated on the outside of the -barrel possibly in juxtaposition with VirB9 (Figure 3.7). Based
on these structural findings, I predicted that G269 and G272 might mark a critical interface of the
OMCC and the translocation channel housed within this structural scaffold.
With respect to the AP, we had previously attempted to define the role of the VirB10 AP
through construction of an AP deletion (127). The deletion was based on an alignment of
VirB10 with H. pylori ComB10. However, in view of the new X-ray structure of the pKM101
O-layer, we reassigned the boundaries of APs of TraF and VirB10, the latter through sequence
alignments and Phyre 2 modeling. I made a new deletion of the AP and re-tested it for its ability
to restore T-DNA transfer and pilus biogenesis to the a ∆virB10 strain. This mutant phenocopied
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Figure 3.7 Summary of phenotypes associate with GxxGxxG motif. Depiction of
three phenotypes observed during characterization of the GxxGxxG motif. (A) G275W
and G275D mutations, located on the outer face of the O-layer, were silent in terms of
T-DNA transfer and pilus biogenesis. (B) Uncoupling mutations at positions at G272,
located in the channel lumen, allowed for attenuated T-DNA transfer, but blocked
detectable pilus biogenesis. (C) A mutation of G269, positioned on the outside of the
core complex, to an Arg residue block both T-DNA transfer and pilus biogenesis.

The structure of the core complex O-layer was generated using Pymol (http://pymol.org)
based on the 3ZBI file deposited into the NCBI protein database.
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the previous AP mutant with respect to substrate transfer but completely abolished our ability
to detect VirB2 pilin on the cell surface.

Models depicting the contributions of the GxxGxxG and the AP domain for pilus
biogenesis.
My data are consistent with two models for pilus biogenesis. In both models, upon
synthesis, VirB2 pilin subunits are delivered into the inner membrane where they are cleaved of
their signal sequences and covalently cyclized by a head-to-tail reaction. Upon receipt of signals
that presently are not specified, the pilins are extracted from the inner membrane pool via the
ATPase activities of VirB4, together with contributions by VirB11.
Model 1: Outer membrane nucleation. The membrane-extracted VirB2 pilin subunits are
delivered into the core complex channel where they transit to the distal region of the OMCC. At
the OMCC they interact with the AP either directly or via interaction with another subunit such
as the pilus tip protein VirB5 (Figure 3.8). The AP contacts then drive polymerization of the
pilin monomers into the extended pilus. According to this model, the AP plays a critical role in
pilus biogenesis by dynamically interacting with pilin monomers to direct their self-assembly
into the pilus. The G269 and G272 substitutions, which are positioned within the interior of the
OMCC chamber, might block pilus biogenesis through steric effects impeding delivery of the
pilins to the AP or, by interfering with formation of AP–pilin subunit contacts. Mutations at
G275, which interestingly map on the outer face of the -barrel, do not affect pilus biogenesis.
Model 2: Inner membrane platform model. Pilin subunits nucleate as the growing pilus
from an inner membrane platform possibly consisting of VirB6 and VirB8. The pilus extends to
the distal end of the OMCC where it is blocked from further extension by the AP domain of
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Figure 3.8 Models for pilus biogenesis in A. tumefaciens. Depiction of two models
for pilus biogenesis. (A) In Model 1, the VirB2 pilin subunit enters the OMCC chamber
after being dislodged from the IM. VirB5 will then exit the cell and make contact with
the AP helices, triggering the release of VirB2 from the channel. The AP will then serve
as an OM platform during pilus polymerization. (B) Model 2 states that VirB2 pilin
subunits enter the channel in the IM. Once extracellular VirB5 comes into contact with
the AP, the AP will allow for the passage of pilin subunits through the channel and
outside of the cell.

The core complex was modified from Figure 6 in Gordon et al. Use of chimeric type IV
secretion systems to define contributions of outer membrane subassemblies for contactdependent translocation Molecular Microbiology 2017 doi: 10.1111/mmi.13700. It was
re-published with permission from John Wiley and Sons Publishing Group. License #
4113880880825
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VirB10 (Figure 3.8).

Dr. Christian Gonzalez-Rivera has shown that the VirB5 homolog,

TraCpKM101, is secreted outside of the cell in the absence of a T4SS. We postulate that these pilus
tip proteins form contacts with the AP on the cell surface and with the tip of the pilus, and that
these contacts cause a conformational change in the AP to allow for pilus extraction.
At this time, it is not possible to discriminate between these models. However, my
further studies of the pKM101 Tra T4SS further establish the compositional and structural
flexibility of the OMCC for substrate transfer, as well as the importance of the OMCC cap for
pilus biogenesis.
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Chapter 4: Genetic Requirements for Plasmid Transfer
and Phage Sensitivity Through the pKM101-encoded
Type IV Secretion System
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Introduction
Gram-negative bacterial T4SSs are comprised of a core set of subunits that are required
for substrate translocation and pilus biogenesis. The Christie laboratory has been characterizing
structure and function relationships of the VirB/VirD4 T4SS from A. tumefaciens for over 25
years. As mentioned in the Introduction, this T4SS is assembled from the 11 VirB subunits and
the VirD4 type IV coupling protein (T4CP) (Figure 4.1). By construction of individual virB
gene deletions, combined with appropriate complementation analyses, the Christie laboratory
established that 10 of the 11 VirB subunits are required to build a functional translocation
channel, whereas all 11 subunits are required to build the T-pilus (67). The 11th gene, virB1,
encodes a lytic transglycosylase whose deletion strongly diminishes T-DNA transfer to plants,
but completely abolishes assembly of detectable pili. Corresponding genetic analyses of the
R388-encoded Trw T4SS and the RP4-encoded Tra/Trb T4SS similarly established the
importance of the associated lytic transglycosylases for pilus biogenesis, as monitored by
sensitivity to male-specific phage, but not for elaboration of functional translocation channels
(45,123). Surprisingly, in the TrwR388 system, the VirB7-like lipoprotein TrwH is not required
for assembly of the translocation channel (123). In A. tumefaciens, by contrast, VirB7 plays an
essential role in stabilizing the outer membrane-associated subunit VirB9 through formation of
an intermolecular disulfide bridge (118,120–122).
The early construction of a complete set of virB gene deletions and complementing
plasmids greatly facilitated studies of the A. tumefaciens VirB/VirD4 system in the Christie
laboratory as well as many other laboratories devoted to studies of this system. When I entered
the laboratory, we were interested in incorporating studies of the E. coli pKM101-encoded Tra
T4SS (TrapKM101) in order to capitalize on the ease of genetic manipulation and growth of E. coli,
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Figure 4.1 Structure of the operons encoding the VirB, Tra, and Trw T4SSs
Operon arrangement of the A. tumefaciens VirB T4SS along with the operons
encoding the pKM101 Tra and R388 Trw T4SSs. Each of the homologs is depicted in
identically colored arrows and the function of each of the proteins is indicated above
the corresponding gene.
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the availability of large numbers of E. coli mutant strains, and in vivo assays developed using this
model organism for refined studies of this T4SS. I first sought to define the genetic requirements
for TrapKM101 T4SS function by construction of a complete set of tra gene deletion mutations and
a corresponding set of tra expression plasmids for complementation studies.

In fact, early

studies by Winans and Walker (1985) had identified the tra gene cluster and provided evidence
for the requirements of most of the tra genes through a Tn5 transposon mutational analysis
(153).

However, these Tn insertions potentially have polar effects on downstream gene

expression, preventing any firm conclusions regarding the essentiality of each tra gene.
Construction of precise gene deletions, together with genetic complementation, would not only
confirm the importance of each tra gene, but also provide a ‘molecular toolkit’ of strains and
plasmids for our future studies.
In this chapter, I developed a combination of genetic approaches including λ red
recombineering and inverse PCR to create a pKM101 “molecular toolkit” (154). This toolkit
consists of non-polar deletions of each of the tra genes, as well as each tra gene expressed
separately from the tightly-controlled PBAD promoter. Among the most striking outcomes from
these studies, I gained evidence that traL, which encodes a putative lytic transglycosylase, is
completely dispensable for elaboration of a fully functional TrapKM101 transfer channel as well as
the conjugative pilus. Additionally, traC, which encodes a putative pilus tip protein, is also
dispensable for elaboration of a functional transfer channel, but required for pilus production. I
discuss these findings in the context of available information for other T4SSs and additional data
from the Christie laboratory suggesting that TraC coordinates with another, previously
uncharacterized protein called KikA to promote donor-recipient cell contacts even in the absence
of pilus production.
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Results
Complementation of tra Mutants in Filter Matings. I deleted 8 of 11 tra genes from the
pKM101 plasmid by recombineering. I was not able to make deletions of traL, traN, and traO. I
characterized the phenotypes of the 8 tra gene mutations, and through further studies by
Roosheel Patel, we were able to evaluate the contributions of the remaining tra genes to
assembly and function of the TrapKM101 T4SS. Most of the deletions abolished plasmid transfer
(Figure 4.2). Similar to previous reports from Winans and Walker, deletion of traC did not
abolish plasmid transfer in solid-surface matings (153) (Figure 4.2). Complementation of each
tra gene deletion with its respective native gene in trans from a PBAD promoter restored pKM101
transfer. (Figure 4.2). Although most of the complementing tra genes restored transfer to levels
similar to wild-type pKM101, complementation of IMC genes traA, traD, and traE only partially
restored transfer (Figure 4.2). These results demonstrate that each of the tra gene deletions is
able to be complemented with the respective native gene in trans.

Susceptibility of tra Mutants to PRD1 and IKe bacteriophages.

Donor-specific

bacteriophages utilize the T4SS, and more specifically the conjugative pilus, as a point of entry
into the cell. Previous studies have sought to determine the genetic requirements for phage
infection of host cells carrying pKM101 or other conjugative T4SSs. Mutations in the tra and
trb genes of pKM101 and RP4, respectively, confer resistance to PRD1 phage (45,153). While
PRD1 sensitivity was restored to RP4 trb mutants through complementation tests, no such
experiments have been performed with pKM101 mutants. All eight of the tra mutations on the
native pKM101 abolished PRD1 and IKe uptake. However, only the ∆traM, ∆traF, and ∆traG
mutants exhibited phage sensitivity when the native gene was expressed in trans (Figure 4.3).
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Figure 4.2 Genetic requirements for plasmid transfer through the pKM101 T4SS.
Bar diagram of E. coli matings monitoring the transfer of native pKM101 and the
deletion mutants both with and without the complementing plasmid. Black bars
represent non-complemented mutants, gray bars represent mutants complemented in
filter matings, and white bars represent mutants complemented in broth matings.
Experiments were performed in triplicate and the histograms represent the average
results with standard deviations.
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Figure 4.3 Restoration of PRD1 and IKe sensitivity.

Bar diagram of E. coli

infection assays monitoring uptake of PRD1 and IKe in complemented ΔtraM, ΔtraF,
and ΔtraG mutants. Sensitivity is measured as the number of plaque forming units/ml
(PFU/ml). Black bars represent PRD1 infection while gray bars represent IKe
infection. Experiments were performed in triplicate and the histograms represent the
average results with standard deviations.
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Lack of complementation of the other tra mutations is not easily explained, although it is
possible that nonstoichiometric production of certain Tra proteins from the strong PBAD promoter
might interfere with phage binding or uptake.
Taken together, these results demonstrate that production of an intact TrapKM101 T4SS is
required for infection by the male-specific phages PRD1 and IKe.

Complementation of tra mutants in broth matings
E. coli cells efficiently transfer the F plasmid to recipients in liquid culture. This is due
to the long, flexible pilus carried by F-plasmid-containing cells which is capable of attaching to
recipient cells and retracting to form mating junctions (155,156). Plasmids such as pKM101,
R388, and RP4 encode short, rigid pili, which are not thought to undergo dynamic rounds of
extension and retraction (155). Therefore, cells containing these plasmids are not predicted to
transfer DNA efficiently in broth.
Interestingly, however, I discovered that pKM101-containing donors are capable of
transferring the plasmid in broth matings, albeit at levels 100-fold lower than on filters (Figure
4.2). The three complemented mutants, ∆traM, ∆traF, and ∆traG, exhibiting phage sensitivity
also served as efficient plasmid donors in broth matings. Additionally, complemented ∆traC and
∆traE mutants conjugatively transferred pKM101, although the ∆traE mutant was more
attenuated than the others. The capacity of cells to transfer in liquid generally correlated with
their phage sensitivity profiles, although some strains resistant to phage uptake served as
proficient donors in broth.
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Complementation of tra mutants in mini-pKM101
As mentioned previously, we were unable to create deletions of traL, traN, and traO on
native pKM101. The ~10 kb region of pKM101 from the 3’ end of korB through the 3’ end of
traG was cloned into pBAD33 to create pCGR100. I tested its ability to deliver plasmid pJG142,
which contains the oriT sequence as well as genes encoding the TraI relaxase, TraK accessory
factor, and TraJ substrate receptor, which collectively are responsible for oriT processing and
delivery of the plasmid substrate to the T4SS channel. pCGR100 mediated transfer of pJG142 at
levels 1,000-fold lower than native pKM101 (Figure 4.4). Complementation of a ∆traO mutant
restored plasmid transfer to pCGR100 levels where as the ∆traN mutant only had plasmid
transfer partially restored (Figure 4.4). The ∆traO and ∆traN mutant strains remained resistant
to phage even when expressing the corresponding traO or traN genes were expressed in trans
(data not shown).
In previous studies, deletions of the cell wall hydrolases VirB1 and p19 associated with
the VirB and F plasmid T4SSs, respectively, resulted in attenuated DNA transfer and loss of
sensitivity to male-specific phages (67,157). Interestingly, however, deletion of traL from the
pKM101 system had no detectable effect on plasmid transfer or phage susceptibility.
Furthermore, complementation of a ∆traL mutant by expression of traL from the PBAD promoter
enhanced plasmid transfer by ~100-fold (Figure 4.4). I also observed a similar enhancement of
plasmid transfer by donors carrying both the WT pKM101 and pCGR100 plasmids (Figure 4.5).
These results confirm that TraN and TraO are essential for building a functional
translocation channel, whereas the TraL hydrolase is completely dispensable. However, cells
that overproduce TraL might be capable of elaborating quantitatively more channels across the
cell wall than traL mutants or even cells expressing traL at WT levels.
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Figure 4.4 Plasmid transfer through the mini-pKM101. Bar diagram of E. coli
matings monitoring transfer of oriT-IJKpGB2 using either wild-type pCGR100 or
deletion mutants with and without the complementing plasmid. Black bars represent
non-complemented mutants, gray bars represent mutants complemented in filter
matings, and white bars represent mutants complemented in broth matings.
Experiments were performed in triplicate and the histograms represent the average
results with standard deviations.
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Figure 4.5 Enhancement of plasmid transfer through overexpression of traL
Bar diagram of E. coli matings monitoring the transfer of native pKM101 and pJG142
in the presence and absence of overproduced TraL. Black bars indicate the absence of
traL in trans while gray bars indicate the presence of overexpressed traL.
Experiments were performed in triplicate and the histograms represent the average
results with standard deviations.
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Discussion
Here, I developed a pKM101 “molecular toolkit” for the addressing current and future
questions related to T4SS structure and function. I used complemented and uncomplemented
pKM101 tra deletion mutants to identify the genetic requirements for construction of a
functional machine. My studies represented the first systematic effort, other than that carried out
by the Christie lab for the A. tumefaciens VirB/VirD4 T4SS, to define the contributions of
individual T4SS genes through construction of markerless deletions. Below, I discuss my
findings in comparison with previous analyses of other T4SSs.
Predictions about the genetic requirements for pKM101 were based on our previous
studies in the VirB system. Similar to those studies and others in R388 and RP4, pKM101 tra
gene deletions abolished all activity as monitored by mating assays and sensitivity to PRD1 and
IKe phages. Similar to the results from Winans and Walker (153), I also showed that TraC is not
essential for plasmid transfer. However, I also found that the cell wall hydrolase, TraL, is
dispensable, and overexpression of traL in either a wild-type or ∆traL background enhanced
transfer.

Contributions of TraC and KikA to pKM101 plasmid transfer
VirB5 has been described as the minor pilin subunit and has been observed at the A.
tumefaciens pilus tip (158). Studies on pKM101-encoded TraC have demonstrated that it can be
localized to the cell surface and form high molecular weight complexes in the presence of a
functional T4SS (87). Because VirB5 in A. tumefaciens is located at the pilus tip, TraC is also
predicted to be the pilus tip protein as point mutations can drastically alter cell susceptibility to
filamentous phage IKe (142). Therefore, it is likely that TraC is involved in forming and
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stabilizing recipient cell contact as part of the pilus. However, my results as well as those from
Winans and Walker have demonstrated that TraC is not essential component of the pKM101
T4SS (153). Therefore, it is likely that other surface proteins are able to mediate recipient cell
contact. Based on other studies from our lab, one possible candidate protein is KikA. The kikA
(killing in Klebisella A) locus is located upstream of the tra operon and encodes a small surface
protein. Although KikA is not critical for pKM101 mobilization on solid surfaces, previous
studies have highlighted its importance in uptake of PRD1 phage (159). Recently, our lab has
demonstrated that KikA is essential for processes including plasmid transfer in broth matings and
mediating recipient cell contact as monitored by the Pseudomonas aeruginosa T6SS killing
assay (discussed in the following chapter). Our lab has also demonstrated that creation of a
double ∆traC/∆kikA mutant abolished residual plasmid transfer, indicating that KikA might
partially substitute for TraC. Further characterization of the role of KikA in T4SS and its
physical relationship with the channel is currently being investigated by our lab.

Contributions of TraL to pKM101 plasmid transfer and pilus biogenesis
Deletion of virB1 in A. tumefaciens reduced T-DNA transfer to plants and abolished pilus
biogenesis (67). Similar results were seen during analysis of the F-plasmid-encoded P19 cell
wall hydrolase (157). However, my results revealed that the pKM101-endoded homolog, TraL,
is nonessential. Additionally, overexpression of traL increased plasmid transfer. Therefore,
TraL could be considered a rate limiting factor in plasmid transfer. By overproducing TraL, this
could allow for production and insertion of more translocation channels into the membrane.
Alternatively, TraL could be secreted into recipient cells and allow for more efficient
translocation through degradation of the recipient cell wall. In order to address these questions,
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future experiments should test the steady state levels of other Tra proteins in the presence and
absence of overproduced TraL. Finally, export of TraL to the recipient cell periplasm can be
tested using fluorescence microscopy to observe localization of fluorescently-labeled TraL and
other recipient-encoded periplasmic proteins.
It is curious why the traL locus is present in the pKM101 tra operon if it is not essential.
One plausible explanation relates to the fact that pKM101 is capable of transferring among a
broad range of Gram-negative bacterial species. It is possible that TraL interacts with other
T4SS components to localize cell wall degradation. In E. coli, the dispensability of TraL might
be explained by redundant activities of other cell wall hydrolases or the assembly of the T4SS
during the early growth phase when the cell wall is being actively remodeled. In other species,
pKM101 might require its own lytic transglycosylase due to a lack of a compensating hydrolase
or temporal differences in T4SS machine assembly in relation to the growth phase.
Evolutionary pressures, therefore, might have maintained traL on pKM101 for retention of its
broad-host-range properties.

Complementation of tra mutants for PRD1 and IKe infection
Complementation of virB, RP4 trb, and F-plasmid deletion mutants restored detectable
pilus production, PRD1 and R17 sensitivity respectively (45,67,132). In my analysis of pKM101
tra deletion mutants, all of the deletion mutants with the exception of traL were resistant to both
PRD1 and IKe. However, complementation only restored sensitivity to ∆traM, ∆traF, and
∆traG mutants.
For those tra mutants in which phage sensitivity was not restored by expression of the
complementing gene in trans, there are a couple of possible explanations. They may not
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elaborate pili or alternatively, they may elaborate wild-type pili, but sustain blocks in the phage
uptake pathway subsequent to phage binding to the pilus receptor. While the PRD1 uptake
pathway is not well understood, filamentous bacteriophages such as M13 and IKe utilize the
TolQRA proteins to cross the IM (160,161). It is possible that overproduction of the Tra proteins
blocks the ability of IKe to bind the cell surface or to interact with TolQRA. Future studies
focused on elucidating the requirements for pKM101 pilus production as well as defining the
pilus assembly pathway will require antibodies against the TraM pilus protein.

Transfer of pKM101 in broth matings
Conjugation in broth media is a well-documented phenomenon in studies of the Fplasmid. This is due to physical structure of the conjugative pilus, which is long and flexible,
making it easy to feel around its physical environment and grab onto a recipient cell. Following
attachment, these pili are able to retract and bring the recipient cell into close contact in spite of
shear forces in the environment (156). Unlike the F-plasmid, pili encoded by pKM101, R388
and RP4 plasmids are short and brittle. Furthermore, there is no evidence of pili retracting or
being involved in recipient cell contact and mating pair stabilization. My data suggests that
production of conjugative pili is important for successful plasmid transfer in broth. However,
further studies carried out by Dr. Christian Gonzalez-Rivera, a postdoctoral fellow in the Christie
lab, suggest that two surface-exposed proteins, the pilus tip protein TraC and KikA, can promote
donor-recipient contacts in broth even in the absence of detectable pilus production.
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Chapter 5: Defining the Role of a Novel Outer
Membrane Alpha Helical Domain in pKM101-encoded
TraF for Plasmid Transfer, Donor-Specific
Bacteriophage Sensitivity, and Recipient Cell Contact
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Introduction
The T4SSs from Gram-negative bacteria are comprised of two large subassemblies: an
inner membrane complex (IMC) and an outer membrane core complex (OMCC). The IMC is
comprised the three inner membrane (IM) ATPases (VirD4, VirB4, and VirB11) and three IM
subunits (VirB3, VirB6, and VirB8). Recent studies also suggest that VirB5 could also comprise
a significant part of the IMC (84). The predicted role of the IMC is to recruit substrates to the
T4SS and help transfer them across the IM. The OMCC is comprised of 14 copies of VirB7,
VirB9, and VirB10 arranged into a large 1 MDa structure (82,90). The OMCC is predicted to be
primarily involved in moving substrates across the OM and establishing contact with recipient
cells (Figure 5.1) (162). Structural studies on the TrwR388 T4SS identified two distinct IMC and
OMCC subassemblies connected together by a central stalk structure (84).

All of these

components were shown to be necessary to build a functional translocation channel in the VirB
T4SS (67).
Unlike the other components of the T4SS, VirB10 is a unique protein in that it spans the
length of the cell envelope. Because it makes contacts with subunits in both the IMC and the
OMCC, it is predicted to act as a scaffolding protein linking the two subassemblies together
(90,98). At the IM, it is predicted to make essential contacts with IM ATPases which are
essential for initiating ATPase-mediated conformational changes in VirB10 (Figure 5.2)
(95,98,107). These contacts are likely mediated through the VirB10 N-terminus as gradual
truncations in this region reduced the affinity of VirD4 for VirB10 (127). The conformational
change brought about by IM ATPase activity is predicted to transduce energy to the OMCC
subunits, such as VirB7 and VirB9. VirB10 makes extensive contacts along its -barrel with
VirB9, which is anchored at the OM by the VirB7 lipoprotein (Figure 5.1) (90). Additionally,
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Figure 5.1 The OMC and its potential role in plasmid transfer (A) Structure of the
pKM101 OMC demonstrating the arrangements of TraN (yellow), TraO (blue), and
TraF (red). The structure of the core complex O-layer was generated using Pymol
(http://pymol.org) based on the 3ZBI file deposited into the NCBI protein database (B)
Cryo-EM images of E.coli donors containing RP4 mixed with E. coli recipients. Black
arrows indicate the positions of mating junctions.

Bottom images are from Samuels AL, Lanka E, Davies JE. Conjugative junctions in
RP4-mediated mating of Escherichia coli. J Bacteriol. 2000 182:2709–15.

The

American Society for Microbiology allows for re-publication of its materials in a
doctoral thesis.
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Figure 5.2 Plasmid transfer through the conjugative pilus. This model demonstrates the
path of DNA through the conjugative T4SS. The positions of the TraJ and TraG ATPases and
the conjugative pilus composed of TraM are indicated. The position of TraF within the cryoEM structure of the is highlighted in green.
The structure of TrwB is Figure 2C from Gomis-Rüth FX et al. The bacterial
conjugation protein TrwB resembles ring helicases and F1-ATPase. Nature 2001 409:637–41.
This image was re-published with permission from Nature Publishing Group. License
Number 4078401439237. The structure of the VirB11-like HP0525 was published as Figure
3C in Yeo HJ et al. Crystal structure of the hexameric traffic ATPase of the Helicobacter
pylori type IV secretion system Mol Cell. 2000 6:1461–72. This image was re-published with
permission from Elsevier. License Number 4078430588294. The pKM101 core complex
structure is Figure 4 from Fronzes R, et al. The structural biology of type IV secretion systems.
Nat Rev Microbiol. 2009 7:703–14. This image was re-published with permission from
Nature Publishing Group. License # 4092681298982.
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VirB10 likely makes critical contacts with VirB2 pilin subunits (Figure 5.2). While VirB2 is
primarily localized to the IM before pilus biogenesis, VirB2 is essential for transfer of T-DNA
across the OM (74). Because T-DNA does not make contact with VirB10, it likely makes
contact with VirB2, possibly assembled as a short pilus in the OMCC lumen. This short pilus
might comprise the translocation channel, allowing for passage of substrates to the cell surface
(Figure 5.2).
In Chapter 3 of this thesis, I analyzed the importance of the VirB10 antenna projection
(AP) domain and C-terminal tail. Both of these regions were amenable to mutations without
affecting plant tumor formation. However, these mutations either attenuated or abolished T-pilus
production. One notable example was a substitution of the VirB10 AP and C-terminal tail for
that of TraF. The C-terminal tail of VirB10 is 43 residues and is ~71% identical to that of TraF
(Figure 5.3). Both of these tails contain a highly-conserved RDLDF sequence that was shown to
be essential for T-DNA transfer and pilus biogenesis in VirB10 (127). Additionally, the crystal
structure of TraF indicates that the C-terminal tail folds back into the lumen of the barrel (90).
Accordingly, this domain might make contacts with substrates and/or pilin subunits as they pass
through the channel (Figure 5.3).
In the previous chapter of this thesis, I highlighted the importance of the pKM101 Tra
subunits for plasmid transfer and phage sensitivity. Complementation of a ΔtraF mutant with
wild-type traF restored both plasmid transfer and phage sensitivity to pKM101. In light of the
structural information from the pKM101 TraN-TraO-TraF core complex and the functional data
from the VirB10 AP, I hypothesized that the TraF AP is a surface exposed domain that is
dispensable for the formation of an OM pore, but critical for pilus biogenesis and the formation
of stable mating junctions through the formation of recipient cell contact. Here, I used chimeric
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Figure 5.3 Similarities between the TraF and VirB10 AP and C-terminal domains.
(A) Crystal structure of TraF with the AP (residues 306-354) highlighted in red and the
C-terminal tail (residues 355-386) highlighted in green. The structure of TraF was
generated using Pymol (http://pymol.org) based on the 3ZBI file deposited into the NCBI
protein database (B) Alignment of the TraF AP and C-terminal tails. The residues
comprising the AP are surrounded by red brackets and the C-terminal tail residues are
bracketed in green. Red letters indicate conserved residues between TraF and VirB10.
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TraF/VirB10 proteins and TraF truncation mutants in order to identify regions within the AP and
C-terminal tail that were critical for plasmid transfer and phage sensitivity. Additionally, I used
chimeric T4SSs containing the IMC of pKM101 and the OMCC of either the VirB/VirD4Ti,
TrwR388, or PtlBp T4SSs to evaluate the importance of the OMCC, and in particular the AP, in
establishing donor-recipient cell contacts.
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Results
The TraF AP is critical for phage sensitivity, but dispensable for plasmid transfer
According to the pKM101 O-layer crystal structure, TraF lines the inner wall of the
channel and forms an OM pore using its AP domain. Based on the functional conservation of the
AP domains in VirB10 and TraF in addition to the dispensability of the VirB10 AP seen in
Chapter 3, I predicted that the TraF AP domain is similarly dispensable for plasmid transfer, but
required for pilus biogenesis. Here, I assayed strains producing various TraF AP and C-terminal
mutants for plasmid transfer and phage sensitivity as an indicator of pilus production.
I began by making deletion mutations throughout the TraF AP. I first replaced the
flexible loop region with a pentaglycine bridge (5xGly), which had no detectable effects on
plasmid transfer (Figure 5.4). A larger deletion of the TraF AP (residues 302-355) resulted in
only a modest decrease in intercellular pKM101 transfer (Figure 5.4). Additionally, neither of
these mutations had any discernable effect on TraF protein accumulation (Figure 5.4). Taken
together with the data presented in Chapter 3, we can conclude that the AP regions of both TraF
and VirB10 are dispensable for DNA transfer, although their presence results in more efficient
conjugation.
Replacement of the flexible loop with a pentaglycine bridge did not abolish IKe
sensitivity, indicating that these mutants restore the presence of a functional conjugative pilus.
However, the ∆AP mutant did not restore sensitivity to either PRD1 or IKe, suggesting that cells
producing this TraF mutant lack pKM101-encoded pili. The TraF ∆AP strain behaved similarly
to its VirB10 counterpart indicating that the AP helices are an essential factor for pilus
biogenesis.
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Figure 5.4 Functionality of TraF truncation mutants. (A) Bar diagram depicting the level
of native pKM101 transfer from donors containing TraF truncation mutants. Frequencies are
depicted as transconjugants per donor. Matings were repeated 3 times and the histogram
represents the average with standard deviations. (B) Bar diagram representing the sensitivity
of donors to PRD1 and IKe. Sensitivity is depicted as the number or plaque forming units per
ml (PFU/ml). Black bars represent PRD1 infections while gray bars represent IKe infections.
Plaque assays were repeated 3 times and the histogram represents the average value with the
standard deviations. (C) Steady state levels of TraF truncation mutants containing an Nterminal 6xHis tag.

158

159
Because the AP domains of both TraF and VirB10 were permissive for mutations,
another substitution was constructed by placing the VirB10 AP helices (residues 284-337) onto
TraF (TraF/VirB10AP). This chimera phenocopied wild-type TraF by restoring plasmid transfer
and phage sensitivity to wild-type levels, (Figure 5.5). As with the previous AP swap, these
results are striking due to the generally low level of identity (~31%) between the TraF and
VirB10 AP domains.

Further substitution of the VirB10 AP flexible loop onto TraF

(TraF/VirB10AP_Loop) still allowed for for plasmid transfer and IKe sensitivity (Figure 5.5).
However, this mutant was not able to restore PRD1 sensitivity.
Taken together, these results demonstrate that the AP is dispensable for DNA transfer,
but critical for pilus biogenesis in both TraF and VirB10. Despite its importance for pilus
production, these domains are able to withstand mutations without significant phenotypic
alterations.

The C-terminal domain of TraF is critical for both plasmid transfer and phage sensitivity
The region of highest identity between TraF and VirB10 is located in the C-terminal tail.
These regions share ~71% identity with most of the homology occurring at the C-terminal end of
the proteins (Figure 5.3). This region contains a highly conserved RDLDF motif found in all
sequenced VirB10 family proteins. According to the TraF crystal structure, the C-terminal tail
folds back into the channel lumen and is buried in the periplasmic -barrel domain. Deletions of
either the AP and C-terminal tail (∆APCT) or just the C-terminal tail (∆CT) resulted in the
abolishment of both pKM101 transfer and phage sensitivity (Figure 5.4). However, these results
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Figure 5.5 Functionality of the TraF/VirB10 chimeras. (A) Bar diagram depicting different
swaps between TraF and VirB10. (B) Histogram depicting transfer frequencies of pKM101
from donors containing TraF/VirB10 chimeras during 2 hour filter matings. Frequencies are
presented as transconjugants per donor. Matings wererepeated 3 times and the histogram
depicts the average values with standard deviations. (C) Bar diagram depicting the sensitivity
of donors containing the TraF/VirB10 chimeras to PRD1 and IKe. Sensitivity is presented as
the number of plaque forming units per ml (PFU/ml). Black bars represent PRD1 infections
while gray bars represent IKe infections.

Plaque assays were repeated 3 times and the

histogram depicts the average values with standard deviations. (D) Steady state levels of
TraF/VirB10 chimeras containing an N-terminal 6xHis tag.
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are difficult to interpret as overall TraF levels in the donor cells was highly diminished. Deletion
of the C-terminal 9 residues (∆9) or the RDLDF sequence (∆RDLDF) did not affect protein
accumulation but abolished all detectable activity (Figure 5.4), suggesting that the C-terminal tail
is critical for plasmid transfer and pilus biogenesis.
Because of the high level of identity of the C-terminal tails, I predicted that substitution
of VirB10 C terminus (residues 335-377) for that of TraF (residues 354-386) would not affect
plasmid transfer or phage sensitivity. Interestingly, the TraF chimera (TraF/VirB10CT) as well as
a chimera producing both the AP and C-terminal tail of VirB10 (TraF/VirB10AP-CT) were not
able to restore phage sensitivity, despite accumulating at abundant levels (Figure 5.5). These
findings are consistent with the results seen with the VirB10/TraFAP-CT chimera, further
suggesting that the C terminus plays a critical role in biogenesis of the cognate pilus.
Taken together, these results demonstrate that the TraF and VirB10 C-terminal tails are
critical for both DNA transfer and pilus biogenesis.

The N-terminal region of TraF does not tolerate substitutions of corresponding VirB10
domains.
The -barrel regions of TraF (194-301) and VirB10 (173-284) share only ~35% identity.
Because TraF tolerated mutations throughout the AP and C-terminal tail, I next wanted to test if
TraF could withstand more extensive domain substations throughout its C-terminal half. A
substitution of the VirB10 -barrel, AP, and C-terminal tail onto TraF (TraF/VirB10BB-CT)
restored transfer to a ΔtraF mutant, albeit at levels 10,000-fold lower than wild-type TraF
(Figure 5.5). This mutant did not restore PRD1 or IKe sensitivity. These results demonstrate
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that the -barrel of VirB10 can functionally substitute for that of TraF, despite the low level of
identity between the two domains.
Because the TraF C-terminal tail is critical for phage sensitivity, I predicted that addition
of the TraF C-terminal tail back onto the TraF/VirB10BB-CT could restore phage uptake. I
constructed two new TraF mutants to test this hypothesis. One of these TraF mutants produced
the -barrel and AP of VirB10 (TraF/VirB10BB-AP), where as the other produced only the
VirB10 -barrel (TraF/VirB10BB). These mutants restored plasmid transfer to a ΔtraF mutant at
levels greater than the TraF/VirB10BB-CT mutant (Figure 5.5). However, they were still unable to
restore phage sensitivity (Figure 5.5). These results also implicate the TraF -barrel as essential
indicating a potential complex interplay between the -barrel and C-terminal tail during pilus
biogenesis.
The role of the N-terminal half of TraF remains undefined. Previous studies suggest that
its N-terminal domain of VirB10 is required for interactions with the VirD4 T4CP (127). Other
experiments with regards to regions such as the TM domain are not as clear. In the VirBAt T4SS,
substitutions of the VirB10 TM domain with that of E.coli FtsN did not have an effect on TDNA transfer (128). However, this was not the case in the TrwR388 system as the TM domain of
TrwE appears to be critical for forming interactions with the TrwB T4CP (95,163). In order to
elucidate the role of these domains in TraF, I created four new TraF chimeric proteins containing
either the VirB10 N-terminal tail (TraF/VirB10NT), TM domain (TraF/VirB10TM), proline-rich
region (TraF/VirB10PRR) or TM through C-terminal tail (TraF/VirB10TM-CT). These mutants
were not able to restore plasmid transfer or phage sensitivity to a ΔtraF mutant (Figure 5.6). The
N-terminal half of TraF does not tolerate substitutions of VirB10 domains, suggesting that this
region forms critical contacts with components of TrapKM101’s IMC subassembly.
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Figure 5.6 Functionality of the TraF/VirB10 N-terminal chimeras. A) Bar diagrams
depicting the N-terminal swaps of VirB10 onto TraF. (B) Histogram displaying the
transfer frequencies of traF mutants complemented with either the genes either for wildtype TraF or N-terminal chimeric TraF/VirB10 proteins.

Mating frequencies are

presented as transconjugants per donor and mating assays were repeated 3 times with the
histogram depicting the average values with standard deviations. (C) Histogram depicting
the sensitivity of traF mutants to PRD1 and IKe when complemented with genes
encoding either WT TraF or the TraF/VirB10 N-terminal chimeras.

Sensitivity is

presented as the number of plaque forming units per ml (PFU/ml). Black bars represent
PRD1 infections while gray bars represent IKe infections. Plaque assays assays were
repeated 3 times and the histogram depicts the average values with standard deviations.
(D) Western blots measuring the steady state levels the TraF/VirB10 N-terminal chimeras.
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Neither the AP nor the C-terminal tail are surface displayed
Previous reports have suggested that the TraF AP is surface displayed (90). However,
these experiments lacked critical controls and conclusions were drawn based on the production
of the TraN-TraO-TraF core complex rather than the entire T4SS.

Additionally, my data

suggests that the C-terminal tail is critical for pilus biogenesis. Based on my data with regards to
the TraF/VirB10 chimeras, I predicted that the TraF AP and C-terminal tail are surface
displayed. In order to test this hypothesis, I performed a dot blot experiment similar to those
done with the OM lipoprotein RcsF (164). In these experiments, I placed FLAG tags in the AP
loop (between residues 330 and 331) and at the end of the C-terminal tail. For a positive control,
I put a FLAG tag at the C-terminal end of TraC, which has been demonstrated by our lab and
others to be surface displayed (87). For negative controls, I inserted FLAG tags at the TraF Nterminal tail, in the lever arm at the periplasmic base of the -barrel, and at the C-terminal
domain of TraE predicted to be in the periplasm. Contrary to our hypothesis, the AP and the Cterminal FLAG tags were not detected on the cell surface (Figure 5.7).

Additionally, C.

Gonzalez-Rivera used BSA-conjugated malaeimide to label cysteine residues placed at the Cterminal end of the AP (residue 360) and at the C-terminal tail (residue 386). Neither of these
cysteine residues were labeled in whole cells. Together, these results suggest that the TraF AP
and C-terminal tail are not surface accessible at least in the absence of target cell contact.

Heterologous OMCCs paired with the pKM101 IMC support plasmid transfer
Although the extensive contacts between TraF and TraO were not critical for building a
functional translocation channel, they may be important for building an efficient one. If this
prediction is correct, replacing TraO with VirB9 might lead to more efficient transfer. Therefore,
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Figure 5.7 Surface display of TraF (A) Colony immunoblots depicting the detection of
FLAG tags placed throughout TraF and the C termini of TraE and TraC. (B) Western
blots detecting the steady state levels of the different FLAG-tagged TraF proteins as well
as C-terminal FLAG-tagged TraE and TraC.
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I constructed a chimeric T4SS containing the IMC of pKM101 and the OMCC from the VirBAt
system. The pKM101 IMC contained TraA, TraB, TraC, TraD, TraE, and the N-terminal half of
TraF (residues 1-193) while the VirB OMCC consisted of VirB7, VirB9, and the C-terminal half
of VirB10 (residues 173-377). To ensure that the codon usage of A. tumefaciens didn’t prevent
optimal production of the VirB proteins, the virB genes were codon optimized for expression in
E. coli. This chimeric Tra/VirB T4SS mediated transfer of the oriT plasmid pJG142, albeit at
levels several orders of magnitude lower than observed for WT pKM101 (Figure 5.8). The
Tra/VirB chimeric T4SS did not mediate PRD1 or IKe uptake, however, suggesting that these
cells do not produce conjugative pili (Figure 5.8).
It is interesting that OMCCs from functionally distinct T4SSs can substitute for one
another. We next wanted to test whether OMCCs from other T4SSs could substitute for that of
pKM101. I first tested for functionality of a chimeric system composed of the OMCC from
plasmid R388 and the IMC from pKM101. TraN and TraO were replaced with R388-encoded
TrwH and TrwF, respectively. TraF was replaced with a TraF/TrwE chimera consisting of the
the N-terminal half of TraF (residues 1-193) and the C-terminal half of TrwE (residues 197-395).
This chimeric T4SS mediated plasmid transfer at levels appreciably higher than observed for the
Tra/VirB chimera (Figures 5.8). Similar to the Tra/VirB chimera, however, this machine did not
mediate uptake of PRD1 and IKe, indicating a lack of pilus production.
I next tested whether a more phylogenetically and functionally distinct OMCC would
functionally pair with the Tra IMC. For this, I made a chimeric Tra/Ptl T4SS. The Ptl T4SS is
produced and utilized by Bordetella pertussis and is functionally unique in three ways. First, it
does not contain a T4CP to recognize pertussis toxin subunits (5). Toxin subunits must go
through the general secretory pathway prior to movement across the OM. Secondly, it does not
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Figure 5.8 Functionality of chimeric T4SSs. (A) Genetic organization of the chimeric
operons in mini-pKM101pBAD24. (B) Bar diagram depicting the level of transfer of
oriT-IJKpGB2 in donors containing either wild-type mini-pKM101pBAD24 or minipKM101pBAD24 encoding the chimeric T4SSs as well as the sensitivity to PRD1 and IKe.
Mating frequencies are presented as transconjugants per donor and mating assays were
repeated in triplicate the histogram represents the average of three experiments along
with standard deviation. S:Sensitive, R:Resistant
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contain a VirB5 or TraC homolog leading to an absence of detectable pili on the cell surface.
Finally, it secretes pertussis toxin independently of recipient cell contact (165). TraN and TraO
were replaced with PtlI and PtlF, respectively. TraF was substituted with a chimeric TraF/PtlG
protein containing the N-terminal half of TraF (residues 1-172) and the C-terminal half of PtlG
(residues 160-374). Similar to the tra/virB gene cluster, the tra/ptl gene cluster was codon
optimized for expression in E. coli. The Tra/Ptl chimera mediated plasmid transfer at levels
lower than the Tra/VirB, but above a threshold of detection. As with the other chimeras, the
Tra/Ptl system did not mediate PRD1 or IKe uptake (Figure 5.8).
Together, these results support a proposal that the type IVa T4SSs are composed of
functionally distinct IMC and OMCC subassemblies, and furthermore, that the OMCCs from
different systems are highly conserved not only their overall architectures as shown by the
structural studies (see Chapter 3), but also in their functions as structural scaffolds for the
translocation channel. While all of the heterologous OMCCs were able to functionally pair with
the pKM101 IMC, the more closely-related Trw OMCC paired in a more productive manner
than its VirB and Ptl counterparts.

Neither the TraF AP nor the C-terminal tail are required for recipient cell contact
Pseudomonas aeruginosa contains a bactericidal type VI secretion system (T6SS), which
is activated upon sensing membrane perturbation. When its membrane is perturbed through
contacts by a neighboring cell, the P. aeruginosa T6SS is activated and in turn injects toxic
effectors that kill the adjoining cell (13). The Mekalanos lab has previously demonstrated that E.
coli containing a functional pKM101 T4SS are killed when incubated with P. aeruginosa
containing a functional T6SS (140). This is likely due to mating junctions formed between E.
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coli and P. aeruginosa. In recent years, the Christie lab has taken advantage of this in order to
define the requirements for recipient cell contact.

By measuring the sensitivity of E. coli

containing pKM101 mutants to P. aeruginosa, we can further identify which steps in conjugation
are blocked by various mutants.
I wanted to measure the sensitivity of E. coli containing the chimeric T4SSs to P.
aeruginosa T6SS killing. Similar to previously described results, DH5α without a T4SS was not
susceptible to T6SS killing.

The cell viability of DH5α containing a wild-type pKM101 tra

operon was reduced by ~ 10-fold (Figure 5.9). Cells containing the chimeric operons were also
susceptible to T6SS killing, but at attenuated levels (Figure 5.9). These results demonstrate that
the reduced levels of transfer are likely not due to the ability of these chimeric T4SSs to mediate
recipient cell contact.
Utilizing the P. aeruginosa T6SS killing assay, I wanted to test my prediction about the
importance of the TraF AP and C-terminal tail in establishing recipient cell contact. A series of
alleles encoding the AP and C-terminal tail mutants were cloned in the native traF locus in minipKM101. Cells containing these plasmids were tested for their sensitivity to killing by P.
aeruginosa. Wild-type traF cloned into its native locus restored sensitivity to ~10-fold (Figure
5.10). The TraF/TrwEAP-CT mutant also gave similar levels of sensitivity as wild-type TraF.
Surprisingly, the TraF∆AP also gave similar levels of sensitivity as wild-type TraF as well. These
results indicate that the TraF AP is not necessary for establishing contact with recipient cells.
TraF∆RDLDF and TraF∆CT9 also restored sensitivity, albeit at lower levels (Figure 5.10). The other
AP-CT chimeras, TraF/VirB10 and TraF/PtlG, mediated sensitivity as well. Taken together,
these results indicate that the AP and the C-terminal end of TraF are not essential for contacting
recipient cells.
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Figure 5.9 Measuring the ability of the chimeric T4SSs to make efficient recipient-cell
contact.

(A)

Representative plate from the P. aeruginosa T6SS killing assay.

(B)

Quantification of the results in panel A. Results are presented in cell viability (CFU/ml). The
P. aeruginosa T6SS killing assay was performed in triplicate and the histogram represents the
average along with standard deviation. Statistical significance of the T6SS-mediated killing
results was calculated using a Student’s t test corresponding to plasmid-free E. coli cells
(*P<0.05, **P<0.01)
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Figure 5.10 Determining the role of the TraF AP-CT in recipient cell contact (A)
Histogram depicting the sensitivity of either wild-type TraF or TraF AP-CT mutants when
each of the alleles were cloned into the native traF locus on mini-pKM101. Results are
presented in cell viability (CFU/ml). The P. aeruginosa T6SS killing assay was performed in
triplicate and the histogram represents the average along with standard deviation.

(B)

Western blots of the WT TraF and AP-CT mutants when each traF allele is expressed from its
native locus.

Statistical significance of the T6SS-mediated killing results was calculated using a Student’s t
test corresponding to plasmid-free E. coli cells (*P<0.05, **P<0.01, NS: not significant)
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Discussion
Bacteria containing a conjugative T4SS will utilize a conjugative pilus to attach to
recipient cells prior to the formation of a stable mating junction. Once donor and recipient cells
are in close contact, DNA will be transferred into the recipient cells. When I joined the Christie
lab, one of my initial goals was to determine which regions of the OMCC were responsible for
making direct contact with recipient cells. The crystal structure of the pKM101 OMCC O-layer
highlighted a unique region of the VirB10 homolog, TraF, which seemed to project outwards
towards the cell surface. I hypothesized that this region was critical for pilus biogenesis and
recipient cell contact.
I began my investigation by making deletion mutations throughout the TraF and Cterminal tail in addition to TraF/VirB10 chimeras. Similar to the results seen with VirB10, the
TraF AP helices are only required for building a cognate pilus.

Additionally, I paired

heterologous OMCCs from either VirB/VirD4Ti, TrwR388, or PtlBp with the IMC of pKM101 and
demonstrated that these chimeric T4SSs were capable of transferring DNA to recipient cells.
These results highlight the plasticity of the Gram-negative bacterial T4SS and demonstrate that
other factors besides OMCC-localized proteins play a significant role in recipient cell contact.
Below, I will discuss my findings in more detail.

Contributions of the TraF AP to plasmid transfer and pilus biogenesis
The crystal structure of the pKM101 core complex features the TraF AP helices as a
potential pore forming domain. However, my analysis of VirB10 suggested that the AP helices
are not critical for substrate transfer. Based on these results, I predicted that deletion of the TraF
AP helices (residues 302-353) would still allow for attenuated plasmid transfer. The TraF∆AP
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mutant restored transfer to levels only 1,000-fold lower than wild-type TraF. Therefore, it is
likely that the TraF AP is part of the OM pore, but is not essential for its formation.
Because the structure of the pKM101 core complex only highlights TraN, TraO, and
TraF, it is likely that the OM pore contains other pKM101 components. As discussed in Chapter
3, pilus polymerization occurs either at an OM platform formed by the AP domain or at an IM
platform within the channel. In both of these models, the pilus structure is protruding through
the OMCC with assistance from the AP. Therefore, the conjugative pilus is likely the candidate
pore-forming structure and the AP is solely involved in aiding the pilus outside of the OM
efficiently.
Unlike plasmid transfer, the TraF AP is critical for pilus biogenesis. As mentioned above,
TraM is likely in the core complex aiding substrates across the OM. However, the AP might
make essential contacts with TraM subunits in the channel lumen and bring them to the surface.
Additionally, our lab has observed TraC subunits secreted outside of the cell in the absence of
the T4SS. In addition to formation of a pilus tip, TraC is also predicted to act as a pilus
nucleation factor (discussed below). Therefore, the AP might also coordinate and localize
extracellular TraC to the channel in order to trigger pilus biogenesis.

Contributions of the TraF C-terminal tail to plasmid transfer and pilus biogenesis
The crystal structure of TraF places the C-terminal tail (residues 354-386) inside the
channel lumen buried within the -barrel. The C-terminal tails of TraF and VirB10 share the
highest region of identity between the two proteins (~71% identical) suggesting that this region
has a conserved function. Deletion of the conserved RDLDF motif in VirB10 abolished T-DNA
transfer and pilus biogenesis. My results demonstrated a similar phenomenon in TraF where
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deletion of these residues abolished plasmid transfer and phage sensitivity. Therefore, this
conserved sequence might be involved in pilus biogenesis through direct contact with pilin
subunits and plasmid transfer through critical contacts with substrates such as the TraI relaxase.
Because of the high degree of homology between the TraF and VirB10 C-terminal tails, I
predicted that the VirB10 C-terminal tail would functionally substitute for that of TraF.
Although plasmid transfer was relatively unaffected, phage sensitivity was completely abolished.
The C-terminal tail of VirB10 contains 11 extra residues. Therefore, it is likely that these
mutants do produce pili, but the extra 11 residues from VirB10 interfere with phage infection.
This prediction is based on other observations where a C-terminal FLAG tag on TraF does not
abolish IKe sensitivity, indicating that the TraF C-terminal end can tolerate extensions and still
support phage sensitivity.
While the C-terminal tail of TraF can handle the addition of epitope tags, it appears to be
less tolerant to deletions. Deletion of the C-terminal residue, N386, abolished sensitivity to
PRD1 and deletion of the C-terminal 9 residues abolished all phage sensitivity and plasmid
transfer. Taken together, these results suggest that the length of the TraF C-terminal tail is
critical for functionality. During plasmid transfer and pilus production, the C-terminal tail might
be dynamic in that it might move inside and outside the OM as it shunts pilin subunits and
substrates outside the cell. Therefore, the length of the TraF C-terminal tail would be critical for
these steps. Unfortunately, I was unable to demonstrate surface display of TraF C-terminal tail.
Other OM proteins or surface lipopolysaccharide might occlude this domain from various
methods of detection. Future work in the Christie lab will focus on determining the spatial
localization of the TraF C-terminal tail with respect to the OM.
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The role of the TraF N-terminal half
Previous work from the Christie lab has highlighted the flexibility of the VirB10 Nterminal tail and TM domain. Insertions of Ala-Cys residues along the length of the VirB10 Nterminal tail and TM domain were phenotypically silent and replacement of the VirB10 TM
domain with that of FtsN still allowed for T-DNA transfer (127,128). These results suggest that
there are loose sequence requirements in the IMC. To examine whether N-terminal domains of
VirB10 could be substituted for those in TraF, chimeric proteins were constructed. None of
these chimeras were functional, however, suggesting that TraF’s N-terminal domains might form
specific contacts with subunits of the IMC. Future work in the Christie lab will focus on the use
of unnatural amino acid-mediated photocrosslinking (discussed in Chapter 6) to determine the
regions of contact between TraF and the TraJ T4CP.

Flexibility throughout Gram-negative bacterial T4SSs
While my experiments were the first to show sequence flexibility in the TraF and VirB10
family of proteins, other experiments have shown that a few other T4SS subunits can be
functionally exchanged with homologs from other T4SS machines.

Replacement of the

periplasmic domain of Brucella suis VirB8 with that of the pSB102 VirB8 homolog, TraJ,
partially restored the ability of B. suis to survive in macrophages (166). Additionally, previous
work in the Christie lab has demonstrated that TraJ T4CPs containing the soluble domain of
heterologous T4CPs are able to recognize and deliver heterologous substrates across the the IM
(29). Finally, with regards to pKM101, expression of either traC, traL, or traD was able to
partially complement an A. tumefaciens ∆virB5, ∆virB1, or ∆virB6 mutant respectively (87–89).
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Together, these results highlight a common ancestry and most likely a common architecture for
these T4SSs despite having diverse purposes.

Separation of the IMC from the OMC
Previous work from the Christie lab has suggested that the IMC is a functionally distinct
subassembly from the OMC. When defining the pathway of T-DNA through the VirBAt T4SS,
removal of VirB9, VirB10, or the VirB2 pilin subunit prevented movement of T-DNA across the
OM, but did not affect contact with IM subunits VirB6 and VirB8 (74). Additionally, the R388
TrwM/VirB3-TrwE/VirB10 core structure revealed the presence of an IMC consisting of
TrwM/VirB3, TrwK/VirB4, TrwJ/VirB5, TrwI/VirB6, and TrwG/VirB8 and an OMCC with
TrwH/B7, TrwF/VirB9, and TrwE/VirB10 connected by a thin, central stalk (84).
These observations have lead to the “two-subassembly” model for building a T4SS where
the IMC is responsible for recognition and delivery of substrates across the IM while the OMCC
is responsible for translocation across the OM and recipient cell recognition. My data support
this model. The sequence stringency at the IMC with regards to TraF appears to be stricter than
in the OMCC indicating they contain different assembly requirements. Additionally, I was able
to pair the pKM101 IMC with a heterologous OMCC, suggesting that these subassemblies are
functionally different and are still able to interact in a productive manner. However, the OMCC
does not appear to be responsible for contacting recipient cells as demonstrated by the Tra/Ptl
T4SS. As B. pertussis secretes toxins into the extracellular milieu, the Ptl OMCC does not
require the ability to contact recipient cells. Therefore, it is likely that other pKM101-encoded
subunits other than the OMCC contribute to the formation of productive contacts with recipient
cells.
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Conclusions
Taken together, these results highlight the importance of the different domains within
TraF with regards to plasmid transfer, phage sensitivity, and recipient-cell contact. In line with
our initial prediction, the AP is not essential for forming the outer membrane pore, where as the
C-terminal tail is critical for plasmid transfer and phage sensitivity. Despite being part of the
OMCC, neither of these domains nor pilus is required for recipient-cell contact. Taking into
account the data presented in this chapter, I am proposing the following unifying model for the
role of the AP and C-terminal tail:
Model: In the absence of a recipient cell, the pKM101 T4SS exists as a “pilus machine”
producing conjugative pili, which extend and slough into the extracellular environment. Once a
target cell is contacted, the channel will switch from a pilus machine to a “substrate channel”.
This switch is accompanied by the docking of the TraJ T4CP to the channel in addition to
substrate processing and docking by the TraI relaxase. During pilus biogenesis, the AP and Cterminal tail are involved in producing an extracellular pilus by allowing the pilus to extend from
the IM to the extracellular mileu. This region of TraF is involved in physical interactions with
the growing pilus, which force it to the cell surface. As pilus structures are often sloughed off,
the AP and C-terminal tail are likely candidate proteins for detaching the pilus from the cell
surface.
Once the T4SS has switched to a substrate channel, TraJ will dock onto the IMC and will
induce an ATPase-mediated conformational change in TraF upon substrate docking. TraF will
then assist the pilus structure in pore formation. This conformational change is not critical for
mating junction formation as a ∆AP mutation was still able to mediate efficient recipient cell
contact as monitored by the T6SS killing assay. Substitution of the pKM101 OMCC for those of
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VirB/VirD4Ti, TrwR388, or PtlBp had little effect on recipient cell contact. This is surprising in
light of the evidence to suggest that B. pertussis does not require recipient cell contact for Ptldependent toxin secretion. These data suggest that OMCC is not directly contacting recipient
cells or the structural similarities between the TrapKM101, VirB/VirD4Ti and TrwR388 with the PtlBp
allow for recipient contact, despite not being required for the formation of a mating junction.
Another protein predicted to be a central component during target cell contact is the
surface protein KikA. Although not important for plasmid transfer on filters, our lab has recently
established the importance of KikA in processes such as broth matings, the T6SS killing assay,
and biofilm formation. C. Gonzalez-Rivera established that KikA produced in the absence of a
T4SS is not sufficient to make contact with recipient P. aeruginosa cells. Therefore, I predict
that the KikA is likely able to interact with all of these heterologous OMCCs in order to establish
stable mating junctions. Current work in the Christie lab is focused on determining the role of
KikA in building a functional T4SS.
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Chapter 6: Summary and Future Directions
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Summary
Gram-negative bacterial T4SSs contain separate IMCs and OMCCs responsible for
recognizing and delivering substrates into the extracellular milieu or into target prokaryotic or
eukaryotic cells. The goal of the work presented in this thesis was to develop the pKM101
molecular toolkit and define the role of the pKM101 OMCC in biologically relevant processes
including plasmid transfer, pilus biogenesis, and recipient cell contact.

When beginning my

studies on the OMCC, I hypothesized that the AP and C-terminal tail were surface-localized
domains that played a critical role in plasmid transfer through the formation of the OM pore,
pilus biogenesis through direct contact with pilin subunits TraM and TraC, and recipient cell
contact through target membrane perturbation.
In Chapter 3, I continued the analysis of the conserved GxxGxxG motif initiated by J.
Kerr and demonstrated that each of the glycine residues is critical for T-DNA transfer as various
mutations at each position attenuated tumor formation on plants. However, only G269 and G272
were critical for pilus biogenesis as G269R and G272R/W mutations abolished detectable levels
of VirB2 on the cell surface. Although my mutational analyses did not uncover a mechanistic
role of the GxxGxxG residues, my findings support the model that the distal end of the OMCC
plays an important role especially for assembly of the T pilus.
Follow-up studies on the VirB10 AP cap began with creating a correct AP deletion.
Previous deletions were based on the sequence alignment with the H. pylori ComB10 homolog
and led to a partial AP deletion. This partial deletion of the VirB10 AP cap abolished detectable
levels of pili as demonstrated by shearing assays. However, T-DNA transfer into plant cells was
only partially attenuated.

A full deletion based on the alignment with TraF phenocopied

previous results demonstrating only a partial loss in T-DNA transfer and a full abolishment of
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detectable VirB2 on the cell surface. Further mutagenesis involved insertion of large, 2x and 3x
FLAG tags in the AP helices, none of which abolished T-DNA transfer or pilus biogenesis
highlighting the importance for maintaining the AP domain, despite its ability to withstand large
mutations. Finally, I tested for the functional conservation of the AP caps between VirB10 and
TraF by substituting the AP of TraF on VirB10. This VirB10/TraFAP chimera phenocopied WT
VirB10, highlighting their functional similarity, despite a low level of sequence identity.
Taken together with previous data from the Christie lab, the VirB10 AP cap is required to build a
functional T-pilus, but dispensable for T-DNA transfer.
Chapter 4 focused on the development of our new pKM101 molecular toolkit now being
used by the Christie lab to address important functional questions related to the T4SS structure.
I, along with other members of our laboratory, created markerless deletions of each tra gene in
the traL-traG (virB1-virB11) operon. We also constructed plasmids containing each of the tra
genes cloned individually behind the tightly-regulated PBAD promoter. In this study, I tested each
of the cloned tra genes for the ability to complement its respective deletion for plasmid transfer
and phage sensitivity. Similar lines of investigation have been performed in the VirBTi, TrwR388,
and TrbRP4, and TrapKM101. Previous analyses of each of the conjugative plasmids have relied on
the usage of transposon mutagenesis in each of the T4SS-encoding genes. Although it is simpler
to utilize transposon mutagenesis on large, mutlicopy plasmids such as pKM101, these often
impose polar effects on downstream genes. Therefore, these complementation experiments were
critical for re-evaluation of the genetic requirements for plasmid transfer in addition to
determining if we would be utilizing pKM101 as a model T4SS.
My initial deletion and complementation analysis showed that all of the tra genes except
traL and traC are essential for substrate transfer. My results with the pKM101∆traC mutant
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were not surprising as Winans and Walker (153) previously showed that a traC transposon
insertion mutation did not abolish pKM101 transfer.

However, my results with the

pKM101∆traL mutant differ from previous cell wall hydrolase deletion mutants. VirB1 and P19
do not contribute to the assembly of a functional VirBTi and TraF T4SS respectively, but removal
of these proteins abolishes detectable levels of pili (67,157). Deletion of traL from pKM101 had
no discernable effect on its ability to transfer plasmid pJG142 or mediate IKe uptake.
Additionally, trans-expression of traL in a wild-type or a ∆traL background increased transfer by
~100-fold, raising the possibility that TraL is a rate-limiting factor for achieving wild-type levels
of transfer.
In chapter 5, I utilized this new pKM101 molecular toolkit to continue my investigations
into the role of the AP and C-terminal tail in plasmid transfer and pilus biogenesis. Truncations
and internal deletions within these 86 residues identified the C-terminal tail as a critical factor in
maintaining the functionality and stability of TraF. TraF mutants containing regions of the
VirB10 AP and C-terminal tail restored plasmid transfer to a ∆traF mutant. Further substitutions
along the length of the -barrel identified a complex interplay in the periplasm critical for pilus
production. In line with our initial hypothesis, the TraF AP is nonessential for plasmid transfer
suggesting that other Tra OM subunits are responsible for forming the substrate pore.
In addition to the TraF AP cap region, Chapter 5 also highlighted the structural flexibility
of the pKM101 T4SS through joining of the pKM101 IMC with the OMCCs of either
VirB/VirD4At, TrwR388, and PtlBp. I hypothesized that substitution of TraN and TraO for VirB7
and VirB9 respectively would increase the frequency of transfer through a channel containing
the TraF/VirB10BB-CT chimera.

This chimera formed a functional translocation channel as

monitored by pJG142 mobilization, though transfer frequencies were not elevated. Similar
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results were seen with Tra/Trw and Tra/Ptl chimeric systems. None of these T4SSs were able to
mediate sensitivity to PRD1 or IKe, suggesting that these cells lack conjugative pili. These data
implicate stringent requirements at the OM for building a conjugative pilus.
With the use of T6SS killing assay, I was able to provide new insight into the role of the
pKM101 OMC in mediating recipient cell contact. None of the TraF truncation mutants or
AP/C-terminal tail chimeras reduced susceptibility to T6SS-mediated killing. These unexpected
results demonstrate that these cells are able to mediate efficient contact with target cells, despite
containing a non-functional TraF protein. I also tested my chimeric Tra/VirB, Tra/Trw and
Tra/Ptl T4SSs in order to identify other OMCC components, which may play a role in recipient
cell contact. All of these mutants made efficient contact, despite their reduced conjugation
efficiency, highlighting the role of other pKM101-encoded surface components, such as KikA, in
mediating the formation of mating junctions.

Remaining questions and future experiments
The data presented in this thesis has shed light on the role of the VirB and pKM101
OMCC with an emphasis on the OM cap region. However, many of the mechanisms that
underlie these observations remain unclear. Below, I will address a subset of the questions that
have been raised as a result of these data.
Do the TraF AP and C-terminal tail directly interact with pilin subunits TraM and
TraC? In Chapters 3 and 5, I presented evidence to suggest that the AP and C-terminal tails of
TraF and VirB10 are critical for pilus biogenesis. In order to gain a mechanistic insight into the
role of the AP and C-terminal tail and the pilus biogenesis pathway, I along with other members
of the Christie lab tested for interactions between TraF and TraC. C. Gonzalez-Rivera gained
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evidence for a TraF-TraC interaction using BS3 crosslinking (Figure 6.1). However, these data
do not present evidence for direct interactions.
I, along with other members of the Christie lab, have invested a large amount of time and
effort into the development of unnatural amino acid-mediated photocrosslinking for detection of
direct interactions between adjacent protein subunits. This technology has been utilized in the
T2SS, T5SS, and the OM lipoprotein, RcsF, for detection of close interactions (164,167,168).
For utilizing this technology, amber stop codons (TAG) are placed at a position in the allele of
interest. This allele is co-transformed into the same strain as the plasmid pEVOL (151). The
pEVOL plasmid contains the genes encoding a tRNA capable of recognizing the amber stop
codon and an aminoacyl tRNA synthestase responsible for covalently linking the unnatural
amino acid with the tRNA (Figure 6.2). The unnatural amino acid, p-benzoyl-l-phenylalanine
(pBpa), is a phenylalanine derivative capable of crosslinking to any C-H bond within a 3Å
distance (Figure 6.3).
During my initial attempts, I was able to demonstrate efficient incorporation of pBpa into
8 positions within the AP and C-terminal tail and one position in the periplasmic lever arm
(Figures 6.4 and 6.5). Most pBpa-incorporated TraF proteins also displayed UV-dependent
photocrosslinking as demonstrated by high-molecular weight bands in Figure 6.5. As only TraF
was FLAG tagged at its C-terminal end, I combined cultures producing different pBpa
incorporated TraF proteins followed by membrane isolation, solubilization, and anti-FLAG
protein pulldowns (Figure 6.6). The combined sample was sent for protein identification using
mass spectrometry. Unfortunately, I was not able to detect interactions with any pKM101encoded Tra protein.
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Figure 6.1 BS3 crosslinking of TraF and TraC. Alleles encoding C-terminally Strep-tagged
TraC and N-terminally FLAG-tagged TraF were expressed in a mini-pKM101 pCGR108
backbone. Protein pulldowns were preformed using α-Strep tag beads and elutions were run on
SDS-PAGE gels followed by western blotting using α-Strep and α-FLAG antibodies to detect
TraC and TraF respectively. These results were genereated by Dr. Christian Gonzalez-Rivera.
The structure of TraF was generated using Pymol (http://pymol.org) based on the 3ZBI file
deposited into the NCBI protein database. The structure of TraC was generated using Pymol
(http://pymol.org) based on the 1R8I file deposited into the NCBI protein database.
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Figure 6.2 pBpa incorporation into TraF. (Left) Depiction of the pEVOL plasmid
and pBAD24::traF plasmid. pEVOL contains genes encoding the tRNA responsible
for recognizing amber stop codons and aaRS required for linking pBpa to the tRNA.
pBAD24::traF contains a traF allele with an amber stop codon (indicated by a red
circle). (Right) Once the tRNA is charged with the pBpa, it then recognizes the
amber stop codon during translation and incorporates pBpa into the growing
polypeptide chain.
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Figure 6.3 Mechanism of p-benzoyl-l-phenylalanine crosslinking.

(Left) The structure of p-

benzoyl-l-phenylalanine (pBpa). When exposed to UV light at 365nm, pBpa will crosslink to other
proteins at a 3A distance. (Right) Once crosslinked, pBpa will form non-breakable covalent links
which can be analyzed biochemically.
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Figure 6.4 Locations of TraF pBpa incorporation. Crystal structure of the C-terminal half of TraF
with pBpa positions highlighted. Positions include P185 (Lever arm), W304 and F316 (AP α2 helix),
N325 and Y334 (flexible loop), Q343 and Y352 (AP α3 helix), F377 (conserved RDLDF motif), and
N386 (C-terminal end). Each of these TraF mutants contains a C-terminal FLAG tag for protein
enrichment and western blot detection.

The structure of TraF was generated using Pymol

(http://pymol.org) based on the 3ZBI file deposited into the NCBI protein database.
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Figure 6.5 pBpa-mediated crosslinking of TraF. (Top) Steady state levels of TraF were observed
when cells were grown in the presence versus absence of pBpa. TraF was detected with western
blotting using α-FLAG antibodies. (Bottom) UV-mediated crosslinking of select TraF pBpa mutants.
After pBpa incorporation and crosslinking, membranes were isolated and solubilized followed by
purification with α-FLAG beads. Elutions from each sample were run on an SDS-PAGE gel followed
by western blotting with α-FLAG antibodies.

200

201

Figure 6.6 Sample preparation for mass spectrometry analysis. Three 1L cultures were
grown and cells were incubated in the presence of 0.2% arabinose and 1mM pBpa followed by
exposure to UV light.

Following crosslinking TraF was enriched and sent for protein

identification. The three samples analyzed were (1) All 8 AP/C-terminal pBpa, (2) C-terminally
FLAG-tagged TraF, and (3) untagged TraF. From left to right, each gel contains the following
lanes: (1) Whole cell lysate (2) Soluble fraction (3) Solubilized membrane fraction (4) Insoluble
membrane fraction (5) Elution from α-FLAG magnetic beads. After washes, affinity beads were
boiled for 5 minutes in Laemmli’s buffer followed by sepeartion of beads from the supernatant.
TraF was detected by western blotting with α-FLAG antibodies. Elution samples were run on a
separate SDS-PAGE gel, followed by extraction of the lane and mass spectrometry analysis.
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Although not as versatile as pBpa-mediated photocrosslinking, Cys crosslinking provides an
alternative route for detection of interactions between the TraF AP/C-terminal tail and pilin
subunits. This method would rely on the insertion of Cys residues throughout the TraF AP/Cterminal tail, TraM, and TraC. Additionally, a crosslinking distance of 2Å or less is required for
forming a detectable interaction.

C. Gonzalez-Rivera and Maxim Bogisch, a former

undergraduate student in the Christie lab, identified a close interaction between KikA and TraC
using Cys residues placed in both proteins. These Cys mutants, along with Cys-substituted
TraM, can be tested for interactions with Cys-substituted TraF.
What is the role of the conserved GxxGxxG sequence?

Although a subset of

mutations in the GxxGxxG sequence lead to reduced levels of T-DNA transfer and surfacedisplayed VirB2, there appeared to be a high degree of flexibility despite being conserved
amongst all known VirB10 family of proteins. I hypothesized that these glycines allow for the
structural flexibility required for substrates and pili to pass through. If this prediction is correct,
there is likely close contacts being made between these glycine residues and substrates or pili.
One approach to test this model involves the use of cysteine crosslinking. A G272C mutation
still allowed for T-DNA transfer and detectable pilus biogenesis. Once a double virB10/virB2
deletion is constructed on the Ti plasmid, the G272C virB10 allele along with various other virB2
Cys mutants can be co-expressed in the same cell and the mutant VirB10 and VirB2 proteins can
be tested for close interactions through the formation of a disulfide bond. In addition to VirB2,
Cys mutations can be constructed in substrates such as the VirD2 relaxase and VirE2. As these
proteins are unfolded prior to translocation, Cys mutations at any location throughout the protein
can be captured by Cys crosslinking provided that it creates close contact with the GxxGxxG
sequence.
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Due to the conservation of the GxxGxxG sequence in TraF, these experiments can also
be performed using pKM101 through insertion of a Cys residue at G294 and throughout the
length of TraI. Despite the recent utilization of pBpa-mediated photocrosslinking in the Christie
lab, Cys crosslinking remains the ideal methodology for two reasons: (i) the crosslinking
distance for Cys crosslinking is shorter (2Å) than the distance for pBpa crosslinking (3Å) and (ii)
insertion of bulky aromatic residues at this location is less desirable than Cys residues (Figure
3.3).
How can phage sensitivity be restored to pKM101 deletion mutants?

Previous

studies on the VirB/VirD4At and TrbRP4 T4SSs demonstrated a restoration of pilus biogenesis
when deletion mutants were complemented with their respective gene in trans. This is not the
case with our collection of pKM101tra deletion mutants as only ∆traM, ∆traF, and ∆traG
mutants developed phage sensitivity when the native gene was expressed in trans. These results
are peculiar as all of the complemented tra mutants had plasmid transfer restored, indicating the
presence of a functional T4SS. I predicted that overproduction of these proteins interferes with
the ability of IKe to interact with the TolQRA proteins in the IM, which are essential for
infection (160). If Tra proteins are interfering with IKe’s ability to interact with TolQRA, then
overproduction of these proteins should allow for a restoration of phage sensitivity if the cells
produce a conjugative pilus. These experiments would force us to reconsider our conclusions
with regards to restoration of pilus biogenesis.
What is the composition of the OM pore? Based on the crystal structure of the
pKM101 OMC, I predicted that the TraF AP helices are the primary factors involved in pore
formation. Contrary to this prediction, deletions of the AP helices in both VirB10 and TraF only
had a modest effect on DNA transfer. These experiments still have yet to identify the major
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components of the OM pore. Possibilities include the other OMCC proteins, TraN/VirB7 and
TraO/VirB9, or the pilin subunit, VirB2.
Gram-negative bacteria are normally resistant to the antibiotic vancomycin as it is not
able to penetrate the OM.

However, A. tumefaciens containing a viable T4SS has been

demonstrated to uptake vancomycin due to the presence of an OM pore which allows the
antibiotic to cross into the periplasm (125). Therefore, testing deletion mutants of traO, traN,
and traM in a strain with wild-type TraF and TraF∆AP mutant should provide insight as to which
proteins form the pore.
Are the IMC and OMC subassemblies functionally independent? The structure of
the R388 TrwM/VirB3-TrwE/VirB10 structure highlights the unique structural composition of
the IMC and OMCC assemblies. As mentioned earlier, work from E. Cascales demonstrated that
OMCC subunits VirB9 and VirB10 are not essential for T-DNA interactions with IMC subunits
(74).

These data raise the interesting possibility of the IMC and OMCC functioning

independently of one another. If these subassemblies are functionally separate, then secretion of
substrates through the T4SS likely resembles the pathway of substrates through the T2SS in that
they are first translocated to the periplasm followed by T4SS-dependent delivery past the OM
(7). My experiments with the chimeric Tra/VirB, Tra/Trw, and Tra/Ptl T4SS support this model
as each of these compositionally unique systems was able to efficiently contact target cells and
deliver the pJG142 plasmid.

I was not able to increase the frequency of transfer of the

TraFVirB10BB-CT and TraF/TrwEBB-CT chimeras (10-6 and 10-2 transconjugants per donor
respectively) through the assembly of the cognate OMCC as essential interactions with the IMC
subunits were likely not present.

206
Although not discussed in this thesis, I also attempted to address this model this through
the use of chimeric T4CPs at the IMC. T. Berry demonstrated that chimeric TraJ proteins
containing the native N-terminal TM domain and a heterologous soluble domain were able to
mediate transfer of heterologous substrates through the pKM101 T4SS (29).

It was

demonstrated around this time that the VirB T4SS from the phytopathogen Xanthomonas citri is
able to mediate the transfer of the toxic cell wall hydrolase Xac2609 to target E. coli cells (169).
When E. coli cells containing pKM101∆traJ along with plasmids encoding TraJ/VirD4Xac_SD,
and Xac2609 were incubated with E. coli target cells, the donor cells were killed in a manner that
was dependent on the presence of the T4SS, the chimeric T4CP, and the Xac2609 substrate
(Figures 6.7 and 6.8). Production of the Xac2610 anti-toxin protein rescued these cells (Figure
6.8). These results suggest that Xac2609 is delivered into the periplasm in a manner that is
dependent of the T4CP and T4SS, supporting a two-step translocation and two subassembly
model for T4SSs.
In order to test for the functional independence of the IMC, our lab has expressed interest
in creating an independent IMC through removal of VirB7, VirB9, and VirB10. To set up a
strict screening process, the N terminus of TraI can be fused to beta lactamase and cells
containing the IMC can be tested for growth in the presence of beta lactam antibiotics. A similar
screening process can be set up with a PhoA-TraI fusion to test for periplasmic transfer.
Which pKM101-encoded proteins are responsible for recipient cell contact? My
results with the T6SS killing assay highlight the dispensability of the TraF AP and C-terminal
tail for contacting target cells.

Therefore, there are other pKM101-encoded factors which

perturb the target cell membrane. Recently, the Christie lab has focused on the role of the KikA
surface protein. C. Gonzalez-Rivera demonstrated that addition of a plasmid encoding KikA

207

Figure 6.7 Schematic of TraJ/VirD4Xac periplasmic translocation assay.

Depiction of the

chimeric T4CP containing the N-terminal TM domain of TraJ and the soluble domain of VirD4 from
the bactericidal T4SS from Xanthomonas citri. Through recognition of the Xac2609 signal sequence
(XacSig), this substrate should be delivered into the periplasm. This assay can be used to further test
the genetic requirements for periplasmic translocation of T4SS substrates. The structure of TrwB is
Figure 2C from Gomis-Rüth FX et al. The bacterial conjugation protein TrwB resembles ring
helicases and F1-ATPase. Nature 2001 409:637–41. This image was re-published with permission
from Nature Publishing Group. License Number 4078401439237.
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Figure 6.8 Xac2609 kills donor cells in a manner dependent on the presence of a functional T4SS.
Histogram depicting the results of donor killing assays. Cell viability was decreased in the presence of
the TraJ/VirD4Xac T4CP and the pKM101 T4SS as well as when Xac2610 is co-prodcued. Key: ∆J:
Native pKM101 containing a markerless deletion of traJ. JD4: The TraJ/VirD4Xac chimeric T4CP.

While missing from the figure, expression of Xac2609 and JD4 individually did not lead to a decrease
in cell viability.
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restored the ability of cells containing mini-pKM101 plasmid pCGR108 to uptake PRD1,
transfer pJG142 in broth and be killed by the P. aeruginosa H1 T6SS. KikA also interacts with
the TraC pilus tip protein, suggesting that it could play a role in pilus extension. As KikA is
localized to the cell surface, it is likely that KikA makes initial contact with target cells prior to
translocation. In a manner similar to that observed in Myxococcus xanthus, one model suggests
that KikA promotes membrane fusion with the recipient cell prior to DNA transfer (170). In
order to test this hypothesis, donor and recipient cells would be labeled with different fluorescent
lipids and membrane exchange could be examined using fluorescence microscopy in the
presence and absence of donor-produced KikA.
Conclusion
During my time in the Christie lab, I significantly contributed to the development of the
pKM101 model T4SS which our lab is currently using and continued previous lines of
investigation into the role of the OMCC in both the VirB and pKM101 systems. My work has
demonstrated that the OMCC is a functionally distinct subassembly from the IMC and this
complex is primarily involved in pilus formation. This pilus, while not essential for recipient
cell contact or plasmid transfer on filters, appears to be important for broth matings, highlighting
its role in bringing recipient cells into close contact. Future directions in the Christie lab will
focus on the contacts made along the length of TraF and how these contacts differ in pilus T4SSs
versus substrate T4SSs.
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